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Glossary	  
	  	  (R)-­‐TRIP	   3,3-­‐Bis(2,4,6-­‐triisopropylphenyl)-­‐1,1´-­‐binaphthyl-­‐2,2´-­‐diylhydrogenphosphate	  2,6-­‐Cl2pyr	   2,6-­‐chloropyridine	  3,5-­‐Me2PhMgBr	   (3,5-­‐dimethylphenyl)magnesium	  bromide	  4-­‐FPhMgBr	   (4-­‐fluorophenyl)	  magnesium	  bromide	  9	  epi-­‐QDA	   9-­‐epi-­‐	  9-­‐amino-­‐	  9-­‐deoxyepi-­‐quinidine	  acac	   Acetylacetonato	  AgNO3	   Silver	  nitrate	  AgOTf	   Silver	  trifluromethansulfonate	  Au(I)	   silve	  (I)	  AuCl3	   silver	  (III)	  trichloride	  BF4	   Tetrafluoroborate	  Bi(OTf)3	   Bismuth	  (III)	  trifluoromethansulfonate	  BINAP	   2,2-­‐bis(diphenylphosphino)-­‐1,1´-­‐binaphthyl	  BINOL	   1,1-­‐Binaphthol	  BnBr	   Benzyl	  bromide	  Boc	   tert-­‐Butoxycarbonyl	  CAN	   Cerium	  ammonium	  nitrate	  Ca(OTf)2	   Calcium	  (II)	  trifluoromethansulfonate	  CDC	   Cross-­‐dehydrogenative-­‐coupling	  CDCl3	   Chloroform	  deuterated	  CH3CN	   Acetonitrile	  CH3NO2	   Nitromethane	  Cu(OAc)2	   Copper	  (II)	  acetate	  Cu(OTf)2	  	   Copper	  (II)	  trifluoromethansulfonate	  DABCO	   1,4-­‐diazabicyclo[2.2.2]octane	  DBU	   1,8-­‐Diazabicyclo[5.4.0]undec-­‐7-­‐ene	  DCE	   Dichloroethane	  DCM	   Dichloromethane	  DDQ	   2,3-­‐Dichloro-­‐5,6-­‐dicyanobenzoquinone	  DET	   Diethyl	  tartrate	  DiPAMP	   Ethane-­‐1,2-­‐diylbis[(2-­‐methoxyphenyl)phenylphosphane]	  DIPEA	   N,N-­‐diisopropylethylamine	  DMF	   Dimethylformamide	  
	  7	  
E	   Electrophile	  ECD	   Electronic	  Circular	  Dichroism	  Et3SiH	   Triethylsilane	  Et2O	   Diethyl	  ether	  Et3B	   Triethyl	  borane	  EtI	  	   Ethyl	  iodide	  EtOAc	   Ethyl	  acetate	  F.C	   Field	  Craft	  Fe(acac)3	   Tris(acetylacetonato)iron(III)	  H20	   water	  HBF4	   Fluoroboric	  acid	  HgO	   Mercury	  (II)	  oxide	  In	   Indium	  In(OTf)3	  	   Indium	  (III)	  trifluoromethansulfonate	  InBr3	   Indium	  (III)	  tribromide	  InCl3	   Indium	  (III)	  trichloride	  K2CO3	   Potassium	  Carbonate	  K3Fe(CN)6	   Potassium	  ferricyanide	  KPF6	   Potassium	  hexafluorophosphate	  K2S2O8	   Potassium	  persulfat	  L-­‐DOPA	  	   L-­‐	  3,4-­‐dihydroxyphenylalanine	  L.A	   Lewis	  acid	  LiBEt3	   Lithium	  triethylborohydride	  or	  Superhydride	  K	  	   rate	  constant	  LUMO	   Lowest	  unoccupied	  molecular	  orbital	  Me3SiBr	   Trimethylsilyl	  bromide	  MeI	   Methyl	  iodide	  MeOH	   Methanol	  N	   Nucleophile	  NaN(SiMe3)2	   Sodium	  bis	  (trimethylsilyl)amide	  NaH	   Sodium	  hydride	  NaH2PO4	   Sodium	  hydrogenphosphate	  Na2SO4	   Sodium	  sulfate	  NaBH4	   Sodium	  tetrafluoroborate	  NaClO2	   Sodium	  chlorite	  NaOH	   Sodium	  hydroxide	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NH3	   ammonia	  NH4Cl	   Ammonium	  chloride	  N-­‐Boc-­‐Phe-­‐OH	   tert-­‐Butoxycarbonyl-­‐Phenylalinine	  O3	   Ozone	  p-­‐Me2PhCHO	  	   Para-­‐dimethylbenzaldehyde	  p-­‐NO2PhCOOH	   Para-­‐nitrobenzoic	  acid	  p-­‐TSA	   p-­‐Toluenesulfonic	  acid	  Pd	   Palladium	  Pd(OPPh3)4	  	   	  Pd/C	   Palladium/carbon	  PdCl2(PPh3)2	   Bis-­‐(triphenylphosphine)palladium	  (II)	  chloride	  Ph	   Phenyl	  PhCOOH	  	   Benzoic	  acid	  Ph3PAuCl	   Chloro	  triphenylphosphine	  gold	  (I)	  Ru	  	   Ruthenium	  s	   Constant	  of	  electrophilicity	  SiO2	   Silice	  oxide	  SN1	   Nucelophilic	  substitution	  SOMO	   highest	  occupied	  molecular	  orbital	  TADDOL	   α,α,α´,α´-­‐Tetraaryl-­‐1,3-­‐dioxolan-­‐4,5-­‐dimethanol	  TBSCl	   tert-­‐Buthyldimethylsilyl	  chloride	  tBuOMe	  	   Methyl	  t-­‐butyl	  ether	  TEA	   triethylamine	  TEMPO	   2,2,6,6-­‐tetramethylpiperidin-­‐1-­‐yloxyl	  TD-­‐DFT	   Time-­‐dependent	  Density	  Functional	  Theory	  TFA	   Trifluoroacetic	  acid	  THF	   tetrahydrofuran	  TiCl4	   Titanium	  tetrachloride	  TMSCHN2	   trimethylsilyldiazomethane	  Zn(OTf)2	   Zinc	  (II)	  	  trifluoromethansulfonate	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  The	  proposal	  in	  my	  thesis	  has	  been	  the	  study	  of	  Stereoselective	  α-­‐alkylation	  through	  SN1	  type	  reaction.	  SN1	  type	  reaction	  involves	  a	  stabilized	  and	  reactive	  carbocation	  intermediate	  By	  taking	  advantages	  of	  stability	  of	  particular	  carbocations,	  the	  use	  of	  carbocations	  in	  selective	  reactions	  has	  been	  important.	  In	  this	  work	  has	  been	  necessary	  to	  know	  the	  stability	  and	  reactivity	  of	  carbocations.	  And	  the	  work	  of	  Mayr	   group	   has	   helped	   to	   rationalize	   the	   behaviour	   and	   reactivity	   between	   the	   carbocations	   and	  nucleophiles	  by	  the	  use	  of	  Mayr’s	  scale	  of	  reactivity.	  	  The	  use	  of	  alcohols	  to	  performed	  the	  stable	  and	  reactive	  carbocations	  have	  been	  the	  key	  in	  my	  thesis.	  The	   direct	   nucleophilic	   substitution	   of	   alcohols	   has	   been	   a	   crucial	   scope	   in	   the	   field	   of	   organic	  synthesis,	   because	   offer	   a	   wide	   range	   of	   intermediates	   for	   the	   synthesis	   of	   natural	   products	   and	  pharmaceutics	   synthesis.	   In	   particular	   the	   catalytic	   nucleophilic	   direct	   substitution	   of	   alcohols	  represents	  a	  novel	  methodology	  for	  the	  preparation	  of	  a	  variety	  of	  derivatives,	  and	  water	  only	  as	  the	  sub-­‐product	  in	  the	  reaction.	  	  The	   stereochemical	   control	   of	   the	   transformation	   C-­‐H	   bond	   into	   stereogenic	   C-­‐C	   bond	   adjacent	   to	  carbonyl	  functionalized	  has	  been	  studied	  for	  asymmetric	  catalysis.	  And	  the	  field	  of	  organocatalysis	  has	  introduced	  the	  use	  of	  small	  organic	  molecule	  as	  catalyst	  for	  stereoselective	  transformations.	  	  Merging	   these	   two	   concepts	   Organocatalysis	   and	   Mayr’s	   scale,	   my	   thesis	   has	   developed	   a	   new	  approach	  for	  the	  α-­‐alkylation	  of	  aldehydes	  and	  ketones	  through	  SN1	  type	  reaction.	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Chapter	  1.	  Introduction	  	  	  
















(W.S.Knowles, 1968 ) (R.Noyori, 1974) (K.B.Sharpless, 1980) 	  	  
Figure	  1.	  The	  first	  catalysts	  introduce	  in	  asymmetric	  catalysis	  
	  Over	  the	  past	   four	  decades	  the	  capacity	  to	   induce	  asymmetric	   transformations	  with	  enantioselective	  catalysis	   has	   remained	   a	   focal	   point	   for	   extensive	   research	   efforts	   in	   both	   industrial	   and	   academic	  settings.	  The	  asymmetric	  catalytic	  reactions	  have	  been	  invented	  in	  accord	  with	  the	  increasing	  need	  for	  enantiopure	  medicinal	  agents	  and	  quickly	  advancement	  of	  the	  field	  of	  asymmetric	  synthesis.	  There	  are	  three	   pillars	   in	   the	   asymmetric	   catalysis,	   bio-­‐and	   metal	   catalyst	   and	   the	   most	   new	   was	   the	  organocatalysis,	  which	  was	  not	  until	  the	  late	  1990s	  born	  as	  organocatalysis.4	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Scheme	  1.	  The	  Knoevenagel	  reaction	  (1896)	  	  This	  background	  set	  the	  stage	  for	  the	  discover	  of	  the	  first	  asymmetric	  amine	  catalyzed	  aldolization	  by	  two	   independent	   reports	   one	   by	   Hajos-­‐Parrish	   and	   other	   for	   Weichert-­‐Sauer-­‐Eder	   of	   an	  enantioselective	  intramolecular	  aldol	  reaction,	  that	  was	  catalyzed	  by	  proline.9a,b.	  	  
	  	  	  
	  
	  
Scheme	  2.	  Hajos-­‐Parrish	  Reaction	  catalyzed	  by	  (S)-­‐proline.	  (1974)	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In	   the	   late	  1990s,	   Yian	   Shi10a	   Schott	  Denmark10b,	   and	  Dan	  Yang10c	   demostrated	   the	   enantiomerically	  pure	   ketones	   could	   have	   been	   used	   to	   catalyze	   the	   enantioselective	   epoxidation	   of	   simple	   alkenes.	  Jacobsen	   and	   Corey	   demonstrated	   the	   first	   example	   hydrogen-­‐bonding-­‐catalysis	   is	   asymmetric	  Strecker	   reaction.11a,b	   Scott	   Miller12	   introduced	   the	   concept	   of	   minimal	   peptides	   for	   the	  enantioselectivity	   kinetic	   resolution	   alcohols.	   These	   works	   demostrated	   the	   use	   of	   small	  organocatalyst	  could	  be	  used	  to	  solve	  problems	  in	  organic	  synthesis.	  	  	  	  
 	  




























Scheme	  4	  	  The	  exponential	  growth	  of	  studies	  and	  publications	  in	  the	  field	  of	  the	  organocatalysis	  can	  be	  explained	  by	  three	  factors,	  1)	  organic	  molecules	  used	  as	  catalysts	  in	  organocatalytic	  reactions	  are	  insensitive	  to	  oxygen	   and	   moisture	   in	   the	   atmosphere.	   2)	   a	   large	   range	   of	   compounds	   source	   of	   chiral	  organocatalysts	  	  are	  naturally	  available	  from	  biologic	  sources	  as	  a	  single	  enantiomers,	  3)	  small	  organic	  molecules	  used	  as	  organocatalysts	   are	   typically	  non-­‐toxic	   and	  environmentally	   friendly.	  The	   studies	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and	   the	   new	   reactions	   discovered	   in	   the	   field	   of	   organocatalysis	   has	   helped	   to	   conceptualize	   the	  organocatalysis	   as	   a	   new	   field	   of	   research	   that	   demonstrated	   the	   use	   of	   small	   organic	  molecule	   to	  catalyze	   stereoselective	   organic	   transformations,	   and	   this	   phrase	   has	   been	   used	   as	   a	   definition	   of	  organocatalysis	  in	  the	  past	  decades	  until	  now.	  	  	  
1.2.1 	  The	  advent	  of	  generic	  mode	  of	  catalyst	  activation15	  
Enamine	  catalysis	  	  Recent	  years	  have	  been	  a	  growth	  in	  the	  field	  of	  asymmetric	  enamine	  catalysis.16	  The	  base	  of	  enamine	  catalysis	  is	  the	  reversible	  generation	  of	  enamine	  from	  a	  catalytic	  amount	  of	  an	  amine	  in	  the	  presence	  of	  stoichiometric	  amount	  of	  a	  carbonyl	  compound.	  The	  key	  factors	  that	  give	  rise	  to	  enamine	  formation	  is	  the	  LUMO	  lowering	  effect	  and	  resulting	  dramatic	  increase	  in	  C-­‐H	  acidity	  in	  α	  upon	  initial	  conversion	  of	  carbonyl	  compound	  into	  iminium	  ion.	  There	  are	  two	  modes	  of	  enamine	  catalysis,	  depending	  on	  the	  class	   of	   electrophiles.	   Aldehydes,	   or	   iminium	   (Mannich	   acceptors)	   can	   react	   as	   electrophiles	   with	  enamines.	  While	  reaction	  with	  π-­‐acceptors	  electrophiles	  with	  enamines	   is	  quite	  straightforward,	   the	  reaction	  of	  other	  electrophiles,	  such	  as	  alkyl	  halides,	  can	  be	  more	  problematic.17	  	  	  
	  
Nucleophilic	  addition	   	   	   	   	  	  	  Substitution	  reactions	  
	  
Scheme	  5.	  Modes	  of	  activation	  in	  enamine	  catalysis	  	  In	  the	  early	  1970s,	  was	  discovered	  the	  first	  example	  of	  aminocatalysis	  asymmetric	  aldol	   reaction	   by	   Hajos-­‐Parrish-­‐Eder-­‐Sauer-­‐Weichert,	   the	   6-­‐enolendo	   aldolization	  reaction.9a,b	   The	   first	   amine-­‐catalyzed	   asymmetric	   direct	   intramolecular	   aldol	  reaction	  was	  developed	  by	  Barbas-­‐Lernen	  and	  List	  in	  2000.	  13,18	  Extensive	   research	   about	   the	   enamine	   catalysis	   mechanism	   has	   been	   studied	   for	  several	  research	  groups,	  and	  the	  mechanistic	  proposal	  seemed	  quite	  similar	  to	  the	  class	  I	  aldolse	  mechanism.	  Mechanistically	  enamine	  catalysis	  could	  be	  describe	  as	  a	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bifunctional	   catalyst	   because	   the	   amine	   catalyst	   (proline)	   interacts	  with	   the	   carbonyl	   compound	   to	  form	   enamine	   species	   and	   simultaneously	   is	   engaged	   with	   electrophile	   partner	   through	   hydrogen	  bond	  interaction	  mediated	  by	  the	  carboxylic	  acid	  moiety.	  Theoretical	  studies	  by	  Houk	  and	  co-­‐workers	  supported	  one	  proline	  mechanism	  in	  which	  the	  sidechain	  enamine	  reacted	  with	  the	  acceptor	  carbony	  group	  under	  activation	  via	  hydrogen	  bonding	  to	  proline’s	  carboxylic	  group.17	  	  
	  
Scheme	  6.	  The	  proposed	  Mechanism	  and	  transition	  state	  of	  proline-­‐catalyzed	  aldolitzations	  	  
Iminium	  catalyst	  In	  1999,	  MacMillan	  group	  introduced	  a	  new	  mode	  of	  activation	  for	  asymmetric	  synthesis	  base	  on	  the	  capacity	  of	  chiral	  amine	  to	  function	  as	  enantioselective	  LUMO-­‐lowering	  catalyst	  that	  was	  employed	  as	  a	   Lewis	   acid.	   This	   strategy	   was	   founded	   on	   the	   mechanistic	   postulate	   that	   (i)	   the	   LUMO-­‐lowering	  activation	  and	   (ii)	   the	  kinetic	   liability	   toward	   ligand	  substitution	   that	  enables	   the	   turnover	  of	  Lewis	  acid	   catalyst.	  MacMillan	   group19	   investigated	   the	   first	   highly	   enantioselective	   amine	   catalyzed	  Diels	  Alder	  reaction	  between	  α,β-­‐insaturate	  aldehydes	  and	  various	  dienes.	  	  	  
O + Lewis acid (LA) O LA
δ
δ




Scheme	  7.	  Concept	  iminium	  activation	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80% yield, 96% ee 	  	  
Scheme	  8.	  Asymmetric	  Organocatalytic	  Epoxidation	  of	  α,β-­‐insaturated	  aldehydes	  
	  The	  β-­‐functionalitzation	  of	  the	  α,β-­‐unsaturated	  carbonyl	  compounds	  has	  become	  a	  new	  methodology	  for	  the	  stereoselective	  synthesis	  based	  on	  cycloadditon	  or	  1,4-­‐addition.	  The	  condensation	  of	  enamine	  between	  the	  secondary	  amine	  and	  α,β-­‐unsaturated	  aldehyde	  forms	  an	  iminium	  ion,	  which	  reacts	  with	  a	  nucleophile	  to	  the	  β-­‐carbon.	  Jørgensen	  and	  co-­‐workers	  studied	  the	  mechanism	  of	  the	  organocatalytic	  














up to 93% ee 	  	  



















99% ee; 3:1 d.r 
    60% yield 	  
Scheme	  10.	  Tandem	  iminium-­‐	  enamine	  catalysis	  	  In	  summary,	  the	  asymmetric	  amine	  catalysis	  has	  become	  a	  new	  source	  in	  the	  design	  of	  new	  catalyst,	  new	  mode	  of	  activation	  and	  new	  reactions	  are	  being	  discovered	  and	  applied	  in	  asymmetric	  synthesis.	  	  	  











Scheme	  11.	  Mode	  of	  activation	  of	  hydrogen	  bonding	  catalyst	  
	  






















































Figure	  2.	  Representative	  catalysts	  for	  the	  H-­‐bond	  donadors	  in	  asymmetric	  catalysis	  	  In	   2003,	   Takemoto	   and	   co-­‐workers	   reported	   the	   application	   of	   thiourea	   derivative	   to	   the	  enantioselective	   addition	   of	   malonate	   to	   β-­‐nitrostyrene.	   In	   this	   reaction,	   theoretical	   investigations	  supported	  a	  chiral	  π-­‐activation	  mechanism	  catalyst.25	  	  





	  up	  to	  96%	  yield	  up	  to	  93%	  ee	  	  

















β-Naph 	  	  
Scheme	  13.	  Direct	  Mannich	  reaction	  catalyzed	  by	  chiral	  phosphoric	  acids	  	  
SOMO	  catalysis	  	  In	   2006,	   MacMillan	   and	   co-­‐workers	   demonstrated	   the	   concept	   of	   singly	   occupier	  molecular	   orbital	  SOMO-­‐activation	   with	   a	   highly	   selective	   α-­‐alkylation	   of	   aldehydes.	   The	   idea	   was	   the	   capacity	   of	  enamine	  and	  iminium	  ions	  to	  rapidly	  interconvert	  via	  a	  redox	  process	  whether	  it	  might	  be	  possible	  to	  interrupt	   this	   equilibrium	   chemically	   and	   thereby	   to	   access	   a	   mode	   of	   catalyst	   that	   intermediate	  between	  enamine	  and	  iminium	  formation.	  MacMillan	  group	  hypothesized	  that	  one	  electron	  oxidation	  of	  a	  transient	  enamine	  species	  should	  generate	  a	  three-­‐π	  electron	  radical	  cation	  with	  a	  singly	  occupied	  molecular	  orbital	  	  (SOMO)	  using	  stoichiometric	  amount	  of	  oxidant.28	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1.3 Asymmetric	  C-­‐C	  bond	  forming	  bond	  	  
α-­‐alkylation	  in	  organocatalysis	  












50% KOH aq 
 toluene





Scheme	  15.	  C2-­‐symmetric	  chiral	  phase-­‐transfer	  catalyst	  in	  catalytic	  enantioselective	  alkylation	  
	  







 allyl bromide (4 eq)
benzene
(Salen)CrCl (2.5 %mol)
84%yield, 94%ee 	  
	  
Scheme	  16.	  Enantioselective	  alkylation	  catalyzed	  with	  Cr(Salen)Cl	  	  The	   problem	   in	   α-­‐alkylation	   of	   aldehydes	   is	   controlled	   to	   perform	   aldehyde	   enolates,	   because	   of	  several	   side	   reactions	   such	   as	   self-­‐condensation,	   Canizzaro	   or	   Tischchenko	   reaction	   and	   N-­‐or	   O-­‐alkylation	  are	  competing	  process	  in	  the	  reaction	  of	  metal	  enolate	  and	  enamine	  catalysis.33	  	  	  There	  are	  two	  problems	  in	  the	  α-­‐alkylation	  reaction:	  	  a) susceptibility	   of	   the	   nucleophilic	   Lewis-­‐	   or	   Brønsted	   base	   catalyst	   toward	   an	   unproductive	  alkylation	  reaction	  with	  electrophile.	  	  b) Racemization	  of	  product	  for	  the	  formation	  of	  acid	  in	  the	  reaction.	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92% yield, 95% ee 	  













72% yield 	  
Scheme	  18.	  Direct	  α-­‐allylic	  alkylation	  	  	  Merging	  both	  catalytic	  cycles	  would	  enable	  C-­‐C	  bond	  formation	  by	  allowing	  enamine	  intermediate	  and	  electrophilic	   palladium	   π-­‐allyl	   complexes.	   Reductive	   elimination	   and	   subsequent	   hydrolysis	   of	   the	  iminium	  intermediate	  would	  regenerate	  de	  Pd(0)	  and	  amine	  catalyst.35.	  MacMillan	  group	  in	  2007	  introduced	  a	  new	  mode	  of	  organocatalytic	  activation,	  termed	  singly	  occupied	  molecular	  orbital	  (SOMO)	  catalysis28,	  which	  has	  been	  described	  in	  the	  paragraph	  1.2.	  	  
Enantioselective	   SOMO	   catalysis	   is	   a	   unique	   and	   versatile	   mode	   of	   organocatalytic	   activation	   that	  
features	   the	   transient	   generation	   of	   a	   3	   π-­‐radical	   cation	   specie,	   which	   can	   participate	   in	   asymmetric	  
bond	   construction	   with	   a	   variety	   of	   π-­‐rich	   nucleophiles	   or	   electron	   neutral	   SOMO-­‐philes.28	   MacMillan	  group	  have	   successfully	   utilitzed	   this	   activation	  mode	   to	   describe	   different	   reactions	   in	   asymmetric	  catalysis	   such	   as	   α-­‐allylic	   alkylations28a,	   α-­‐enolation28b,	   α-­‐vinylation36,	   α-­‐chlorination,	   α-­‐allylation	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up to 82% yield







up to 89% yield



























up to 86% yield 

























up to 93% yield




Scheme	  19.	  Reactions	  of	  SOMO	  catalysis	  and	  photoredox	  by	  MacMillan	  group	  	  	  This	  new	  asymmentric	  alkylation	  methodology	  proposed	  a	  dual-­‐catalysis	  from	  alkylation	  of	  aldehydes.	  The	   proposed	   mechanism	   was	   the	   generation	   of	   π-­‐electron-­‐rich	   enamine	   from	   amine	   catalyst	   and	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up to 92% yield
up to d.r 12:1










up to 95% yield























up to 70% yield 
up to 94 % ee
Ref.41
Ref.42
Ref.43 	  	  
Scheme	  20.	  α-­‐alkylation	  of	  aldehydes	  via	  SN1	  type	  reaction	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 93% yield 
orto:para = 11: 89 	  
Scheme	  22.	  Friedel-­‐Crafts	  reaction	  	  Generally,	  the	  carbenium	  ions	  are	  believed	  to	  be	  unstable	  species	  and	  highly	  reactive;	  however	  there	  is	  a	  quantitative	  approach	  to	  classify	  the	  stability	  and	  reactivity	  of	  carbocations.	  A	  quantitative	  definition	  of	   activated	   alcohols	   can	   be	   derived	   from	   stability	   of	   carbocation	   generated	   by	   alcohols.	   If	   the	  carbocation	  is	  very	  electrophile	  and	  it	  reacts	  to	  diffusion	  limit,	  only	  a	  limited	  range	  of	  nucleophiles	  will	  be	  able	   to	   intercept	   the	  presence	  of	  carbocation.	  Mayr’s	  group	  has	   investigated	  all	   these	  concepts	  of	  electrophilicity	  and	  nucleophilicity.	  Several	  can	  be	  rationally	  designed	  through	  the	  use	  of	  Mayr´s	  scale	  of	  reactivity	  47	  In	  a	  recent	  review	  44	  were	  described	  many	  methodologies	  for	  the	  direct	  nucleophilic	  SN1	  type	  reaction	  using	  catalytic	  amount	  of	  Brønsted	  acid	  or	  Lewis	  acid.	  	  
Direct	  substitution	  of	  alcohols	  with	  catalytic	  amount	  of	  Brønsted	  acids	  Only	   a	   few	   groups	   have	   presented	   the	   direct	   substitution	   of	   alcohols	   through	   Brønsted	   acids.	   Sanz	  described	  the	  nucleophilic	  direct	  substitution	  of	  secondary	  o	  propargylic	  alcohols	  by	  catalytic	  amount	  of	  Brønsted	  acids,	  in	  particular	  p-­‐Toluensulfonic	  acid	  (pTSA,	  pKa	  -­‐5).	  48	  However,	  the	  major	  contribution	  in	  SN1-­‐type	  reactions	  has	  been	  described	  by	  the	  activation	  of	  alcohols	  through	  catalytic	  amount	  of	  Lewis	  acids.	  	  
Direct	  substitution	  of	  alcohols	  with	  catalytic	  amount	  of	  Lewis	  acids	  Bismuth(III)	  catalyzed	  benzylation	  of	  arenes	  with	  alcohols	  was	  described	  by	  Rueping	  group.49	  The	  use	  of	  BiCl3	   in	   catalytic	   amount	  was	  described	  by	  Zhan	  and	   co	  workers50	   in	   the	   substitution	   reaction	  of	  propargylic	  alcohols	  with	  carbon	  or	  heteroatom	  centred	  nucleophiles.	  Indium	  salts	  were	  reported	  by	  Shibasaki	  and	  Matsunaga	  in	  2007.	  They	  described	  the	  reaction	  of	  propargylic	  alcohols	  with	  amines	  in	  the	   presence	   of	   Bi(OTf)3	   /	   KPF6	  .51	   Borane	   as	   Lewis	   acid,	   was	   reported	   by	   Li	   and	   co-­‐workers52	  in	   a	  catalytic	   F.C	   intermolecular	   cyclization	   of	   iodinated	   allylic	   alcohols.	   Baba	   and	   co-­‐workers53	  reported	  the	  use	  InCl3	  in	  the	  direct	  substitution	  of	  allylic	  alcohols	  with	  malonate.	  Other	   SN1	   type	   reaction	   using	   In(III)	   as	   	   a	   catalysts	  was	   the	   catalytic	   amination	   of	   a	   Baylis-­‐Hillamn	  adduct	  promoted	  by	  In(OTf)3.54	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Scheme	  23.	  Carbocations	  generated	  by	  Lewis	  acids.	  	  In	   conclusion,	   the	   carbocations	   generated	  by	   the	   treatment	  of	   alcohols	  with	  Lewis	   acids	  o	  Brønsted	  acids	   can	   be	   considered	   new	   synthetic	   targets	   for	   nucleophiles.	   By	   taking	   the	   challenge	   that	   the	  employment	  of	  these	  species	  are	  imposing,	  new	  processes	  can	  be	  certainly	  realized.	  To	  include	  in	  the	  challenge,	   stereoselective	   transformations	   that	   are	   using	   carbenium	   ion	   are	   certainly	   the	   most	  difficult,	   as	   in	  many	   SN1-­‐type	   reaction	   the	   carbenium	   ion	   are	   attached	   by	   nucleophiles	   at	   the	   same	  manner	  to	  the	  top	  or	  to	  the	  bottom	  face.	  	  	  As	  we	  will	  present	   in	   the	  next	  chapters,	  we	  have	  taken	  this	  challenge	  and	  thanks	  to	   the	  opportunity	  offered	  by	  organometallic	  and	  organocatalysis	  methodologies,	  we	  have	  discovered	  and	  studied	  novel	  stereoselective	  SN1-­‐type	  reactions.	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Chapter	   2.	   Merging	   Organocatalysis	   with	   an	   Indium	   (III)-­‐	   Mediated	  Process:	   	   A	   Stereoselective	   α-­‐alkylation	   of	   Aldehydes	   with	   Allylic,	  Benzhylic	  and	  benzhydrylic	  alcohols.	  	  	  
I. Introduction	  general	  	  
1.	  Combining	  Organocatalysis	  and	  metal	  catalysis	  	  The	   asymmetric	   catalysis	   involves	   now	   both	   fields	   of	   the	   organometallic	   catalysis	   and	  organocatalysis.1	  The	  organic	  reactions	  promoted	  by	  transition	  metals	  catalysts	  have	  been	  established	  as	   a	   powerful	   tool	   in	   organic	   synthesis	   for	   the	   efficiency	   and	   versatility.2	   On	   the	   other	   hand,	  organocatalysis	  has	  grown	  up	  to	  become	  one	  of	  the	  most	  useful	  methodology	  in	  organic	  chemistry,	  the	  use	   of	   small	   organic	   molecule	   as	   catalyst	   in	   organic	   transformations.3	   One	   advantages	   in	  organocatalysis	   is	   which	   can	   promote	   various	   organic	   transformations	   through	   unique	   activation	  mode,	   as	   compared	   to	   transition	   metal.	   Therefore	   the	   combination	   between	   organocatalysis	   and	  organometallic	   catalysis	   can	   promote	   a	   new	   approach	   in	   the	   synthesis	   of	   intermediates	   for	   natural	  products	  or	  pharmacologic	  products.	  Thus	  in	  the	  recent	  years,	  the	  concept	  to	  combine	  transition	  metal	  catalyst	  and	  organocatalysis	  has	  appeared	  as	  a	  new	  strategy	  for	  developing	  new	  reactions	  and	  to	  solve	  problems	  not	  possible	  resolved	  by	  simply	  employing	  one	  of	  the	  two	  catalysts.	  4	  The	  α-­‐alkylation	   of	   carbonyl	   compounds	   is	   a	   fundamental	   carbon-­‐carbon	   bond	   forming	   reaction	   in	  organic	  synthesis.5	  The	  direct	  α-­‐alkylation	  of	  non	  activated	  aldehydes	  and	  ketones	  is	  challenging	  due	  to	  competing	  side	  reactions,	  such	  as	  aldol	  -­‐condensation,	  Cannizzaro	  or	  Tischenko	  reactions,	  and	  N-­‐or	  O-­‐alkylations.6	  Therefore,	  there	  are	  a	  few	  methods	  for	  the	  catalytic	  intermolecular	  α-­‐alkylation	  of	  non	  activated	   aldehydes	   and	   ketones	   using	   metal	   catalyzed	   reactions.	   In	   general	   these	   α-­‐alkylation	   of	  carbonyl	  compounds	  are	  performed	  using	  stoichiometric	  amount	  of	  metals	  or	  additives.	  Tamaru	  and	  co-­‐workers7	  reported	  an α-­‐allylic	  alkylation	  of	  aldehydes	  possible	   in	  presence	  of	   catalytic	  amount	  of	  palladium	  and	  a	  slight	  excess	  of	  Et3B.	  
In	   the	   field	   of	   organocatalysis,	  many	   groups	   have	   studied	   the	  α-­‐alkylation	   of	   aldehydes	   and	   ketone	  using	   chiral	   primary	   or	   secondary	   amines	   as	   catalyst	   through	   different	   mode	   of	   activation.	   One	  pioneering	  group	  was	  List	  and	  co-­‐workers8	  that	  reported	  the	  amino	  acid	  catalyzed	  intramolecular	  α-­‐alkylation	  reaction.	  Cordova’s	  group	  was	  the	  first	  to	  report	  the	  concept	  of	  combined	  transition	  metal	  and	  aminocatalysis	  with	  the	  direct	  catalytic	  intermolecular	  α-­‐allylic	  alkylation	  of	  aldehydes	  and	  cyclic	  ketones	   in	  an	  achiral	   fashion.9	  This	  novel	   catalytic	   reaction	   the	  α-­‐allylic	   alkylation	  of	   aldehydes	  and	  cyclic	  ketones	  with	  allyl	  acetates	  could	  be	  accomplished	  by	  combining	  enamine-­‐	  and	  transition-­‐metal	  catalysis	  in	  one	  pot.	  Thus,	  the	  merging	  of	  the	  two	  catalytic	  cycles	  would	  enable	  to	  activate	  electrophile	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Figure	  1.	  π-­‐acid	  activation	  of	  C-­‐C	  triple	  bond	  toward	  nucleophilic	  attack	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2.	  Stable	  carbocations	  Mayr’s	  Scale	  
On	  the	  other	  hand,	  the	  generation	  of	  stable	  carbocations	  has	  been	  employed	  as	  alternative	  alkylation	  agent	   to	   perform	   enantioselective	   intermolecular	  α-­‐alkylation	   of	   aldehydes.	   The	   pioneering	   groups	  have	   been	   Melchiorre	   and	   co-­‐workers16	  and	   Cozzi	   group17	   that	   reported	   independently	   two	   works	  using	   stable	   carbocations	   with	   enamine	   catalysis.	   Recently	   Jacobsen	   group18	   reported	   the	  enantioselective	  α-­‐alkylation	  using	  hydrogen	  bond	  catalyst	  through	  anion	  binding.	  Mayr	  has	  developed	  a	  kinetic	  method	  for	  predicting	  the	  rates	  of	  reactivity	  between	  electrophiles	  and	  nucleophiles,	   which	   established	   that	   some	   carbocations	   and	   related	   electrophiles	   could	   be	  characterized	  by	  one	  electrophilic	  parameter	  (E),	   that	   is	  useful	   for	  predicting	  rates	  of	  reactions	  with	  nucleophiles.19	  The	  same	  from	  nucleophiles	  was	  assigned	  two	  parameters	  (N)	  and	  s.	  Eq[1]20	  	  	  	   	  
	  
	  
log	  k	  =	  s	  (E+N)	  
	  	  This	  rate	  equation	  established	  a	  table	  of	  reactivity	  between	  electrophiles	  and	  nucleophiles,	  showing	  in	  the	   Figure	   2.	   A	   easy	   interpretation	   of	   the	   table	   should	   be:	   a	   nucleophile	   that	   react	  with	   the	   parent	  benzhydrylium	  ion	  on	  the	  top	  of	  Figure	  2	  within	  1	  min	  would	  require	  20	  billion	  years	  to	  react	  with	  the	  carbenium	   ion	   at	   the	   bottom.	   On	   the	   other	   hand,	   a	   comparable	   reactivity	   range	   is	   established	   by	  nucleophiles	   listed,	   which	   are	   arranged	   according	   the	   increasing	   nucleophilicity	   from	   the	   top	   to	  bottom.	  Thus	  the	  nucleophiles	  in	  the	  top	  do	  not	  react	  with	  the	  electrophiles	  at	  the	  bottom,	  while	  the	  nucleophiles	   at	   the	   bottom	   react	   with	   the	   electrophiles	   at	   the	   top	   with	   diffusion	   control.	   And	   the	  nucleophiles	  and	  electrophiles	  with	  similar	  range	  in	  Figure	  2	  can	  be	  combined	  with	  activation	  control.	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Figure	  2.	  Scale	  of	  reactivity	  between	  Nucelophiles	  and	  electrophiles	  	  	  	  The	   key	   of	   combination	   of	   nucleophiles	   and	   electrophiles	   that	   will	   take	   place	   in	   synthetic	  transformations,	   is	   related	   to	   reaction	   rate.	   For	   qualitative	   analysis	   from	  Mayr’s	   group,	   can	   expect	  electrophiles-­‐nucleophiles	  combination	  take	  place	  if	  N+E	  >	  -­‐5.	  19c	  Since	  diffusion	  limit	  is	  reached	  at	  K	  =	  105-­‐1010	  M-­‐1s-­‐1	  when	  N+E	  >	  10.	  To	  explain	  this	  equation	  is	  showing	  the	  Figure	  3,	  where	  in	  the	  green	  part	   are	   found	   the	   most	   synthetic	   used	   reactions,	   in	   the	   red	   part,	   the	   nucleophile-­‐electrophile	  combination	  take	  place	  through	  diffusion,	  not	  control	  in	  the	  reactivity.	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Figure	  3.	  Table	  of	  reactivity	  between	  nucleophiles	  and	  electrophiles	  	  From	   the	   reactivity	   parameters	   N,	   E	   and	   s	   that	   have	   been	   derived	   from	   reactivates	   toward	   of	   the	  reference	  compounds	  can	  be	  expected	  to	  provide	  new	  predictions	  for	  nucleophiles	  and	  electrophiles,	  without	  the	  need	  for	  reparametrization	  of	  the	  parameters.	  	  	  
3.	  Stereoselective	  allylic	  alkylation	  
	  
Allylic	  alkylation	  through	  metal	  catalyst.	  SN1	  reaction	  The	  reactions	  of	  allylic	  alkylations	  have	  been	  performed	  with	  activated	  nucleophiles	  or	  acylated	  allyl	  alcohols,	  the	  use	  of	  direct	  substitution	  of	  allylic	  alcohols	  could	  be	  considered	  as	  a	  clean	  process	  for	  the	  generation	  of	  water	  as	  only	  side	  product.	  The	  allylic	  alkylation	  represent	  an	  important	  transformation	  in	   organic	   chemistry	   and	   various	   metal	   processes	   have	   been	   describes	   for	   this	   reaction.	   Thus,	   the	  direct	  activation	  of	  allylic	  alcohols	  represented	  a	  powerful	  method	  in	  organic	  chemistry.	  Baba	  group21	  developed	   a	   direct	   process	   C-­‐C	   bond	   formation	   from	   allylic	   alcohols	   and	   different	   activated	  nucleophiles	   in	  presence	  of	   Indium	  catalytic.	  Recently,	   two	   independently	  group	  reported	   the	  use	  of	  bismuth	   catalyst	   in	   direct	   substitution	   of	   alcohol	   with	   different	   nucleophiles.	   One	   work	   was	   from	  Rueping	  group	  22	  that	  reported	  the	  first	  Bismuth	  catalyzed	  direct	  allylic	  alkylation	  with	  different	  1,3-­‐
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Scheme	  4.	  Model	  of	  reaction	  for	  stereoselective	  α-­‐alkyaltion	  of	  aldehydes	  	  The	  generation	  of	  allylic	  carbocations	  from	  corresponding	  alcohols	  and	  their	  reaction	  with	  aldehydes	  in	   presence	   of	   an	   organocatalyst	   could	   be	   considered	   a	   new	   strategy	   for	   enantioselective	   allylic	  alkylation.	  Thus	  to	  promoted	  the	  formation	  of	  stabilized	  allyl	  carbocations	  was	  proposed	  to	  use	  Lewis	  acid	   as	   co-­‐catalyst.	   In	   this	  work	   has	   been	   reported	   a	   stereoselective	  α-­‐alkylation	   of	   aldehydes	  with	  allylic	  alcohols,	  merging	  two	  concepts	  enamine	  catalysis	  and	  metal	  catalysis.	  	  	  A	  Stereoselective α-­‐alkylation	  of	  aldehydes	  with	  allylic	  alcohols	  
II. Results	  and	  Discussion	  	  The	  direct	  substitution	  of	  allylic	  alcohols	  with	  enamine	  specie	  as	  nucleophiles	   is	  considered	  an	   ideal	  process	  for	  the	  C-­‐C	  bond	  formation	  because	  the	  transformation	  of	  the	  starting	  material	  would	  not	  be	  required	  and	  the	  generation	  of	  water	  as	  the	  only	  side	  product.	  However,	   the	  main	  limitations	  of	  this	  strategy	  are	  the	  catalytic	  activation	  of	  alcohol	  is	  generally	  difficult	  because	  of	  the	  inefficiently	  ability	  of	  the	   hydroxide	   group	   as	   leaving	   group,	   and	   the	   range	   of	   possible	   nucleophiles	   is	   limited	   in	   this	  reaction.23	  	  The	   first	   experiments	  were	   investigated	  with	   1,3-­‐diphenylallyl	   alcohol	  4	   as	   a	  model	   substrate	  with	  octanal	  and	  20	  mol%	  of	  MacMillan	  catalyst	  3	  TFA	  using	  various	  acids	  as	  co-­‐catalyst.	  	  Brønsted	  acids	  were	  insufficiently	  reactive	  to	  perform	  the	  stabilized	  carbocation	  from	  allylic	  alcohol.	  The	  screening	  of	  Lewis	  acid	  such	  as	  Cu(OTf)2,	  Zn(OTf)2,	  La(OTf)3,	  Bi(OTf)3,	  AuCl3,	  Ph3PAuCl	  gave	  either	  a	  complex	  mixture	  of	  products	  or	  not	  presence	  of	  product.	  	  Recent	  advances	   in	  activation	  of	  allylic	  alcohols	  have	  been	  based	   in	  the	  use	  of	   InCl3	  as	  emerged	  as	  a	  powerful	  direct	  nucleophilic	  substitution	  of	  alcohols.21	  We	  were	  attracted	  to	  the	  use	  of	  indium	  (III)	  by	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the	   compatibility	   of	   indium	   salts	  with	  water	   and	  basic	   amines.	   The	  model	   reaction	  was	   tested	  with	  different	  indiums	  salts	  and	  indium	  complex.	  On	  the	  base	  of	  these	  results,	  InBr3	  was	  found	  to	  act	  as	  the	  best	   co-­‐catalyst	   affording	   the	  desired	  product	  5	   in	  50%	  yield	   (table	  1,	   entry	  5).	  Other	   indiums	  salts	  gave	   lower	  yield	  or	  poor	  enantioselectivity	  or	  not	  product	  was	  observed.	  The	  screening	  the	  solvents	  showed	   that	   only	   DCM	   gave	   the	   desired	   product	   in	   50%	   ee	   (table	   1,	   entry	   5),	   other	   solvents	  were	  ineffective	  in	  the	  reaction.	  	  	  	  
Ph Ph

















anti-5 	  	   entrya	   Time	  (h)	   solvent	   d.rb	   ee	  (%)c	  1	   60	   toluene	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  2	   60	   tBuOMe	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  3	   60	   CH3CN	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  4	   60	   CH3NO2	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  5	   12	   DCM	   1:1	   50	  The	  reactions	  were	  performed	  at	  r.t	  with	  1	  eq	  of	  alcohol	  4,	  3eq	  of	  octanal	  in	  presence	  of	  20	  mol%	   of	   InBr3	   (0.33M	   solution	   in	   CH3CN)	   was	   added	   and	   the	   reaction	   was	   running	   until	  complet	  conversion,	  controlled	  by	  TLC.b	  for	  all	  the	  reactions	  the	  d.r	  ratio	  measured	  by	  1NMR	  spectroscopy.	   c	  Determined	  by	  HPLC	  analysis.	  The	  syn	  and	  anti	  had	  the	  same	  enantiomeric	  excess.	  	  







































entrya	   catalyst	   time	  (h)	   Yield	  (%)b	   d.rc	   ee	  (%)d	  1	   3	  TFA	   12	   71	   1:1	   71	  2	   3	   24	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  3	   7	   24	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  4	   5	   12	   70	   1:1	   82	  a	  the	  reactions	  were	  performed	  at	  0°C	  with	  alcohol	  4	  (1eq),	  aldehyde	  (3eq)	  in	  presence	  of	  20mol%	  catalyst	  and	  InBr3	  (20mol%,	  0.33M	  solution	  in	  CH3CN).b	  Yield	  after	  chromatography	  purification.	  c	  For	  all	  the	  reactions	  the	  d.r	  ratio	  was	  determined	  by	  1HNMR	  spectroscopic	  analysis.	  d	  Determined	  by	  chiral	  HPLC	  analysis	  of	  the	  isolated	  products	  or	  of	  the	  corresponding	  alcohol.	  The	  syn	  and	  anti	  diasterisomers	  had	  the	  same	  excess	  enantiomeric.	  	  	  
Table2.	  Organocatalytic	  α-­‐alkylation	  of	  octanal	  with	  allylic	  alcohol	  in	  presence	  of	  InBr3	  and	  different	  catalysts	  	  	  To	   improve	   the	   efficiency	   of	   the	   reaction	   was	   used	   only	   5	   mol%	   of	   InBr3	   without	   any	   change	   in	  enantioselective	   and	   yield	   than	   using	   20mol%	   InBr3	   (70%	   yield,	   80%ee),	   but	   the	   time	   of	   reaction	  increase	   72	   hours.	   Using	   a	   complex	   InBr3-­‐BINOL	   the	   reaction	   took	   place	   in	   5	   hours	   with	   80%	  enantioselectivity.	  	  The	  limitation	  in	  this	  reaction	  was	  the	  moderate	  enantioselectivity	  and	  poor	  diastereselectivity	  (1:1)	  to	   obtained	   in	   the	   reaction	   using	   1,3-­‐diphenyl	   allylic	   alcohol	   4	   and	   different	   linear	   aldehydes.	  According	   to	   the	   addition	   of	   aldehydes	   to	   benzhydrols	   the	   sterical	   hindrance	   of	   benzhydrilic	  carbocations	  is	  controlling	  the	  d.r	  of	  the	  reaction17,	  then	  to	  improve	  the	  stereoselectivity	  was	  planned	  to	  increase	  the	  hindrance	  of	  carbocation	  generated	  in	  the	  reaction.	  	  	  










Figure	  4	  Hypothesis	  about	  approach	  carbenium	  ion	  versus	  enamine	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Table	  3.	  α-­‐alkylation	  of	  allylic	  alcohols	  with	  aldehydes	  	  Introduction	   of	   phenyl	   substituent	   in	   β-­‐position	   increased	   the	   d.r	   in	   the	   reaction	   up	   to	   2:1	   syn	  stereoselectivity.	  (Table	  3,	  entry	  1)	  	  Different	   heteroaromatic	   and	   aromatic	   groups	   were	   tested	   in	   the	   optimal	   conditions	   using	   linear	  aldehydes.	   For	   the	   simple	   aryl	   substituent	   in	   allylic	   alcohols	   good	   yields	   and	   enantioselectivity	  was	  obtained	  in	  50-­‐90%	  yield,	  87-­‐91%	  ee.	  In	  all	  case,	   irrespective	  of	  the	  aldehydes	  employed,	  a	  d.r	  radio	  2:1	  was	  obtained.	   (Table	  3,	  entry	  1-­‐4).	  Thus,	   the	   increased	  hindrance	  of	   the	  β-­‐position	  enhances	  the	  steric	  interaction	  with	  the	  tert-­‐butyl	  group	  of	  the	  MacMillan	  catalyst	  in	  the	  transition	  state	  (figure	  4).	  
entrya	   R1	   R2	   Y(%)b	   d.rc	   ee	  (%)	  synd	   ee	  (%)	  antid	  1	   Ph	  	   nC6H13	   9a;	  70	   2:1	   90	   75	  2	   Ph	   CH3	   9b;63	   2:1	   88	  (2S,3R)	   80	  (2S,3S)	  3	   Ph	   Bn	   9c;	  90	   2:1	   89	   64	  4	   Ph	   nC3H7	   9d;50	   2:1	   91	   77	  5	   3-­‐Thiophenyl	   nC6H13	   9e;	  56	   2:1	   87	   56	  6	   3,5-­‐Me2Ph	   nC6H13	   9f;	  53	   2:1	   85	   69	  7	   3,5-­‐Me2Ph	   CH3	   9g;	  69	   2:1	   85	   73	  8	   9-­‐Phenanthrenyl	   nC6H13	   9h;	  66	   4:1	   86	   67	  9	   9-­‐Phenanthrenyl	   CH3	   9i;	  57	   4:1	   88	   75	  10	   (2-­‐MeO-­‐6-­‐Me)Ph	   nC6H13	   9j;	  65	   2:1	   88	   79	  11	   (2-­‐MeO-­‐6-­‐Me)Ph	   CH3	   9k;	  50	   2:1	   93	   84	  12	   2-­‐MeO-­‐1-­‐Naphthyl	   nC6H13	   9l;	  71	   3:1	   91	   68	  13	   2-­‐MeO-­‐1-­‐Naphthyl	   CH3	   9m;	  75	   5:1	   94	   87	  14	   2-­‐MeO-­‐1-­‐Naphthyl	   Bn	   9n;	  77	   5:1	   98	   65	  15	   (2-­‐MeO-­‐6-­‐CH2OMe)Ph	   CH3	   9o;	  65	   4:1	   95	   81	  a	  The	  reactions	  were	  performed	  at	  0°C	  with	  alcohols	  8	  (1eq),	  aldehyde	  (3eq)	  in	  presence	  of	  20mol%	  catalyst	  3	  and	  InBr3	  (20mol%,	  0.33M	  solution	  in	  CH3CN).b	  Yield	  after	  chromatography	  purification.	  c	  For	  all	  the	  reactions	  the	  d.r	  ratio	  was	  determined	  by	  1HNMR	  spectroscopic	  analysis.	   d	  Determined	  by	  chiral	  HPLC	  analysis	  of	   the	  isolated	  products	  or	  of	  the	  corresponding	  alcohol.	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Furthermore	   introducing	  differently	  aryl	  substituent	   in	  position	  orto	  as	  well	  as	  9-­‐Phenanthrenyl,	  (2-­‐MeO-­‐6-­‐Me)Ph,	  2-­‐MeO-­‐1-­‐Naphtyl	  or	  (2-­‐MeO-­‐6-­‐CH2OMe)Ph	  afforded	  the	  allyl	  alkylation	  with	  a	  d.r	  to	  up	  5:1	  in	  favour	  of	  the	  syn-­‐diasterisomer.	  (Table	  3,	  entry	  8-­‐16)	  	  


























9m; 75% Y; d.r 11:1
96% syn: 85% anti ee
9n; 73% Y; d.r 20:1





Table	  4.	  Using	  Brønsted	  acid	  as	  co-­‐catalyst	  	  	  	  	  	  
Determination	  of	  absolute	  configuration	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Scheme	  6.	  Several	  reactions	  were	  carried	  out	  to	  obtain	  compounds	  14b	  and	  15b	  in	  45%	  yield	  	  In	   summary,	   in	   this	  work	   has	   been	   reported	   the	   use	   of	   InBr3	   as	   co	   –catalyst	   in	   the	  α-­‐alkylation	   of	  aldehydes	  with	   allylic	   alcohols.	  With	   the	   successful	   realization	  of	   this	  previously	   results	  using	   InBr3	  was	  hypothesized	  that	  In(III)	  co-­‐catalyst	  would	  also	  be	  suitable	  for	  the	  activation	  of	  benzhylic	  alcohols	  and	  benzyhydrylic	  alcohols.	  	  	  	  	  	  	  	  	  	  
	   44	  Indium	   (III)	   promoted	   Organocatalytic	   enantioselective	   α-­‐alkylation	  of	  aldehydes	  with	  Benzhylic	  and	  benzhydrylic	  alcohols.	  	  	  The	   benzylic	   and	   benzhydrylic	   carbocations	   have	   the	   same	   behaviour	   that	   allylic	   carbocations,	  furthermore	  are	  positioned	  in	  the	  limits	  of	  reactivity	  over	  -­‐7	  on	  Mayr’s	  Scale.19	  The	   compatibility	   of	   indium	   (III)	   Lewis	   acid	   with	   enamine	   catalysis	   has	   open	   a	   new	   approach	   to	  generate	   stable	   carbocation	   from	   un-­‐reactive	   alcohols	   that	   are	   not	   possible	   generated	   through	  Brønsted	  acids	  catalyst.	  In	  the	  work	  of	  stereoselective	  allylic	  alkylation	  has	  been	  employed	  the	  InB3	  as	  co-­‐catalyst	  without	  using	  palladium	  or	  iridium	  salts	  to	  activated	  the	  allylic	  alcohol.27	  Here,	  to	  open	  the	  scope	  of	  this	  new	  methodology	  towards	  benzylic	  and	  benzhydrylic	  alcohols,	  substrates	  that	  could	  give	  access	   to	   useful	   intermediates	   for	   the	   synthesis	   of	   biologically	   active	   enatioenriched	   diarylethane	  products	   or	   structure	  with	   biologic	   proprieties.	  Moreover	   the	   development	   of	   direct	   substitution	   of	  alcohol	  is	  an	  important	  task	  in	  efficient,	  economic	  and	  ecology	  valuables	  transformations.	  	  	  	  


































18a; 80% Yield, d.r 1:1 
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  Entrya	   L.A	   cat	   solvent	   Yield	  (%)b	   d.rc	   ee	  maj	  %d	   ee	  min%d	  1	   InBr3	   3	  (2S,5R)	   DCM	   73	   3:1	   78	   35	  2	   In(OTf)3	   3	  (2S,5R)	   DCM	   80	   5:1	   79	   36	  3	   Bi(OTf)3	   3	  (2S,5R)	   DCM	   75	   4:1	   70	   26	  4	   InCl3	   3	  (2S,5R)	   DCM	   75	   3:1	   79	   40	  5e	   -­‐-­‐-­‐	   3	  (2S,5R)	   DCM	   60	   4:1	   50	   50	  6	   In(OTf)3	   20	  	   DCM	   80	   7:1	   98	   56	  7	   In(OTf)3	   20	   CH3CN	   50	   3:1	   97	   42	  8	   In(OTf)3	   20	   n-­‐hexane	   80	   5:1	   99	   85	  a	  All	  the	  reactions	  were	  performed	  at	  0°C	  with	  1	  eq.	  of	  alcohol,	  3eq.	  of	  aldehyde,	  20	  mol	  %	  cat	  and	  20	  mol%	  co	  –catalyst	   at	   0°C.	   Time	   of	   reaction	   6	   hours.	   b	   Isolate	   yield	   after	   chromatographic	   purification.	   C	   d.r	   ratio	   was	  measured	  on	  the	  crude	  of	  reaction	  mixture	  by	  1H	  NMR.d	  Enantiomeric	  excesses	  were	  measured	  by	  Chiral	  HPLC	  e	  the	  reaction	  was	  carried	  out	  with	  20	  mol%	  TFA.	  	   	  











































































	   84%;	  d.r	  2:1	  93%	  anti:	  90%	  syn	  ee	   	   70%;	  d.r	  1.5:1	  88%	  anti:	  80%	  syn	  ee	   	   60%,	  d.r	  1:1	  94%	  anti:	  95%	  syn	  ee	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Table	  6.	  Stereoselective	  α-­‐alkylation	  of	  aldehydes	  with	  benzhydrylic	  alcohols	  	  The	   introduction	   of	   the	   NMe2	   group	  was	   essential	   to	   stabilized	   the	   carbenium	   ion,	   so	   the	   study	   of	  benzhylic	   alcohols	   was	   investigated	   with	   p-­‐NMe2	   group	   in	   order	   to	   be	   enough	   to	   stabilized	   the	  carbenium	   ion.	   The α-­‐alkylation	   with	   benzylic	   alcohols	   was	   evaluated	   using	   propanal,	   1-­‐(4-­‐dimethylamino)phenyl)pentan-­‐1-­‐ol	  21,	  catalyst	  20	  and	  a	  series	  of	  Lewis	  acids.	  As	  was	  showed	  in	  table	  7.	   Initial	   investigations	   revealed	   one	   secondary	   reaction	   that	   was	   elimination	   reaction	   generating	  alkene	   as	   side	   product.	   As	   revealed	   in	   table	   7,	   using	   DCM	   or	   acetonitrile	   as	   solvent	   the	   majority	  product	  was	  alkene	  23.	  Use	  of	  apolar	  solvents	  such	  as	  n-­‐hexane	  or	  toluene	  significantly	  improved	  the	  conversion	  at	  product	  22.	  Water	  as	  solvent	  did	  not	  afford	  any	  product	  (table7,	  entry	  8).	  The	  addition	  of	  Me3SiBr	  did	  not	  increase	  the	  yield.	  Finally,	  the	  use	  of	  In(OTf)3	  was	  important	  in	  order	  to	  minimized	  the	  formation	  of	  the	  alkene	  23	  and	  performing	  the	  reaction,	  at	  0°C	  gave	  the	  total	  conversion	  at	  product	  






















	   	  
	   79%,	  d.r	  1:1	  90%	  anti:	  81%	  syn	  ee	   	   88%	  ,	  d.r	  1.1:1	  	  88anti:	  86%syn	  ee	   	   	  All	  the	  reactions	  were	  performed	  at	  0°C	  using	  1	  eq	  of	  alcohol,	  3	  eq.	  of	  aldehyde,	  20mol%	  catalyst	  20	  and	  20mol%	  In(OTf)3,	   and	  were	   conducted	   until	   completation	   (by	   TLC)	   for	   6	   hours.	   Isolated	   yields	   after	   chromatographic	  purification.	  The	  d.r	  ratio	  determined	  by	  1HNMR.	  Enantiomeric	  excess	  were	  measured	  by	  chiral	  HPLC	  
	  49	  
3	   InBr3	   toluene	   41	   59	  4	   InCl3/Me3SiBr	   DCM	   15	   85	  5	   InCl3/Me3SiBr	   n-­‐hexane	   61	   39	  6	   InCl3/Me3SiBr	   MeCN	   30	   70	  7	   In(OTf)3	   DCM	   30	   70	  8	   In(OTf)3	   H2O	   -­‐-­‐-­‐	   n.d	  9	   In(OTf)3	   n-­‐hexane	   80	   20	  10b	   In(OTf)3	   n-­‐hexane	   94	   0	  aAll	  the	  reactions	  were	  performed	  at	  r.t	  with	  20mol%	  catalyst,	  20	  mol	  %	  L.A	  ,	  3	  eq	  of	  aldehyde	  and	  1	  eq	  alcohol.	  b	  the	  reaction	  were	  conducted	  at	  0°C	  until	  completion	  by	  TLC.	  C.	  The	  yields	  after	  chromatography	  purification.	  	  
	  



















Y = 94%, d.r 2:1 
 98:94 % ee
Y = 94%, d.r 4.5:1 
 98:90 % ee
21 22
20 24
	  All	  the	  reactions	  were	  performed	  at	  0°C	  with	  20mol%	  catalyst,	  20	  mol	  %	  In(OTf)3	  ,	  3	   eq	   of	   aldehyde	   and	   1	   eq	   alcohol.	   The	   reaction	   were	   conducted	   at	   0°C	   until	  completion	   by	   TLC.	   The	   yields	   after	   chromatography	   purification.	   The	   d.r	   ratio	  determined	  by	  1HNMR.	  Enantiomeric	  excess	  were	  measured	  by	  chiral	  HPLC	  	  
Table	  8.	  Screening	  different	  imidazolidinone	  derivatives	  as	  catalysts	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Y= 94%, d.r 4.5:1
98%anti : 90%syn ee
Y= 85%, d.r 6:1
99%anti : 86%syn ee
Y=45%, d.r 6:1
97%anti : 82%syn ee
Y=92%, d.r 4.5:1











































92%anti : 86%syn ee
Y=90%, d.r 3:1
76%anti : 94%syn ee
Y=60%, d.r 2:1
96%anti : 92%syn ee
Y=60%, d.r 2.5:1
96%anti : 91%syn ee
Y=75%, d.r 2.5:1
96%anti : 91%syn ee 	  Yield	   after	   chromatographic	   purification.	   For	   all	   reactions	   the	   d.r	   (anti	   vs.syn)	   was	  measured	  by	  using	   1H	  NMR	  and	  HPLC	  analysis.	  Determined	  by	  chiral	  HPLC	  analysis	  of	  the	  isolated	  products	  or	  of	  corresponding	  alcohols.	  	  
Table	  9.	  Representative	  stereoselective	  α-­‐alkylation	  of	  aldehydes	  with	  benzhylic	  alcohols.	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Determination	  of	  absolute	  configuration	  	  	  
The	  absolute	  and	  relative	  configuration	  from	  alkylation	  of	  benzhydrylic	  alcohols	  	  The	  relative	  configuration	  of	  anti-­‐syn	  adduct	  was	  established	  by	  the	  reaction	  of	  benzyhdrylic	  alcohol	  
























Scheme	  8.	  Determination	  configuration	  	  From	  this	  synthesis	  of	  Evans	  only	  was	  possible	  determined	  one	  stereocenter	  at	  the	  2	  C	  position.	  The	  determination	   of	   the	   other	   stereocenter	   was	   stablished	   by	   comparison	   of	   the	   HPLC	   trace	   of	   the	  product	   28	   obtained	   in	   the	   organocatalysis	   reaction	   after	   reduction	   to	   corresponding	   alcohol.	   The	  stereisomer	   obtained	   in	   the	   reaction	   was	   in	   agreement	   with	   our	   previously	   suggest	   model.	   The	  diasterisomeric	   ration	  of	   the	  major	  diastereoisomer	  was	  assigned	  as	  anti	  on	   the	  basis	  of	   the	   results	  obtained	  with	  he	  benzylic	  substrates.	  	  	  














    [PdCl2(PPh3)2]
    THFR
30; 82%
31: 93%32; R = 3,5-dimethylphenyl; 87 % 





29; d.r 2.7:1 





	  	  	  
Scheme	  9.	  Functionalization	  of	  the	  products	  obtained	  by	  the	  organocatalytic	  alkylation	  through	  a	  Pd-­‐catalyzed	  arylation	  of	  the	  trimethyl	  ammonium	  triflate	  	  	  The	   substrate	   30	   obtained	   from	   the	   reduction	   NaBH4,	   removal	   of	   the	   silyl	   group,	   catalytic	  hydrogenation	   of	   the	   triple	   bond	   was	   protected	   with	   TBSCl	   to	   obtain	   the	   product	   31	   that	   was	  transformed	   into	   the	   corresponding	  ammonium	   triflate	  and	  successive	   treatment	  of	   ammonium	  salt	  with	   3,5-­‐Me2PhMgBr	   and	   4-­‐FPhMgBr	   and	   catalytic	   amount	   of	   complex	   of	   palladium	   to	   obtain	   the	  desired	  product	  32.	  (Scheme	  9)	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IV.	  Conclusion	  	  	  In	   summary,	   in	   this	   chapter	  were	  described	   two	  stereoselective	  processes:	  one	   from	  allylic	   alcohols	  and	   other	   from	   benzhydrilic	   and	   benzylic	   alcohols,	   both	  with	   the	   same	   concept	   using	   In(III)	   as	   co-­‐catalyst	   to	   generated	   stabilized	   cations	   that	   react	   with	   enamine	   catalysis,	   merging	   the	   enamine	  catalysis	   with	   metal-­‐catalysis	   process.	   However,	   in	   this	   work	   has	   described	   the	   first	   catalytic	  stereoselective	   addition	   of	   aldehydes	   to	   allylic,	   benzhydrilic	   and	   benzylic	   alcohols	   promoted	   by	   the	  combination	  of	   organocatalysis	   and	  metal-­‐catalyzed	  process.	   Furthermore	   in	   this	  work	   is	   presented	  the	  tolerance	  of	  In	  (III)	  salts	  with	  enamine	  base	  catalyst	  and	  water	  generate	  during	  the	  reaction.	  And	  the	  possibility	  to	  generated	  stable	  carbocation	  with	  unreactive	  alcohols	  in	  the	  stereoselective	  SN1	  type	  reactions.	  	  A	   wide	   range	   of	   applications	   for	   pharmaceutically	   or	   compounds	   intermediates	   in	   the	   synthesis	   of	  natural	   products	   can	   be	   applied	   this	   new	   methodology	   in	   the	   stereoselective	   construction	   of	   C-­‐C	  bonds,	  by	  marriage	  the	  organocatalysis	  and	  organometallic	  catalysis.	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V.	  Experimental	  section	  A	  Stereoselective α-­‐alkylation	  of	  aldehydes	  with	  allylic	  alcohols	  
Procedure	  for	  the	  starting	  materials	  
1,1,3-­‐triphenylallylalcohol	  	  Compound	  8	  R1=	  Ph	  was	  prepared	  by	  the	  addition	  of	  phenylmagnesium	  chloride	  to	  
β-­‐phenylcinnamaldehyde	   to	   obtain	   the	   desired	   product	   (ref.	   29	   of	   the	  Communication).	   1NMR	   (200MHz,	   CDCl3)	   δ	   7.39-­‐7.27	   (15H,	   m);	   6.31	   (1H,	   d,	   J	   =	  9.2Hz);	  5.28	  (1H,	  d,	  J	  =	  9.2Hz);	  1.92	  (OH,	  s).	  	  
1-­‐(3-­‐thiophene)-­‐3,3-­‐diphenylprop-­‐2-­‐en-­‐1-­‐ol	  	  To	  a	  solution	  of	  3-­‐bromo-­‐thiophene	  (162mg,	  1.0mmol)	  in	  anhydrous	  Et2O	  (1mL)	  under	  inert	  atmosphere	  was	  added	  n-­‐BuLi	  (1.2mmol,	  480µL,	  2.5M	  in	  hexane)	  at	  -­‐78°C.	  The	  mixture	  was	  stirred	  for	  15	  min	  at	   the	  same	  temperature.	  The	  mixture	  was	  warmed	  at	  0°C	  and	  stirred	  for	  1	  hour,	  and	  then	  β-­‐phenylcinnamaldehyde	  (208mg,	  1.0mmol)	  was	  added	   at	   0°C.	   The	   resulting	  mixture	  was	  warmed	   at	   room	   temperature	   until	   no	   further	   conversion	  took	   place	   (controlled	   by	   TLC).	   Then	   the	   reaction	  was	   quenched	  with	   saturated	   NH4Cl	   aq.	   and	   the	  organic	  layer	  was	  separated.	  The	  aqueous	  layer	  was	  extracted	  twice	  with	  DCM.	  The	  combined	  organic	  layer	  was	  washed	  with	  water	  and	  brine,	  dried	  over	  Na2SO4,	  and	  concentrated	  to	  give	  orange	  oil.	  The	  residue	  was	  purified	  by	  flash	  chromatography	  (SiO2;	  cyclohexane:	  Et2O	  =	  7:3)	  to	  afford	  the	  product	  in	  (200mg,	   0.70mmol,	   70%	   yield)	   as	   a	   yellow	   solid.	   1H	   NMR	   (200MHz,	   CDCl3)	   δ	   7.42-­‐7.20	   (11H,	  m);	  7.07-­‐6.91	  (2H,	  m);	  6.33	  (1H,	  d,	  J	  =	  10.6Hz);	  5.59	  (1H,d,	  J	  =	  10.6Hz);	  2.21	  (OH,s).	  	  
1-­‐(3,5-­‐dimethylphenyl)-­‐3,3-­‐diphenylprop-­‐2-­‐en-­‐1-­‐ol	  	  To	   a	   solution	   of	   3,5-­‐dimethyphenylmagnesium	   bromide	   (1.4mL,	   0.65M	   in	  THF)	   was	   added	   β-­‐phenylcinnamaldehyde	   (100mg,0.48mmol)	   under	   inert	  atmosphere	  at	  0°C.	  The	  mixture	  was	  allowed	  to	  warm	  at	  room	  temperature	  until	   no	   further	   conversion	   took	   place	   (monitored	   by	   TLC),	   and	   then	   the	  solution	   was	   quenched	   with	   water,	   and	   the	   organic	   layer	   was	   separated.	   The	   aqueous	   layer	   was	  separated	   and	   extracted	   twice	  with	   Et2O.	   The	   combined	   organic	   layer	  was	  washed	  with	  water	   and	  brine,	  dried	  over	  Na2SO4,	  and	  concentrated	  to	  afford	  the	  product	  in	  (150mg,	  0.48mmol,	  99%	  yield).	  1H	  
NMR	   (200MHz,	  CDCl3)	  δ	  7.43-­‐7.22	  (10H,	  m);	  6.99	  (2H,	  s);	  6.92	  (1H,	  s);	  6.32	  (1H,	  d,	   J	  =	  9.2Hz);	  5.20	  (1H,	  d,	  J	  =	  9.2Hz);	  2.32	  (6H,	  m);	  1.93	  (OH,s).	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To	  a	  solution	  of	  9-­‐bromophenanthrene	  (257mg,	  1mmol)	  in	  anhydrous	  Et2O:	  benzene	  (2mL;	  1:1)	  under	  inert	  atmosphere	  were	  added	  Mg	  (24mg,	  1mmol)	  and	   I2	   (2mg,	   0.76mol%).	   The	   resulting	  mixture	  was	   stirred	   at	   reflux	   for	   1	  hour.	   The	   Grignard	   solution	   of	   phenanthren-­‐9-­‐ylmagnesium	   bromide	  (1mmol,	   0.5M	   in	   Et2O:	   benzene)	   obtained	   was	   cooled	   to	   0°C,	   then	   was	  added	  β-­‐phenylcinnamaldehyde	   (187mg,	   0.9mmol)	   in	   anhydrous	   Et2O	   (0.5mL).	   The	   mixture	   was	  gradually	   warmed	   to	   room	   temperature,	   and	   stirred	   for	   2	   hours.	   The	   reaction	   was	   quenched	   with	  water,	  and	  the	  organic	  layer	  was	  separated.	  The	  organic	  layer	  was	  washed	  with	  brine	  and	  water,	  dried	  over	   Na2SO4,	   and	   concentrated	   to	   give	   yellow	   orange	   oil.	   The	   residue	   was	   purified	   by	   flash	  chromatography	   (Si02;	   cyclohexane/Et2O	   =	   7:3)	   to	   afford	   the	   product	   in	   (312	   mg,	   0.81mmol,	   90%	  yield)	  as	  a	  yellow	  solid.	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  8.76-­‐8.66	  (2H,	  m);	  8.00	  (1H,	  s);	  7.93-­‐7.84	  (2H,	  m);	  7.70-­‐7.25	  (14H);	  6.48	  (1H	  ,d,	  J	  =	  9.2Hz);	  	  5.96	  (1H,d,J	  =	  9.2Hz);	  2.00	  (OH,	  s).	  	  	  
1-­‐(2-­‐methoxy-­‐5-­‐methylphenyl)	  -­‐3,3-­‐diphenylallylalcohol	  	  To	   a	   solution	   of	   2-­‐bromo-­‐4-­‐methylphenol	   (242µL,	   2mmol)	   in	   dry	   DMF	   (2mL)	  were	  added	  K2CO3	  (414mg,	  3mmol)	  and	  MeI	  (246µL,	  4mmol)	  and	  the	  resulting	  mixture	  was	  stirred	  at	  reflux	  for	  24	  hours	  (monitored	  by	  TLC).	  The	  reaction	  was	  quenched	  with	  water.	  The	  organic	   layer	  was	   separated,	   and	   the	  aqueous	   layer	  further	   extracted	   with	   Et2O.	   The	   combined	   organic	   layer	   was	   washed	   with	  water,	   dried	   over	   Na2SO4	   and	   concentrated	   to	   give	   quantitatively	   the	   product	   2-­‐bromo-­‐4-­‐methoxyanisol.	   The	   purified	   product	   2-­‐bromo-­‐4-­‐methoxyanisol	   (200mg,	   1mmol)	   was	   dissolved	   in	  anhydrous	   Et2O	   (1mL)	   under	   inert	   atmosphere	   and	   n-­‐BuLi	   was	   added	   (400µL,	   1mmol,	   2.5M	   in	  hexane)	   at	   -­‐78°C.	   The	   mixture	   was	   stirred	   for	   15	   min	   at	   the	   same	   temperature.	   The	   mixture	   was	  warmed	  at	  0°C	  for	  1	  hour,	  and	  then	  β-­‐phenylcinnamaldehyde	  (208mg,	  1mmol)	  was	  added	  at	  0°C.	  The	  mixture	  was	  allowed	  to	  warm	  from	  0°C	  to	  room	  temperature	  in	  2	  hours.	  The	  reaction	  was	  quenched	  with	  saturated	  NH4Cl	  aq.	  and	  the	  organic	  layer	  was	  separated.	  The	  aqueous	  layer	  was	  extracted	  twice	  with	   Et2O.	   The	   combined	   organic	   layer	   was	   washed	   with	   water	   and	   brine,	   dried	   over	   Na2SO4	   and	  concentrated.	   The	   residue	  was	   purified	   by	   flash	   chromatography	   (SiO2;	   cyclohexane:	   Et2O	   =	   7:3)	   to	  afford	  the	  product	  in	  (297mg,	  0.9mmol,	  90%yield)	  as	  a	  white	  oil.	  1H	  NMR	   (200MHz,	  CDCl3)	  δ	  7.41-­‐7.18	  (10H,m);	  7.05	  (1H,s);	  6.83-­‐6.77	  (2H,m);	  6.48	  (1H,	  d,	  J	  =	  9.2Hz);	  5.36	  (1H,	  bd,	  J	  =	  9.2	  Hz);	  3.83	  (3H,	  s);	  3.14	  (OH,s);	  2.30	  (3H,	  s).	  	  	  
1-­‐(2-­‐methoxynaphtalen-­‐1-­‐yl)	  -­‐3,3-­‐	  diphenylallylalcohol	  	  Following	   the	   same	   procedure	   described	   for	   1-­‐(3-­‐thiophene)-­‐3,3-­‐









phenylcinnamaldehyde.	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  7.83-­‐7.74	  (2H,	  m);	  7.4-­‐7.2	  (14H,	  m);	  6.70	  (1H,d,J	  =	  9.4Hz);	  6.08	  (1H,	  bd);	  4.05	  (3H,	  s);	  1.59	  (OH,	  s).	  	  	  
1-­‐(2-­‐methoxy-­‐6-­‐(methoxymethyl)phenyl)-­‐	  3,3-­‐	  diphenylallylalcohol	  	  To	  a	  solution	  of	  NaH	  (106mg,	  2.6mmol),	  in	  anhydrous	  THF	  (1.0mL)	  under	  inert	  atmosphere	  were	  added	  (3-­‐methoxyphenyl)methanol	  (184mg,	  1.3	  mol)	  and	  MeI	  (	   124µL,	   2mmol)	   at	   0°C.	   The	  mixture	   was	   warmed	   at	   room	   temperature	   and	  stirred	  until	  no	   further	  conversion	   took	  place	   (monitored	  by	  TLC).	  The	  reaction	  was	  quenched	  with	  water	   and	   the	   organic	   layer	  was	   separated.	   The	   aqueous	   layer	  was	   extracted	   twice	  with	   EtO2.	   The	  combined	   organic	   layer	   was	   washed	   with	   water,	   dried	   over	   Na2SO4,	   and	   concentrated	   to	   give	   1-­‐methoxy-­‐3-­‐(methoxymethyl)benzene	  (176mg,	  1.15mmol),	  which	  was	  dissolved	  in	  anhydrous	  hexane	  (3mL)	  under	   inert	   atmosphere	   at	   0°C.	  Then	  n-­‐BuLi	   (555µL,	   1.4mmol,	   2.5M	   in	  n-­‐hexane)	  was	   added	  and	  the	  mixture	  was	  stirred	  for	  5	  days	  at	  0°C.	  Then	  β-­‐phenylcinnamaldehyde	  (187mg,	  1,03mmol)	  was	  added	   slowly	  at	   the	   same	   temperature.	  The	  mixture	  was	  warmed	  at	   room	   temperature,	   then	   it	  was	  stirred	   for	   24	   hours,	   quenched	   with	   saturate	   NH4Cl	   aq.	   and	   the	   organic	   phase	   was	   separated.	   The	  aqueous	  layer	  was	  extracted	  twice	  with	  EtO2.	  	  The	  combined	  organic	  layer	  was	  washed	  with	  water	  and	  brine,	   dried	   over	   Na2SO4,	   and	   concentrated.	   The	   residue	   was	   purified	   by	   column	   chromatography	  (SiO2;	   cyclohexane:	  Et2O	  =	  7:3)	   to	  afford	   the	  product	   in	   (200mg,	  0.5	  mmol,	  62%	  yield)	  as	  an	  orange	  solid.	  1H	  NMR	  (400MHz,	  CDCl3)	  δ	  7.4-­‐7.18	  (11H,	  m);	  6.90	  (2H,	  d,	  J	  =	  8Hz);	  6.57	  (1H,d,	  J	  =	  13.6Hz);	  5.5	  (1H,	  bs);	  4.01	  (1H,	  d,	  J	  =	  11.6);	  3.92	  (1H,	  d,	  J	  =	  11.6);	  3.89	  (3H,	  s);	  3.04	  (3H,	  s)	  1.5	  (OH,	  s).	  	  	  
Organocatalytic	  allylic	  alkylations	  of	  aldehydes	  with	  alcohols	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2-­‐	  (1,3-­‐diphenylallyl)octanal	  (5-­‐syn;	  5-­‐anti)	  Compound	   5	   was	   obtained	   as	   white	   oil	   (90%	   yield;	   d.r:	   1:1;	   82%syn:	  82%anti	  ee).	  1H	  NMR	  (400MHz,CDCl3)	  δ=	  9.64	  (1H,	  d,	  J	  =	  4Hz);	  9.48	  (1H,	  d,	   J	  =	  3.6Hz);	  7.36-­‐7.19	  (20H,	  m);	  6.47	  (1H,	  d,	   J	  =	  20.4Hz);	  6.43	  (1H,	  d,	   J	  =	  20.4Hz);	   6.34-­‐6-­‐27	   (2H,	  m);	   3.71	   (2H,	  m);	   2.8-­‐2.75	   (2H,	  m);	   1.7-­‐1.65	   (4H,	  m);	   	   1.29-­‐1.16	   (16H,	  m);	   0.83	   (6H,	   t,	   J	   =	   7.2Hz).	   	  HPLC-­‐MS:	   tr:	   15.97	  min;	   tr	   :	   16.34	  min;	  m/z:	   338	  (M+H2O);	  343	  (M+Na)	  .	  	  
2-­‐	  (1,3-­‐diphenylallyl)octanol	  	  The	  compound	  from	  5	  (1eq,	  0.1mmol)	  was	  reduced	  in	  the	  crude	  reaction	  mixture	  with	  with	  DIBAL	  (2	  eq.)	   at	   -­‐78°C.	   The	   solution	  was	   stirred	   during	   15	  min	   at	   the	   same	   temperature,	   and	   quenched	  with	  water.	  The	  mixture	  was	   concentrated	  and	  extracted	  with	  ethyl	   acetate.	  The	   residue	  was	  purified	  by	  flash	  chromatography	  (SiO2;	  cyclohexane:	  Et2O	  =	  7:3),	   to	  obtain	  compound	  5	   alcohol	  as	  a	  yellow	  oil	  (72%yield,	  d.r	  1:1;	  80%syn,	  80%	  anti	  ee).	  1H	  NMR	  (400MHz,	  CDCl3)	  δ	  7.37-­‐7.19	  (20H,m);	  6.47-­‐6.41	  (4H,m);	  3.76-­‐3.65	  (2H,m);	  3.59-­‐3.43	  (4H,m);	  1.98-­‐1.85	  (2H,m);	  1.41-­‐1.59	  (4H,m);	  1.18-­‐1.05	  (16H,m);	  0.89-­‐0.83	  (6H,m).	  13C	  NMR	  (100MHz,	  CDCl3)	  δ	  143.6	  (	  2C);	  143.3	  (	  C);	  137.3	  (	  C);	  132.7	  (CH);	  132.1	  (CH);	  131.0	  (CH);	  130.3	  (CH);	  128.7	  (2CH);	  128.6	  (2CH);	  128.5	  (CH);	  128.4	  (2CH);	  128.3	  (CH);	  128.0	  	  (2CH);	  127.8	  (2CH);	  127.2	  (CH);	  127.1	  (CH);	  126.3	  (CH);	  126.3	  (CH);	  126.2	  (4CH);	  63.0	  (CH2OH);	  62.8	  (CH2OH);	  51.8	  (CH);	  51.1	  (CH);	  45.6	  (CH);	  45.4	  (CH);	  31.8	  (2CH2);	  29.7	  (CH2);	  29.6	  (CH2);	  29.4	  (CH2);	  28.5	   (CH2);	   28.2	   (CH2);	   27.2	   (CH2);	   26.9	   (CH2);	   22.6	   (CH2);	   14.0	   (2CH3).	  HPLC	   analysis	   IC,	   gradient	  from	   99:1	   (n-­‐hexane:	   i-­‐PrOH)	   to	   9:1	   in	   30’,	   flow	   0.5mL/min;	   TM(maj):	   26.0min;	   tm(maj):	   21.0min;	  TM(min):	  31.3min;	  tm(min):	  38.4min.	  	  
	  
	  









2-­‐methyl-­‐2,5,5-­‐triphenylpent-­‐4-­‐enal	  (9b)	  Compound	  9b	  was	   obtained	   as	   a	   yellow	  oil	   (63%	  yield,	   d.r	   2:1,	   88%syn;	   80%anti	  ee).	   1H	   NMR	   (200MHz,	   CDCl3)	   δ	   9.56	   (1Hanti,	   d,	   J	   =	   3.4Hz);	   9.39	   (1Hsyn,	   d,	   J	  =2.2Hz);	  7.40-­‐7.10	  (30Haromatic,	  m);	  6.31	  (1Hanti,	  d,	  J	  =	  10.6Hz);	  6.27	  (1Hsyn,	  d,	  J	  =	  11Hz);	  3.78(1Hsyn,	  t,	  J	  =	  8.8Hz);	  3.58	  (1Hanti,	  t,	  J	  =	  10.2Hz);	  2.89-­‐2.78	  (2H,	  m);	  1.13	  (3Hsyn,	  d,	   J	  =	  6.4Hz);	  0.85	   (3Hanti,	  d,	   J	  =	  7Hz).	  13C	   NMR	   (50MHz,	   CDCl3)	   δ	  204.4	   (CHOanti);	  204.0	  (CHOsyn);	   143.5	   (C);	   143.0	   (C);	   142.0	   (2C);	   141.9	   (C);	   141.6	   (C);	   139.5	   (C);	   130.6	   (C);	   129.7	   (3C);	  129.2	   (C);	  128.8	   (4C);	  128.4	   (4C);	  128.3	   (2C);	  128.2	   (3C);	  128.1	   (2C);	  127.9	   (2C);	  127.8	   (3C);	  127.5	  (2C);	   127.4	   (2C);	   127.3	   (2C);	   126.8	   (2C);	   52.6	   (CHanti);	   52.1	   (CHsyn);	   47.2	   (CHanti);	   46.4	   (CHsyn);	  12.4	   (CH3anti);	   11.6	   (CH3syn).	  HRMS	   Calcd	   for	   C24H22O:	   326.16707	   [M]+,	   found:	   396.24588.	   	  HPLC	  
analysis	  OD-­‐H,	  99.5:0.5	   (n-­‐hexane:	   i-­‐PrOH),	   flow	  0.6mL/min.	  TM(maj):	  13.7	  min;	   tm(maj):	  20.5min;	  TM(min):	  19.4min;	  tm	  (min):	  12.9	  min.	  	  
	  
2-­‐benzyl-­‐3,5,5-­‐triphenylpent-­‐4-­‐enal	  (9c)	  Compound	  9c	  was	  obtained	  as	  a	  yellow	  oil	  (90%	  yield,	  d.r	  2:1,	  89%syn;	  64%anti	  ee).	   1H	  NMR	  (200MHz,	  CDCl3)	  δ	  	  9.5	  (CHOanti,	  d,	  J	  =	  2.8Hz);	  9.42	  (CHOsyn,	  d,	  J	  =	  2.8Hz);	  7.43-­‐7.08	  (40H	  aromatic);	  6.38(	  1Hsyn,	  d,	  J	  =	  10.6Hz);	  6.33	  (1Hanti,	  d,	  J	  =	  10.6Hz);	  3.87	  (1H,	  t,	   J	  =	  10.6Hz);	   	  3.7	  (	  1H,	  t,	   J	  =	  10,6Hz);	  3.20-­‐3.04	  (2H,	  m);	  2.96	  (4H,	  1d,	  J	  =	  7	  Hz).	  13C	  NMR	  (50MHz,	  CDCl3)	  δ	  203.6	  (CHOanti);	  203.4	  (CHOsyn);	  143.7	  (C);	  143.4	  (C);	  141.9	  (C);	  141.7	  (C);	  141.3	  (2C);	  139.4	  (C);	  139.1	  (2C);	  138.7	  (C);	  129.7	  (2CH);	  129.6	   (2CH);	   129.1	   (2CH);	   129.0	   (2CH);	   128.9	   (2CH);	   128.7	   (2CH);	   128.6	   (CH);	   128.5	   (3CH);	   128.4	  (4CH);	   128.4	   (2CH);	   128.3	   (CH);	   128.2	   (3CH);	   128.1	   (CH);	   127.9	   (2CH);	   127.5	   (2CH);	   127.5	   (2CH);	  127.4	  (2CH);	  127.3	  (3CH);	  126.9	  (2CH);	  126.3	  (2CH);	  60.1	  (CHanti);	  59.6	  (CHsyn);	  46.3	  (CHsyn);	  46.2	  (CHanti);	   33.7	   (CH2anti);	   33.4	   (CH2syn).	   HPLC-­‐MS	   tr	   (syn):	   13.4min;	   tr	   (anti)	   13.9min;	   m/z:	   425	  (M+Na).	   HPLC	   analysis	   OD-­‐H,	   99.5:0.5	   (n-­‐hexane:	   i-­‐PrOH),	   flow	   0.6mL/min.	   TM(maj):	   23.4min;	  tm(maj):	  22.5min;	  TM(min):	  25.8min;	  tm(min):	  17.5min.	  
	  
3,5,5-­‐triphenyl-­‐2-­‐propylpent-­‐4-­‐enal	  (9d)	  Compound	  9d	  was	   obtained	   as	   a	   yellow	  oil	   (50%	  yield,	   d.r	   2:1,	   91%syn;	   77%anti	  ee).1HNMR	   (200MHz,	   CDCl3)	   δ	   9.42	   (CHOanti,	  d,	   J	  =	  4.6Hz);	  9.33	   (CHOsyn,	  d,	   J	  =	  4Hz);	  7.45-­‐7.109	  (30H,	  m);	  6.26	  (1Hsyn,	  d,	  J	  =	  10.6Hz);	  6.25	  (1Hanti,	  d,	  J	  =	  10.6Hz);	  3.73	  (1H,	  t,	   J	  =	  10.6Hz);	  3.6	  (1H,	  t,	   J	  =	  10.6	  Hz);	  2.81-­‐2.68	  (2H,	  m);	  1.6-­‐1.5	  (4H,	  m);	  1.33	   -­‐1.09	   (4H,	  m);	   0.905	   (3H,	   t,	   J	   =	   7Hz);	   0.75	   (3H,	   t,	   J=	  7Hz).	   13C	   NMR	   (50MHz,	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128.1	  (2CH);	  128.0	  (CH);	  127.9	  (CH);	  127.8	  (3CH);	  127.4	  (4CH);	  127.2	  (2CH);	  127.0	  (CH);	  126.8	  (CH);	  58.3	   (CHanti);	  57.6	   (CHsyn);	  46.1	   (CHanti);	  45.9	   (CH	  syn);	  29.6	   (2CH2);	  20.4	   (CH2);	  20.2	   (CH2);	  14.1	  (CH3syn);	  13.8	  (CH3anti).	  HPLC-­‐MS:	  tr	  (syn):	  13.1min;	  tr	  (anti):	  13.7;	  m/z:	  377	  (M+Na).	  HPLC	  analysis	  IC,	   99.5:0.5	   (n-­‐hexane:	   i-­‐PrOH),	   flow	   0.6	   mL/min,	   T=40ºC.	   TM(maj):	   13.2min;	   tm(maj):	   13.8min;	  TM(min):	  20.8min;	  tm(min):	  16.9	  min.	  	  	  
2-­‐(3,3-­‐diphenyl-­‐1-­‐(thiophen-­‐3-­‐yl)allyl)octanal	  (9e)	  Compound	  9e	  was	   obtained	   as	   a	   yellow	   oil	   (56%	  yield,	   d.r	   2:1,	   87%syn;	   56%anti	  ee).1H	   NMR	   (200MHz,	   CDCl3)	   δ	   9.45	   (CHOanti,	   d,	   J	   =	   4Hz);	   9.42	   (CHOsyn,	   d,	   J	   =	  3.6Hz);	  7.40-­‐7.09	  (24H,	  m);	  6.94	  (1Hanti,	  d,	   J	  =	  5.6Hz);	  6.89	  (	  1Hsyn,	  d,	   J	  =	  5.4Hz);	  	  6.20	  (	  1Hsyn,d,	  J	  =	  10.6Hz);	  6.19	  (1Hanti,	  d,	  J	  =	  10.6Hz);	  4.20-­‐4.37	  (2H,	  m);	  2.68-­‐2.64	  (2H	  syn+anti,	  m);	  1.6-­‐1.5	  (	  4H,	  m);	  1.26	  -­‐1.14	  (16H,	  m);	  0.87	  (6H,	   t,	   J	  =	  6.6Hz).	  13C	  
NMR	   (100MHz,	   CDCl3)	   δ	   203.5	   (CHOanti);	   203.1	   (CHOsyn);	   144.6	   (C);	   141.6	   (C);	  139.9	   (2C);	   138.8	   (2C);	   132.4	   (CH);	   130.0	   (CH);	   129.9	   (CH);	   	   129.8	   (CH);	   129.7	  (4CH);	   128.5	   (3CH);	   128.3	   (3CH);	   128.2	   (CH);	   127.7(2CH);	   127.6	   (3CH);	   127.4	   (4CH);	   127.3	   (CH);	  127.2	   (2CH);	   124.8	   (CH);	   109.9	   (C);	   108.2	   (C);	   58.9	   (CHanti);	   58.8	   (CHsyn);	   40.6	   (CHanti);	   40.5	  (CHsyn);	  31.5	  (2CH2);	  29.7	  (2CH2);	  29.2	  (2CH2);	  26.9	  (2CH2);	  22.5	  (2CH2);	  14.0	  (2CH3	  syn+anti).	  HPLC-­‐
MS:	   tr:	   (syn)	   17.4min;	   tr:	   (anti)	   17.9min;	  m/z:	   425	   (M+Na).	  HRMS	   Calcd	   for	   C27H30OS:	   402.201734	  [M]+,	   found:	   402.20211.	  HPLC	   analysis	  OD-­‐H,	   99:1	   (n-­‐hexane:	   i-­‐PrOH),	   flow	   0.5	  mL/min.	   TM(maj):	  12.0min;	  tm(maj):	  13.9min;	  TM(min):	  13.0min;	  tm(min):	  11.1min.	  	  	  	  












3-­‐(3,5-­‐dimethylphenyl)-­‐2-­‐methyl-­‐5,5-­‐diphenylpent-­‐4-­‐enal	  (9g)	  Compound	   9g	   was	   obtained	   as	   a	   yellow	   oil	   (69%	   yield,	   d.r	   2:1,	   85%syn;	  73%anti	   ee).1H	   NMR	   (400MHz,	   CDCl3)	   δ	   9.53	   (1Hanti,	   d,	   J=	   3.6Hz);	   9.37	  (1Hsyn,	  d,	   J=0.8Hz);	  7.40-­‐7.35	   (6H,	  m);	  7.28	   -­‐7.17	   (10H,	  m);	  7.1-­‐7.09	   (4H,	  m);	  6.87	  	  (1Hanti,	  s);	  6.85	  (1Hsyn,	  s);	  6.79	  (2Hsyn,	  s);	  6.77(2Hanti,	  s);	  6.28(	  1Hsyn,	  d,	   J	   =	   10.8Hz);	   6.26	   (	   1Hanti,	   d,	   J	   =	   10.8Hz);	   3.68(1Hsyn,	   t,	   J	   =	   9.6Hz);	   3.49	  (1Hanti,	   t,	   J	  =	  9.6Hz);	  2.82-­‐2.7	  (2Hsyn+anti,	  m);	  2.30	  (6Hanti,	   s);	  2.29	  (6Hsyn,	  s);	  1.10	  (3Hsyn,	  d,	   J	  =	  6.8Hz);	  0.84	  (3Hanti,	  d,	  J	  =	  6.8Hz).	  	  13C	  NMR	  (100MHz,	  CDCl3)	  δ	  204.3	  (2CHO	  syn	  +	  anti);	  143.1	  (2C);	  141.8	   (4C);	   139.6	   (2C);	   138.3	   (4C);	   130.0	   (CH);	   129.8	   (2CH);	   129.7	   (CH);	   129.5	   (CH);	   128.6	   (2CH);	  128.4	   (3CH);	   128.3(3CH);	   128.2	   (2CH);	   128.1	   (CH);	   127.4	   (3CH);	   127.36	   (2CH);	   127.3	   (4CH);	   125.7	  (CH);	   125.5	   (2CH);	   52.6	   (CHanti);	   52.1	   (CHsyn);	   47.1	   (CHanti);	   	   46.3	   (CHsyn);	   21.4	   (4CH);	   12.4	  (CH3anti);	   11.6	   (CH3syn).	  HPLC-­‐MS:	   tr:	   (syn)	   13.5min;	   tr:	   (anti)	   13.9min;	   m/z:	   377	   (M+Na).	  HRMS	  Calcd	   for	   C26H26O:	   354.19836	   [M]+,	   found:	   354.19815.	   HPLC	   analysis	   IC,	   gradient	   from	   99:1	   (n-­‐hexane:i-­‐PrOH)	  to	  90:10	  in	  30	  min,	  flow	  0.5mL/min.	  TM(maj):	  11.5	  min;	  tm(maj):	  12.6	  min;	  TM(min):	  14.9min;	  tm(min):	  11.0min.	  	  	  
2-­‐(1-­‐(phenanthrene-­‐9-­‐yl)-­‐3,3-­‐diphenylallyl)octanal	  (9h)	  Compound	  9h	  was	  obtained	  as	  a	  yellow	  oil	  (66%	  yield,	  d.r	  4:1,	  86%syn;	  67%anti	  ee).	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  9.67	  (CHOanti,	  d,	  J=3.6Hz);	  9.49	  (CHOsyn,d,	  J	  =	  3Hz);	   8.84-­‐8.67	   (4H,	   m);	   7.91-­‐7.01	   (34H,	   m);	   6.60	   (2Hsyn+anti,	   d,	   J	   =	   10.6Hz);	  4.75	  (1Hsyn,	  dd,	   J	  =	  7.4Hz,	   J=10.6Hz);	  4.64	  (1H,	   t,	   J=8Hz);	  2.96	  (2Hsyn+anti,	  m);	  1.84-­‐1.6	   (4H,	  m);	   1.40-­‐1.02	   (16H,	  m);	   0.84	   (6Hsyn+anti,	   t,	   J	   =	   6.6Hz).	   13C	   NMR	  
(50MHz,	   CDCl3)	   δ	   204.9	   (CHOanti);	   203.9	   (CHOsyn);143.8	   (2C);	   142.2	   (2C);	  139.3	  (2C);	  136.6	  (2C);	  131.4	  (2C);	  131.0	  (2C);	  130.1	  (2C);	  129.8	  (6C);	  129.6	  (2C);	  128.5	  (3C);	  128.3	  (6C);	  128.2	  (6C);	  128	  (2C);	  127.6	  (6C);	  126.7	  (2C);	  126.6	  (2C);	  126.4	  (2C);	  123.6	  (C);	  123.5	   (C);	   123.4	   (C);	   122.4	   (2C);	   57.9	   (CHanti);	   57.8	   (CHsyn);	   40.2	   (2CHsyn+anti);	   31.5	   (CH2);	   29.7	  (CH2);	   29.2	   (CH2);	   	   29.1	   (CH2);	   27.6	   (CH2);	   27.1	   (CH2);	   26.9	   (CH2);	   26.7	   (CH2);	   22.5	   (2CH2);	   14.0	  (2CH3syn+anti).	   HRMS	   Calcd	   for	   C37H36O:	   496.27662	   [M]+,	   found:	   354.19815.	   HPLC	   analysis	   IC,	  gradient	  from	  99:1	  (n-­‐hexane:i-­‐PrOH)	  to	  90:1	  in	  30	  min,	  flow	  0.6mL/min.	  TM(maj):	  19.9min;	  tm(maj):	  15.8min;	  TM(min):	  14.3min;	  tm(min):	  13.9min.	  	  












	   62	  
(2H,	  d,	  J	  =	  8.4Hz);	  7.7-­‐7.58	  (6H,	  m);	  7.58-­‐7.51	  (2H,	  m);	  7.35-­‐7.25	  (16H,m);	  7.04	  (2Hsyn,	  d,	  J	  =	  8.4Hz);	  	  7.01	  (2Hanti,	  d,	  J	  =	  8Hz);	  6.6	  (1Hanti,	  d,	  J	  =	  10.4Hz);	  6.61	  (1Hsyn,	  d,	  J	  =	  10.4	  Hz);	  4.84	  (1Hsyn,	  dd,	  J	  =	  6.4Hz,	   J	   =	   10Hz);	   4.53	   (1Hanti,	   dd,	   J=8.4Hz,	   J	   =	   10.4Hz);	   3.09-­‐3.05	   (2Hsyn+anti,	   m);	   1.2	   (3H,	   d,	  J=7.2Hz);	  0.90	  (3H,	  d,	  J	  =	  6.8Hz).	  13C	  NMR	  (100MHz,	  CDCl3)	  δ	  203.6	  (CHOanti);	  203.6	  (CHOsyn);	  144.2	  (2C);	  142.3	  (2C);	  139.4	  (2C);	  136.6	  (2C);	  131.4	  (2C);	  131.0	  (2C);	  129.8	  (6C);	  129.7	  (2C);	  129.6	  (2C);	  128.5	  (CH);	  128.5	  (CH);	  128.3	  (4CH);	  128.2	  (4CH);	  127.6	  (3CH);	  127.6	  (3CH);	  127.5	  (CH);	  127.5	  (2CH);	  127.07	  (CH);	  126.8	  (2CH);	  126.8	  (CH);	  126.7	  (CH);	  126.6	  (CH);	  126.6	  (2CH);	  126.4	  (CH);	  126.3	  (CH);	  123.8	   (CH);	   123.5	   (CH);	   123.4	   (2CH);	   122.4	   (CH);	   52.5	   (CHanti);	   51.6	   (CHsyn);	   40.4	   (2CHsyn+anti);	  10.5	  (2CH3syn+anti).	  HPLC-­‐MS:	  tr:	  (syn)	  15.0min;	  tr:	  (anti)	  15.4min;	  m/z:	  449	  (M+Na).	  HPLC	  analysis	  IC,	   gradient	   from	   99:1	   (n-­‐hexane:i-­‐PrOH)	   to	   90:10	   in	   30	   min,	   flow	   0.5mL/min.	   TM(maj):	   18.6min;	  tm(maj):	  17.9min;	  TM(min):	  15.5min;	  tm(min):	  13.9min.	  	  	  
2-­‐(2-­‐methoxy-­‐5-­‐methylphenyl)-­‐3,3-­‐diphenylallyl)octanal	  (9j)	  	  Compound	  9j	  was	  obtained	  as	  a	  yellow	  oil	  (65	  %	  yield,	  d.r	  2:1,	  88%syn	  ee;	  79%anti	  ee).	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  9.43	  (1Hanti,	  d,	  J=4.4Hz);	  9.29	  (1Hsyn,	  d,	  J	  =	  4Hz);	  7.39-­‐6.94	  (24H,	  m);	  6.78	  (2H,	  pseudo-­‐t,	  J	  =	  8.8Hz);	  6.42	  (1Hsyn,	  d,	  J	  =	  10.6Hz);	  6.40	  (1Hanti,	  d,	   J	  =	  10.6Hz);	  4.13-­‐4.10	  (2H,	  m);	  3.78	  (3Hanti,	   s);	  3.75	  (3Hsyn,	   s);	  2.82-­‐2.75	  (2Hsyn+anti,	  m);	  2.30	  (3Hanti,	  s);	  2.27	  (3Hsyn,	  s);	  1.6	  (4H,	  m);	  1.31-­‐1.13	  (16H,	  m);	   0.92-­‐0.80	   (6H,	   m).	   13C	   NMR	   (50MHz,CDCl3)	   δ	   205.6	   (CHOanti);	   204.8	  (CHOsyn);	  155.0	  (C);	  154.4	  (C);	  143.1	  (2C);	  142.9	  (C)	  ;	  142.6	  (C);	  142.5	  (C);	  139.8	  (2C);	  130.1	   (5CH);	   	   130.0	   (CH);	  129.7	   (2C);	  129.7	   (C);	  129.3	   (2CH);	  128.2	   (5CH);	  128.1	   (5CH);	   	   127.6	   (2CH);	   127.5	   (2CH);	   127.3	   (2CH);	   127.2	   (2CH);	   110.9	   (CH);	   111.0	   (CH);	   57.1	  (2CH3);	   55.4	   (2CH);	   40.51	   (2CH);	   31.7	   (CH2);	   31.6	   (CH2);	   29.5	   (CH2);	   29.1	   (CH2);	   27.8	   (2CH2);	   27.3	  (CH2);	   27.0	   (CH2);	   22.7	   (CH2);	   22.6	   (CH2);	   20.7	   (2CH3);	   14.2	   (CH3);	   14.1	   (CH3).	   HRMS	   Calcd	   for	  C31H36O2:	  440.27153	  [M]+,	   found:	  440.27135.	  HPLC	  analysis	   IC,	  (reduction	  to	  alcohol)	  gradient	  from	  99:1	   (n-­‐hexane:	   i-­‐PrOH)	   to	   90:10	   in	   30min,	   flow	   0.5mL/min.	   TM(maj):	   13.9min;	   tm(maj):	   15.0min;	  TM(min):	  15.6min;	  tm(min):	  16.0min.	  	  	  
	  
	  3-­‐(2-­‐methoxy-­‐5-­‐methylphenyl)-­‐2-­‐methyl-­‐5,5-­‐diphenylpent-­‐4-­‐enal	  (9k)	  Compound	   9k	   was	   obtained	   as	   a	   yellow	   oil	   (50%	   yield;	   d.r:	   2:1,	   93%syn	   ee;	  84%anti	   ee).1H	   NMR	   (400MHz,	   CDCl3)	   δ	   9.45	   (CHOanti,	   d,	   J	   =	   3.2Hz);	   9.27	  (CHOsyn,	  d,	  J	  =	  2Hz);	  7.28-­‐7.12	  (20H,	  m);	  6.99-­‐6.92	  (2H,	  m);	  6.86	  (1H,	  s);	  6.82	  (1H,	  s);	  6.68	  (2H,	  m);	  6.36	  (1Hanti,	  d,	  J	  =	  10.4Hz);	  6.33	  (1Hsyn,	  d,	  J=	  11.2Hz);	  4.01-­‐3.96	  (1Hsyn,	   m);	   3.8	   (1Hanti,	   m);	   3.67	   (3Hanti,	   s);	   3.62	   (3Hsyn,	   s);	   2.9-­‐2.80	  (2Hsyn+anti);	  2.19	  (3Hanti,	  s);	  2.18	  (3Hsyn,	  s);	  1.00	  (3Hsyn,	  d,	  J	  =	  6.8Hz);	  0.74	  (3Hanti,	  d,	  J=7.2Hz).	  13C	  










(2CH);	  128.01	  (2CH);	  127.5	  (2CH);	  127.4	  (2CH);	  127.2	  (CH);	  127.15	  (2CH);	  127.1	  (2CH);	  126.6	  (CH);	  110.8	  (2CH);	  55.2	  (2CH3);	  51.4	  (CHanti);	  50.8	  (CHsyn);	  41.6	  (CHanti);	  41.1	  (CHsyn);	  25.28	  (CH3syn);	  20.5	   (CH3anti);	   12.1	   (CH3anti);	   11.7	   (CH3syn).	   HRMS	   Calcd	   for	   C26H26O2:	   370.19328	   [M]+,	   found:	  440.27135.	  HPLC	   analysis	   OD-­‐H	   (reduction	   to	   alcohol),	   gradient	   from	   99:1	   (n-­‐hexane:	   i-­‐PrOH)	   to	  90:30	  in	  30	  min,	  flow	  0.5mL/min.	  TM(maj):	  18.7min;	  tm(maj):	  18.2min;	  TM(min):	  25.1min;	  tm(min):	  22.6min.	  	  
(S)-­‐2-­‐	  ((R)-­‐	  1-­‐(2-­‐methoxynaphthalen-­‐1-­‐yl)-­‐3,3-­‐diphenylallyl)octanal	  (9l)	  Compound	  was	  obtained	  9l	  as	  a	  yellow	  oil	  (71%	  yield,	  d.r	  3:1,	  91%syn;	  68%anti	  ee	   ).	  1H	   NMR	   (200MHz,	   CDCl3)	   δ	   syn	  9.17	   (CHO,	   d,	   J	   =	   4.4Hz);	   7.75	   (2H,	   d,	   J	   =	  9.2Hz);	  7.34	  (2H,	  d,	  J	  =	  7Hz);	  7.28-­‐7.22	  (10H,	  m);	  7.02	  (2H,	  d,	  J	  =	  5.4Hz);	  6.92	  (1H,	  d,	   J	   =	  9.4Hz);	  4.62-­‐4-­‐6	   (1H,	  m);	  4.00	   (3H,	  bs);	  3.32-­‐3.30	   (1H,	  m);	  1.76-­‐1.72	   (2H,	  m);	  1.29	   (8H,	  m);	  0.91	   (3H,	   t,	   J	   =	  6.4Hz).	   13C	   NMR	   (50MHz,	   CDCl3)	   δsyn	   204.4	  (CHO);	   142.2	   (C);	   139.8	   (2C);	   132.0	   (C);	   130.1	   (2CH);	   129.5	   (2C);	   129.3	   (CH);	  129.2	  (CH);	  128.5	  (CH);	  128.4	  (CH);	  128.1	  (4CH);	  127.0	  (4CH);	  126.3	  (CH);	  123.2	  (2CH);	  121.9	  (C);	  99.8	  (CH);	  56.0	  (CH);	  56.0	  (CH3);	  31.6	  (CH2);	  29.4	  (CH2);	  29.0	  (CH2);	  27.2	  (CH2);	  22.6	  (CH2);	   14.1	   (CH3).	   	   HPLC-­‐MS:	   tr:	   (syn)	   27.1min;	   m/z:	   350	   (M-­‐octanal).	   HRMS	   Calcd	   for	   C34H36O2:	  476.27153	  [M]+,	  found:	  440.27135.	  HPLC	  analysis	   IC,	  gradient	  from	  99:1	  (n-­‐hexane:i-­‐PrOH)	  to	  90:10	  in	   30	   min,	   flow	   0.5mL/min.	   TM(maj):	   17.7min;	   tm(maj):	   15.8min;	   TM(min):	   14.9min;	   tm(min):	  13.9min.	  	  
	  
(2R,3S)-­‐3-­‐(2-­‐methoxynaphtalen-­‐1-­‐yl)-­‐2-­‐methyl-­‐5,5-­‐diphenylpent-­‐4-­‐enal	  (9m)	  Compound	  9m	  was	  obtained	  as	  a	  yellow	  oil	  (75%	  yield,	  d.r	  5:1,	  94%syn;	  87%anti	  ee).	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  syn	  9.26	  (1H,	  d,	  J=2.6Hz);	  7.79-­‐7.7	  (2H,	  m);	  7.4-­‐7-­‐24	   (12H,	  m);	  7.03-­‐6.99	   (2H,	  m);	  6.94	   (1H,	  d,	   J=10Hz);	  4.53	   (1H,	  m);	  3.99	   (3H,	  bs);	  3.4-­‐3.43	  (1H,	  m);	  1.22	  (3H,	  d,	  J=7Hz).	  13C	  NMR	  (100MHz,	  CDCl3)	  δsyn	  204.6	  (CHO);	   142.2	   (2C);	   139.8	   (2C);	   132.1	   (2C);	   130.1	   (2CH);	   130	   (CH);	   129.5	   (C);	  129.2	  (CH);	  129.0	  (CH);	  	  128.6	  (CH);	  128.4	  (CH);	  128.1	  (CH);	  128	  (CH);	  127.2	  (CH);	  127.1	  (CH);	  127.0	  (2CH);	   126.3	   (2CH);	   123.2	   (2CH);	   56.0	   (CH3+CH);	   49.4	   (CH);	   13.5	   (CH3).	  HRMS	   Calcd	   for	   C29H26O2:	  406.19328	  [M]+,	  found:	  406.19344.	  HPLC	  analysis	   IC,	  gradient	  from	  99:1	  (n-­‐hexane:i-­‐PrOH)	  to	  90:10	  in	  30	  min,	  flow	  0.5mL/min.	  TM(maj):	  19.3min;	  tm(maj):	  18.7min;	  TM(min):	  15.9min;	  tm(min):	  15.1.	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conversion	  took	  place	  (monitored	  by	  TLC)	  at	  the	  same	  temperature.	  Then	  the	  reaction	  was	  quenched	  with	  water.	   The	  organic	   layer	  was	   separated,	   and	   the	   aqueous	   layer	  was	   extracted	   twice	  with	  Et2O.	  The	  combined	  organic	  layer	  was	  washed	  with	  water,	  dried	  over	  Na2SO4,	  and	  concentrated.	  The	  residue	  was	   purified	   by	   flash	   chromatography	   (SiO2:	   cyclohexane:	   Et2O	   =	   7:3),	   to	   obtain	   9n	   as	   a	   yellow	   oil	  (73%	  yield,	  d.r	  20:1,	  99%syn;	  55%anti).	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  syn	  9.3	  (1H,	  d,	  J=3Hz);	  7.78-­‐7.7	  (2H,	  m);	  7.36-­‐7.01	  (19H,	  m);	  6.97	  (1H,	  d,	  J=9.8Hz);	  4.65	  (1H,	  m);	  4.0	  (3H,	  bs);	  3.7	  (1H,	  m);	  3.0	  (2H,	  d,	  J	  =	  7Hz).	   13C	   NMR	   (50MHz,	   CDCl3)	   δsyn	   203.5	   (CHO);	  142.2	   (2C);	   	   139.8	   (C);	  139.4	   (2C);	  132.2	   (C);	  130.2	  (2CH);	  129.6	  (C);	  129.4	  (CH);	  	  129.1	  (3CH);	  128.5	  (3CH);	  128.2	  (3CH);	  127.3	  (2CH);	  127.2	  (3CH);	  126.4	   (CH);	   126.2	   (CH);	   123.4	   (2CH);	   121.3	   (C);	   113.4	   (CH);	   	   56.7	   (CH);	   56.1	   (CH3+CH);	   29.8	   (CH2).	  
HRMS	  Calcd	  for	  C35H30O2:	  482.22458	  [M]+,	  found:	  406.19344.	  HPLC	  analysis	  ODH,	  gradient	  from	  99:1	  (n-­‐hexane:i-­‐PrOH)	   to	   90:10	   in	   30	   min,	   flow	   0.5mL/min.	   TM(maj):	   26.2min;	   tm(maj):	   24.0min;	  TM(min):	  19.1min;	  tm(min):	  20.1min.	  	  
(2R,3S)-­‐	  3-­‐(2-­‐methoxy-­‐6-­‐(methoxymethyl)phenyl)-­‐2-­‐methyl-­‐5,5-­‐diphenylpent-­‐4-­‐enal	  (9o)	  Following	  the	  same	  procedure	  described	  for	  9n,	  compound	  9o	  was	  obtained	  as	  a	  yellow	  oil	  (75%	  yield,	  d.r	  11:1,	  96%syn;	  85%anti	  ee).	  1H	  NMR	  (200MHz,	  CDCl3)	  
δsyn	  9.31	  (1H,	  d,	   J=2.2Hz),	  7.43-­‐7.13	  (11H,	  m);	  6.92-­‐6.79	  (3H,	  m);	   	  3.93	  (3H,	  s);	  	  3.84	  (1H,	  t,	  J	  =	  9.8Hz);	  3.6-­‐3.4	  (2H,	  m);3.31-­‐3.24	  	  (1H,	  m);	  	  3.02	  (3H,	  s);	  1.20	  (3H,	  d,	  J=	  7Hz).	  13C	  NMR	  (100MHz,	  CDCl3)	  	  δ	  syn	  	  205.2	  (CHO);	  142.2	  (2C);	  140.1	  (C);	  136.9	  (	  2C);	  130.0	  (1CH);	  129.9	  (2CH);	  128.6	  (2CH);	  128.4	  (C);	  128.1	  (2CH);	  127.5	  (CH);	  127.1	  (CH);	  127.0	  (CH);	  126.9	  (2CH);	  122.2	  (CH);	  111.5	  (CH);	  	  72.8	  (CH2);	  57.5	  (CH);	  	  55.3	  (2CH3O);	  30.9	  (CH);	  13.3	  (CH3).	  ESI-­‐MS	  m/z:	   423	   (M+Na).	   	   HPLC	   analysis	   IC	   (reduction	   to	   alcohol),	   gradient	   from	   99:1	   (n-­‐hexane:	  i-­‐PrOH)	  to	  90:10	  in	  30	  min,	  flow	  0.5	  mL/min.	  TM(maj):	  30.1min;	  tm(maj):	  31.4min;	  TM(min):	  25.1	  min;	  tm(min):	  24.6min.	  	  
	  
Determination	  of	  relative	  and	  absolute	  configuration	  	  Compounds	   14b	   and	   15b	   were	   prepared	   from	   9b	   through	   the	   sequence	   described	   in	   scheme	   6;	  compounds	  ent-­‐14b	  and	  ent-­‐15b	  were	  prepared	  from	  ent-­‐9b,	  obtained	  by	  using	  ent-­‐3	  ((2S,5S)-­‐(−)-­‐2-­‐





























ECD	   spectra.	   UV	   absorption	   spectra	  were	   recorded	   at	   25	   °C	   in	   the	   190-­‐300	   nm	   spectral	   region	   in	  acetonitrile	   by	  means	   of	   Perkin-­‐Elmer	   Lambda	   45	   spectrophotometer.	   The	   cell	   path	   length	  was	   0.1	  mm,	  concentration	  was	  5.7	  mM	  for	  14b	  and	  6.3	  mM	  for	  ent-­‐14b.	  CD	  spectra	  were	  recorded	  at	  25°C	  in	  acetonitrile	  by	  employing	  a	   Jasco	  J-­‐810	  spectropolarimeter,	   in	  the	  range	  190-­‐300	  nm,	  with	  the	  same	  concentration	   and	   path	   lengths	   of	   0.2	  mm.	   The	   values	   are	   expressed	   in	   terms	   of	   the	  molar	   circular	  dichroism	  Δε,	  expressed	  as	  L	  mol-­‐1cm-­‐1.	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Figure	   S1.	  Graphical	   representations	  of	   the	   two	  puckering	  conformations	  assumed	  by	   the	  modelled	  compounds.	  Generic	  substituent	  groups	  attached	  to	  C4	  and	  C5	  are	  represented	  by	  spheres	  of	  different	  colours	  (C3:	  ice	  blue	  and	  green;	  C4:	  dark	  red	  and	  purple).	  The	   DFTB	   optimised	   structures	   of	   the	   four	   stable	   isomers	   (two	   conformers	   for	   each	   of	   the	   two	  stereoisomers,	   see	   Figure	   S2)	   found	   in	   the	   preliminary	   study	   were	   used	   for	   the	   following	  investigations.	  
Accurate	   conformational	   investigation.	   The	   structure	   of	   the	   four	   isomers	   has	   been	   subjected	   to	  geometry	  optimization	  in	  search	  for	  local	  minima	  of	  the	  potential	  energy	  surface	  (PES).	  The	  nature	  of	  the	  found	  critical	  points	  was	  then	  ascertained	  by	  means	  of	  frequency	  calculations.	  All	  calculations	  have	  been	  performed	  with	  the	  Gaussian	  0332]	  (G03.E01)	  software	  package	  at	  the	  DFT(B3LYP)/6-­‐31+g*	  level	  using	   the	  default	   convergence	   criteria;	   [33-­‐35]	   solvent	   effects	  due	   to	   the	  presence	  of	   acetonitrile	  were	  taken	  into	  account	  by	  using	  the	  SCRF-­‐CPCM[36-­‐38]	  method.	  All	  DFT	  optimized	  geometries,	  represented	  in	  S2,	  resulted	  to	  be	  similar	  to	  those	  obtained	  at	  the	  SCC-­‐DFTB	  level,	  but	  DFT	  energy	  differences	  are	  generally	   considered	  more	  accurate	  and	   thus	   reported	  here	   (Table	  S1).	  After	  all	   critical	  points	  have	  been	   confirmed	  as	  minima	  on	   the	  PES	  by	   frequency	   calculations	   (no	   imaginary	   frequency	  value	  has	  been	  found)	  a	  local	  conformational	  investigation	  was	  performed	  to	  exclude	  recondite	  shallow	  minima	  overlooked	  by	  the	  optimization	  procedure.	  To	  this	  purpose	  the	  puckering	  of	  C4	  was	  constrained	  while	  a	  relaxed	  scan	  was	  performed	  on	  the	  dihedral	  angle	  centred	  on	  the	  bond	  connecting	  the	  phenyl	  group	  to	   the	   4-­‐membered	   ring.	   For	   all	   four	   isomers	   no	   other	  minimum	  was	   found	   by	   rotating	   the	   phenyl	  group,	   thus	   confirming	   that	   the	   conformational	   freedom	   of	   all	   stereoisomer	   is	   limited	   to	   the	   two	  considered	  puckering	  conformers.	  	  
	  
Figure	  S2.	  DFT(B3LYP)/6-­‐31+g*	  optimised	  geometries	  of	  the	  two	  puckering	  conformers	  (A,B)	  of	  the	  
anti	  stereoisomers	  (3S,4R)	  and	  (3R,4S).	  
Table	  S1.	  Energy	  values	  computed	  at	  the	  DFT(B3LYP)/6-­‐31+g*	  level	  for	  the	  four	  isomers.	  Energy	  (E),	  zero-­‐point	   energy	   (ZPE),	   Gibbs	   energy	   correction	   (G	   corr.),	   zero-­‐point	   corrected	   energy	   (E+ZPE),	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Gibbs	   free	   energy	   (G),	   Gibbs	   free	   energy	   difference	   with	   respect	   the	   more	   stable	   isomer	   (3B),	  frequency	  value	  of	  the	  fist	  normal	  modes	  (ν1,	  ν2,	  ν3).	  
	   E	  (hartree)	   ZPE	  (hartree)	   G	  corr.	  (hartree)	   E+ZPE	  (hartree)	   G	  (hartree)	   ΔG	  (kcal	  mol-­‐1)	   ν1	  (cm-­‐1)	   ν2	  (cm-­‐1)	   ν3	  (cm-­‐1)	  
(3S,4R
)A	  
-­‐576.884053	   0.206815	   0.168974	   -­‐576.677238	   -­‐576.715079	   0.09	   39.7642	   61.9151	   88.5092	  
(3S,4R
)B	  
-­‐576.879912	   0.206980	   0.168594	   -­‐576.672932	   -­‐576.711318	   2.45	   24.7361	   50.3873	   93.8375	  
(3R,4S
)A	  
-­‐576.879748	   0.206824	   0.167581	   -­‐576.672924	   -­‐576.712167	   1.91	   14.8603	   34.9199	   94.5158	  
(3R,4S
)B	  
-­‐576.884172	   0.206778	   0.168956	   -­‐576.677394	   -­‐576.715216	   0.00	   39.7877	   63.2234	   89.1317	  	  The	  ECD	  spectra	  for	  the	  four	  isomers	  were	  computed	  [39-­‐46]	  at	  the	  TD-­‐DFT(B3LYP)/6-­‐31+g*	  level	  using	  the	   previously	   optimised	   geometries.	   40	   transitions	   have	   been	   used	   to	   cover	   the	   interesting	  absorption	  range.	  Spectra	  have	  been	  obtained	  by	  using	  the	  SpecDis	  software[47]	  setting	  a	  bandwidth	  γ	  =	  0.16	  eV.[44,	  48,	  49]	  For	  each	  stereoisomer	  the	  spectrum	  was	  obtained	  by	  adding	  the	  spectra	  of	  the	  two	  conformers	  A	   and	  B,	   according	   to	   Boltzmann	  weights	   computed	   by	   their	   relative	   Gibbs	   free	   energy	  (Table	  S2).[47]	  For	  both	  enantiomers	  the	  resulting	  spectrum	  is	  dominated	  by	  the	  component	  due	  to	  the	  conformer	  where	  the	  phenyl	  group	  is	  placed	  in	  and	  equatorial	  position,	  namely	  (3S,4R)A	  and	  (4S,3R)A	  (Figure	  S3,S4).	  The	  obtained	  spectra	  have	  been	  compared	  with	  those	  measured	  experimentally	  for	  14	  and	  ent-­‐14;	  As	  shown	  in	  Table	  S2,	  the	  ECD	  spectrum	  calculated	  for	  the	  (3S,4R)	  configuration	  matched	  the	  profile	  and	  relative	   intensities	   of	   the	   experimental	   spectrum	   of	  14,	   while	   the	   ECD	   spectrum	   calculated	   for	   the	  (3R,4S)	  configuration	  was	  in	  agreement	  with	  the	  experimental	  spectrum	  of	  ent-­‐14.	  Consequently,	  the	  absolute	   (3S,4R)	   configuration	   was	   assigned	   to	   compound	   14	   and	   the	   (3R,4S)	   configuration	   to	  compound	  ent-­‐14.	  As	  a	  result,	  the	  (3S,4S)	  and	  (3R,4R)	  configurations	  were	  attributed	  to	  the	  minor	  syn	  isomers	  15	  and	  ent-­‐15,	  respectively.	  	  The	  absolute	  configurations	  of	  all	  other	  products	  were	  assigned	  on	  the	  basis	  of	  regularity	  in	  their	  NMR	  spectra	  and	  of	  the	  assumption	  of	  a	  common	  mechanistic	  path.	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Figure	  S3.	  Calculated	  Optical	  Rotation	  for	  the	  two	  conformers	  of	  each	  enantiomer.	  
	  
Figure	  S4.	  Comparison	  between	  experimental	  and	  computed	  Optical	  rotation.	  	  Indium	   (III)	   promoted	   Organocatalytic	   enantioselective	   α-­‐alkylation	   of	  aldehydes	  with	  Benzhylic	  and	  benzhydrylic	  alcohols.	  	  	  
Starting	  materials	  	  




NMR	  (400MHz,CDCl3)	  δ	  7.30	  (d,	  2H,	  J	  =	  8.7Hz);	  7.22	  (d,	  2H,	  J	  =	  8.3Hz),	  6.87	  (d,	  2H,	  J	  =	  8.7Hz),	  6.70	  (d,	  2H,	   J	   =	   8.7Hz),	   5.75	   (m,	   1H),	   3.80	   (s,	   3H;	   OCH3),	   2.94	   (s,	   6H,	   N(CH3)2),	   1.56	   (s,	   OH).	   13C	   NMR	  
(50MHz,CDCl3)	  δ	  158.8,	  136.6	  127.6	  (3C),	  127.5	  (3C),	  113.5(2C),	  112,5	  (2C),	  75.6,	  55.2,	  40.7(2C)	  	  
	  
4-­‐(dimethylamino)phenyl)(phenyl)methanol	  (18)	  A	   vial	   equipped	  with	  magnetic	   stir	   bar	   and	   under	   innert	   atmosphere	  was	  charged	   with	   phenylmagnesium	   bromide	   (0.2mmol,	   1.0M	   in	   THF)	   in	  anhydrous	  THF	  (0.1	  M)	  The	  solution	  was	  stirred	  during	  5	  minuts	  at	  0°C,	  and	  p-­‐N-­‐dimethylaminobenzaldehyde	  (0.2mmol,	  30mg)	  was	  added	  at	   the	  same	  temperature,	   and	   the	  mixture	  was	  warmed	  at	   r.t	   and	  stirring	  until	  no	   further	  conversion	   took	  place	  (controlled	  by	  TLC).	  The	  reaction	  was	  worked	  up	  with	  H2O.	  The	  organic	  layer	  was	  separated,	  and	  the	  aqueous	  layer	  was	  extracted	  twice	  with	  EtOAc.	  The	  collect	  organic	  layers	  were	  dried	  over	  Na2SO4	  and	  concentrated	   under	   reduce	   pressure	   obtain	   a	   yellow	   oil.	   The	   residue	   was	   purified	   by	   flash	  chromatography	   (SiO2;	   cyclohexane:	   Et2O;	   7:3)	   give	   18	   as	   yellow	   oil.	   (Yield	   90%).	   1H	   NMR	  
(400MHz,CDCl3)	  δ	  7.38	  (d,	  2H,	  J	  =	  6.4Hz);	  7.31	  (t,	  2H,	  J	  =	  7.2Hz);	  7.23	  (m,	  1H);	  7.20	  (d,	  2H,	  J	  =	  8.4Hz);	  6.68	  (d,	  2H,	  J	  =	  8.8Hz);	  5.76	  (s,	  1H);	  2.92	  (s,	  6H);	  2.00	  (s,	  OH).	  13C	  NMR	  (50MHz,CDCl3)	  δ	  150.0;	  144;	  131.8;	  128.1	  (2C);	  127.6	  (2C);	  126.9(2C);	  126.2;	  112.4	  (2C);	  75.8;	  40.5;	  40.4.	  	  	  
biphenyl-­‐2-­‐yl(4-­‐(dimethylamino)phenyl)methanol	  (19)	  	  A	   vial	   equipped	   with	   magnetic	   stir	   bar	   and	   under	   inert	   atmosphere	   was	  charged	  with	  2-­‐bromodiphenyl	   (1mmol,	  233mg)	  and	  anhydrous	  THF	   (1M,	  1mL).	   The	   solution	  was	   stirred	   at	   -­‐78°C	   for	   5minuts,	   and	   a	   solution	   of	   n-­‐BuLi	  (0.5mL,	  2.5M	  in	  hexane)	  was	  added	  slowly.	  The	  mixture	  was	  warmed	  at	   0°C	   and	   stirring	   during	   1	   hours.	   After	   p-­‐N-­‐dimethylaminobenzadldehyde	   (1mmol,	   149mg)	   was	  added	   at	   the	   same	   temperature	   and	   the	   solution	   was	   warmed	   at	   r.t	   and	   stirring	   until	   no	   further	  conversion	  took	  place	  (controlled	  by	  TLC).	  The	  reaction	  was	  worked	  up	  with	  NH4Cl	  aq	  solution.	  The	  organic	   layer	   was	   separated,	   and	   the	   aqueous	   layer	   was	   extracted	   twice	   with	   EtOAc.	   The	   collect	  organic	  layers	  were	  dried	  over	  Na2SO4	  and	  concentrated	  under	  reduce	  pressure	  give	  19	  a	  yellow	  oil.	  The	  residue	  was	  purified	  by	  flash	  chromatography	  (SiO2;	  cyclohexane:Et2O;	  7:3).	  Yiled	  90%.	  1H	  NMR	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(4-­‐(dimethylamino)phenyl)(2-­‐methoxyphenyl)methanol	  	  According	   at	   the	   same	   procedure	   from	   compound	   19	   using	   1-­‐bromo-­‐2-­‐methoxybenzene.	  The	  residue	  was	  purified	  by	  flash	  chromatography	  (SiO2,	  cyclohexane:	  Et2O,	  7:3)	  to	  afford	  the	  product	  as	  a	  yellow	  oil	  (80%	  yield)	  1H	  
NMR	  (200MHz,	  CDCl3)	  δ	  7.4	  -­‐7.26	  (m,	  4H);	  7.1-­‐6.8	  (m,	  2H);	  6.74	  (d,	  2H,	  J	  =	  8.8Hz);	  6.1	  (s,	  1H);	  3.83	  (s,	  3H);	  2.95	  (s,	  6H).	  13C	  NMR	   (50MHz,CDCl3)	   δ	  156.6	  (C);	  149.8	  (C);	  132.4	  (C);	  131.3	  (C);	  128.2	  (1CH);	  127.5	  (3CH);	  120.5	  (CH);	  112.2	  (2CH);	  110.4	  (CH);	  71.1	  (CH);	  55.3	  (OCH3);	  40.5	  (2	  CH3)	  	  	  
(2-­‐(benzyloxy)phenyl)(4-­‐(dimethylamino)phenyl)methanol.	  According	   at	   the	   Grignard	   procedure	   using	   4-­‐N,N-­‐dimethylaniline	  magnesium	  bromide	  solution	  (1.1eq,	  0.5M	  in	  THF)	  at	  0°C	  in	  1mL	  THF	  was	  slowly	   added	   (1eq)	   of	   2-­‐(benzyloxy)benzaldehyde.	   The	   residue	   was	  purified	  by	  flash	  chromatographic	  (SiO2,	  cyclohexane:	  EtOAc,	  7:3)	  to	  afford	  the	  product	  as	  a	  yellow	  solid.	  1H	  NMR	  (200MHz,	  CDCl3)	  δ	  7.47-­‐7.24	  (m,	  9H);	  7.06-­‐6.94	  (m,	  2H);	  6.74	  (d,	  2H,	  J	  =	  8.8Hz);	  6.09	  (s,	  1H);	  5.08	  (s,	  2H);	  2.98	  (s,	  6H).	  13C	  NMR	  (125MHz,CDCl3)	  δ	  155.6	  (C);	  149.9	  (C);	   136.6	   (C);	   132.2	   (C);	   131.5	   (C);	   128.4	   (2CH);	   128.2	   (CH);	   127.8	   (CH);	   127.6	   (2CH);	   127.5(CH);	  127.3(2H);	  120.8(CH);	  112.3	  (2CH);	  111.7	  (CH);	  71.9	  (CH);	  69.9	  (CH2);	  40.7	  (CH3);	  40.6	  (CH3).	  	  
	  













(4-­‐methoxyphenyl)(thiophen-­‐2-­‐yl)methanol	  A	   vial	   equipped	   with	   magnetic	   stir	   bar	   and	   under	   inert	   atmosphere	   was	  charged	   with	   2-­‐iodothiophene	   (4.4	   mmol,	   487	   ml)	   and	   anhydrous	   THF	   (5	  mL).	  the	  solution	  was	  stirred	  at	  -­‐78º	  C	  for	  5	  minutes,	  and	  a	  solution	  of	  n-­‐BuLi	  (2.5	  M	  in	  hexane,	  1.9	  mL)	  was	  added	  slowly.	  The	  mixture	  was	  stirred	  during	  1	  hours	  at	  the	  same	  temperature.	  After	  p-­‐OMe-­‐benzaldehyde	  (3.67	  mmol,	  500	  mg)	  was	  slowly	  added	  at	  the	  same	  temperature	  and	  the	  solution	  was	  warmed	  at	  0º	  C	  and	  stirring	  until	  no	   further	  conversion	  took	  place	   (	   controlled	  by	  TLC).	   The	   reaction	  was	  worked	  up	  with	   saturated	   solution	  of	  NH4Cl.	   The	  organic	   layer	   was	   separated,	   and	   the	   aqueous	   layer	   was	   extracted	   twice	   with	   EtOAc.	   The	   collect	  organic	  layers	  were	  dried	  over	  Na2SO4	  and	  concentrated	  under	  reduce	  pressure	  obtain	  yellow	  oil.	  The	  residue	   was	   purified	   by	   flash	   chromatography	   (SiO2;	   cyclohexane:	   EtOAc,	   8:2)	   obtain	   the	   desired	  product	  as	  an	  white	  solid,	  60%	  yield.	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  7.38	  (d,	  J	  =	  8.7	  Hz,	  2H);	  7.26	  (dd,	  J	  =	  4.7	  Hz,	  J	  =	  5.9	  Hz,	  1H),	  6.95	  (dd,	  J	  =	  3.5	  Hz,	  J	  =	  5.1	  Hz,	  1H);	  6.91	  (d,	  J	  =	  8.7	  Hz,	  1H);	  6.89	  (m,	  1H);	  6.03	  (d,	  J	  =	  3.5	  Hz,	  1H);	  3.82	  (s,	  3H);	  2.38	  (d,	  J	  =	  3.9	  Hz,	  1H).	  13C	  NMR	   (50	  MHz,	  CDCl3)	  δ	  159.1	  (C);	  148.4.	  (C);	  135.4	  (C);	  127.6	  (2CH);	  126.5	  (CH);	  125.0	  (CH);	  124.5	  (CH);	  113.7	  (2CH);	  71.8	  (CH);	  55.1	  (2CH3).	  ESI-­‐MS:	  m/z	  =	  	  203.1	  [M-­‐H2O]+,	  243.1	  [M+Na]+.	  
	  
Synthesis	  of	  alcohols	  from	  benzylic	  alcohols	  	  
	  	   	  To	  a	   solution	  of	  4-­‐(dimethylamino)benzaldehyde	   (1.34	  mmol,	  200	  mg)	   in	  anhydrous	  THF	  (5	  ml)	  at	   -­‐78	  °C,	  n-­‐BuLi	  (2.5	  M	   in	  hexane,	  1.34	  mmol,	  540	  mL)	  was	  added	  dropwise	  at	  -­‐78°C.	  After	  that,	  the	  solution	  was	  wormed	  up	  and	  stirred	  at	  0	  °C	  until	  complete	  consumption	  of	   the	  aldehyde	  (TLC)	  and	  water	   (2	  mL)	  was	  added.	  The	   solvent	  was	  evaporated	  under	   reduced	  pressure,	  CH2Cl2	   (10	  mL)	  was	  added	   and	   the	   organic	   phases	  were	   extracted	  with	   CH2Cl2	   (2	   x	   10	  mL).	   The	   collected	   organic	   layer	  were	  washed	  with	  brine,	  dried	  over	  Na2SO4	  and	  concentrated.	  	  Flash	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   9/1)	   of	   the	   residue	   give	   the	   desired	   alcohol	   in	  75%	  yield	  (207mg).	  Yellowish	  liquid;	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  0.90	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.24	  (m,	  1H),	  1.36	  (m,	  2H),	  1.70	  (m,	  1H),	  1.83	  (m,	  2H),	  4.57	  (t,	  J	  =	  6,7	  Hz,	  1H),	  6.74	  (d,	  J	  =	  8.6	  Hz,	  2H),	  7.23	  
OH
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(d,	  J	  =	  8.6	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C)	  δ	  14.0,	  22.6,	  28.2,	  38.4,	  40.6	  (2C),	  74.4,	  112.5	  (2C),	  127.8	  (2C),	  132.9,	  150.1;	  ESI-­‐MS:	  m/z	  =	  	  208.2	  [M+H]+,	  230.1	  [M+Na]+,	  437.3	  [2M+Na]+.	  	   To	   a	   solution	   of	   4-­‐(dimethylamino)benzaldehyde	   (1.0	   mmol,	   149	   mg)	   in	  anhydrous	  THF	  (1	  ml)	  at	  0	   °C,	  EtMgBr	   (1.0	  M	   in	  THF,	  1.1	  mmol,	  1.1	  mL)	  was	  added	   dropwise	   at	   0°C.	   After	   that,	   the	   solution	   was	   stirred	   at	   0	   °C	   until	  complete	  consumption	  of	  the	  aldehyde	  (TLC)	  and	  water	  (1	  mL)	  was	  added.	  The	  solvent	   was	   evaporated	   under	   reduced	   pressure,	   CH2Cl2	   (10	  mL)	   was	   added	  and	   the	   organic	   phases	   were	   extracted	   with	   CH2Cl2	   (2	   x	   10	   mL).	   The	   collected	   organic	   layer	   were	  washed	  with	   brine,	   dried	   over	   Na2SO4	   and	   concentrated.	   Flash	   chromatography	   (cyclohexane/ethyl	  acetate	  =	  9/1)	  of	  the	  residue	  give	  the	  desired	  alcohol	  in	  93%	  yield	  (167	  mg).	  Colorless	  oil;	  yield:	  192	  mg	  (80%);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  0.92	  (t,	  J	  =	  7.5	  Hz,	  3H),	  1.74	  (m,	  1H),	  1.84	  (m,	  1H)	  ,2.03	  (bs,	  1H),	  2.96	  (s,	  6H),	  4.49	  (t,	  J	  =	  6.7	  Hz,	  1H),	  6.74	  (d,	  J	  =	  8.6	  Hz,	  2H),	  7.23	  (d,	  J	  =	  8.6	  Hz,	  2H);	  13C	  NMR	  









Synthesis	  of	  alcohol	  	  	  
	  	  In	  a	  three-­‐neck	  round	  botton	  flask	  charged	  with	  nitrogen,	  to	  a	  suspension	  of	  metal	  Zn	  (6.0	  mmol,	  390	  mg)	  in	  anhydrous	  THF	  (3.0	  ml),	  TMSCl	  (0.96	  mmol,	  121	  ml)	  was	  added	  at	  room	  temperature	  and	  the	  reaction	  was	  put	  under	  reflux	  three	  times.	  After	  15	  minutes,	  ethyl	  2-­‐bromoacetate	  (6.0	  mmol,	  665	  ml)	  was	  added	  dropwise	  and	  the	  reaction	  was	  left	  under	  reflux	  until	  the	  complete	  consumption	  of	  metal	  zink.	   The	   solution	   was	   cooled	   down	   at	   rt,	   than	   a	   solution	   of	   4-­‐(dimethylamino)benzaldehyde	   (6.9	  mmol,	   446	  mg)	   in	   dry	  THF	   (30ml)	  was	   added	  dropwise.	   After	   2.5	   hours,	   AcOEt	  was	   added	   and	   the	  resulting	  mixture	  was	  filtered.	  The	  collected	  organic	  layer	  were	  washed	  with	  brine,	  dried	  over	  Na2SO4	  and	   concentrated.	   Flash	   chromatography	   (cyclohexane/ethyl	   acetate	  =	  9/1)	  of	   the	   residue	  give	  A	   in	  25%	  yield	  (348	  mg).	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(B):	   colourless	   oil;	   yield:	   192	   mg	   (80%);	   1H	   NMR	   (400	   MHz,	   CDCl3,	  
25°C)	  δ	  2.00-­‐2.12	  (m,	  1H),	  1.86-­‐1.96(m,	  1H),	  2.49	  (bs,	  2H),	  2.96	  (s,	  6H),	  3.86	  (dd,	  J	  =	  5.1	  Hz,	  J	  =	  5.9	  Hz,	  2H),	  4.87	  (dd,	  J	  =	  3.54	  Hz,	  J	  =	  9.1	  Hz,	  1H),	  6.74	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.25	  (d,	  J	  =	  8.7	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  
25°C)	  δ	  40.3,	  40.6	  (2C),	  61.6,	  74.4,	  112.5	  (2C),	  126.7	  (2C),	  128.6,	  150.3;	  ESI-­‐MS:	  m/z	  =196.2	  [M+H]+,	  218.1	  [M+Na]+,	  413.3	  [2M+Na]+.	  	  To	  a	  solution	  of	  B	  (0.25	  mmol,	  48.8	  mg)	  in	  THF	  (1.0	  mL)	  at	  0°C,	  NaH	  (60%	  in	  mineral	  oil)	  (0.23	  mmol,	  9.2	  mg)	  was	  added.	  After	  30	  minutes,	  TBSCl	   (0.23	  mmol,	  34.5	  mg)	  was	  added	  and	   the	   reaction	  was	  stirred	  at	  0°C	  for	  2	  hours.	  The	  collected	  organic	  layer	  were	  washed	  with	  brine,	  dried	  over	  Na2SO4	  and	  concentrated.	  Flash	  chromatography	  (cyclohexane/ethyl	  acetate	  =	  7/3)	  of	  the	  residue	  give	  2k	  in	  89%	  yield	  (68.7	  mg).	  	  	   affording	   the	  desired	  alcohol	  as	  a	  yellow	  oil;	  yied:	  68.7	  mg	  (89%);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δ=	  -­‐0.08	  (s,	  6H),	  0.92	  (s,	  9H),1.83-­‐1.91	  (m,	  1H),	  1.91-­‐2.02	  (m,	  1H),	  2.92	  (s,	  6H),	  3.40	  (bs,	  1H),	  3.	  82	  (m,	  2H),	  4.84	  (dd,	  J	  =	  3.5	  Hz,	  J	  =	  8.3	  Hz,	  1H),	  6.72	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.23	  (d,	  J=	  8.7	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	  δ=	  -­‐5.5	  (2C),	  18.1,	  25.9	  (3C),	  40.7	  (2C),	  62.1,	  73.4,	  112.5	  (2C),	  126.6	  (2C),	  132.6,	  150;	  ESI-­‐MS:	  m/z	  =	  292.3	  [M-­‐OH]+,	  310.3	  [M+H]+,	  332.1	  [M+Na]+,	  641.3	  [2M+Na]+.	  
	  
Synthesis	  of	  products	  	  
	  
	  





pressure.	  Flash	  chromatography	  (cyclohexane/ethyl	  acetate	  =	  8/2)	  of	  the	  residue	  give	  C	  in	  61%	  yield	  (505	  mg).	   	  Affording	  the	  desired	  alcohol	  as	  a	  yellow	  oil;	  yield:	  505	  mg	  (61%);	  1H	  
NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  1.31	  (t,	  J	  =	  7.5	  Hz),	  2.96	  (s,	  6H),	  4.24	  (q,	  J	  =	  7.5	  Hz,	  2H),	  5.48	  (bs,	  1H),	  6.71	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.38	  (d,	  J	  =	  8.7	  Hz,	   2H);	   13C	   NMR	   (100	  MHz,	   CDCl3,	   25°C):	   δ=	   14.0,	   40.0	   (2C),	   62.0,	  64.2,	   77.5,	   86.8,	   112.3	   (2C),	   125.1,	   127.9	   (2C),	   132.0,	   154.3;	   ESI-­‐MS:	  m/z	   =	   	   403.1	   [M+Na]+,	   783.3	  [2M+Na]+.	  
	  To	   a	   solution	   of	  C	   (0.5	  mmol,	   125	  mg)	   in	  MeOH	   (3	  mL),	   Pd/C	   (10%	  wt,	   13mg)	  was	   added	   and	   the	  reaction	  was	  keep	  under	  H2	  atmosphere	   (1	  atm).	  After	  21	  hours	   the	  reaction	  was	   filtered	   through	  a	  Celite	   pad	   and	   the	   organic	   layer	   was	   separated	   and	   concentrated	   under	   reduce	   pressure.	   Flash	  chromatography:	  (cyclohexane/Et2O=	  8/2)	  mixture	  to	  give	  2l	  (90%,	  117	  mg)	  as	  yellow	  oil.	  Affording	   the	  desired	  alcohol	  as	  a	  yellow	  oil;	  yield:	  117	  mg	  (90%);	  1H	  
NMR	   (400	  MHz,	   CDCl3,	   25°C):	  δ	  1.26	  (t,	   J	  =	  7,5	  Hz	  1H),	  2.01	  (bs,	  1H),	  1.99-­‐2.18	  (m,	  2H),	  2.40	  (ddd,	  J	  =	  8.3	  Hz,	  J	  =	  2.7	  Hz,	  J	  =	  2.0	  Hz,	  2H),	  2.95	  (s,	  6H),	  4.13	  (q,	  J	  =	  7.1	  Hz,	  2H),	  4.65	  (dd,	  J	  =	  5.5	  Hz,	  J	  =	  7.1	  Hz,	  1H),	  6.73	  (d,	   J	  =	  8.7	  Hz,	  2H),	  7.23	  (d,	   J=	  8.7	  Hz,	  2H);	  13C	  NMR	   (100	  MHz,	   CDCl3,	   25°C)	  δ	  14.2,	  30.9,	  33.6,	  40.6	  (2C),	   60.4,	   73.4,	   112.5	   (2C),	   126.8	   (2C),	   131.9,	   150.3,	   173.9;	   ESI-­‐MS:	  m/z	   =	   234.2	   [M-­‐OH]+,	   252.2	  [M+H]+,	  274.1	  [M+Na]+,	  525.2	  [2M+Na]+.	  	  NH3(g)	  was	  bubbled	  for	  10	  minutes	  to	  a	  solution	  of	  2l	  (0.55	  mmol,	  138	  mg)	  in	  MeOH	  (3	  mL).	  After	  21	  hours	   the	   reaction	   was	   concentrated	   under	   reduce	   pressure	   and	   the	   product	   was	   purify	   by	   flash	  chromatography:	  (AcOEt/MeOH=	  9/1)	  to	  afford	  the	  product	  2m	  (95%,	  119	  mg)	  as	  yellow	  oil.	  	   Affording	   the	  desired	  alcohol	  as	  a	   yellow	  oil;	  yield	  119	  mg	  (95%);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δ=	  2.04	  (m,	  2H),	  2.32	  (m,	  2H),	  2.93	  (s,	  6H),	  4.65	  (t,	  J	  =	  5.2	  Hz,	  1H),	  5.71	  (bs,	  1H),	  5.87	  (bs,	  1H),	  6.70	  (d,	  J	  =	  8.8	  Hz,	  2H),	  7.21	   (d,	   J=	  8.8	  Hz,	  2H);	   13C	   NMR	   (100	  MHz,	   CDCl3,	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   The	   compound	  D	  was	   prepared	   adding	   alkyne	   derivate	   (prepared	  according	   to	   the	   literature	   procedure i )	   to	   4-­‐(dimethylamino)benzaldehyde.	   Orange	   oil;	   yield:	   94%.	   1H	   NMR	  
(400	  MHz,	  CDCl3,	  25°C)	  δ	  1.41	  (s,	  9H),	  2.91	  (s,	  6H),	  4.44	  (d,	  J	  =	  1.6	  Hz,	  2H),	  5.32	  (bs,	  1H),	  6.64	  (m,	  2H),	  7.27	  (m,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	  δ=	  28.2,	  40.0,	  40.5	  (2C),	  64.3,	  80.9,	  82.2,	  84.0,	  112.3	  (2C),	  126.2,	  126.5,	  127.8,	  128.3	  (2C),	  128.6	  (2C),	  142.0,	  150.6,	  154.1;	  ESI-­‐MS:	  m/z	  =	  286	  [M-­‐OH]-­‐,	  403.1	  [M+Na]+,	  783.3	  [2M+Na]+.	  	   To	   a	   solution	   of	  D	   (0.34	  mmol,	   129	  mg)	   in	  MeOH	   (3	  mL),	   Pd/C	  (10%	  wt,	  13	  mg)	  was	  added	  and	  the	  reaction	  was	  keep	  under	  H2	  atmosphere	   (1	   atm).	   After	   21	   hours	   the	   reaction	   was	   filtered	  through	   a	   Celite	   pad	   and	   the	   organic	   layer	   was	   separated	   and	  concentrated	   under	   reduce	   pressure.	   Flash	   chromatography:	  (cyclohexane/Et2O=	  8/2)	  mixture	  to	  give	  the	  desired	  alcohol	  in	  (90%,	  117	  mg)	  as	  orange	  oil;	  1H	  NMR	  
(400	  MHz,	  CDCl3,	  25°C)	  δ	  1.42	  (s,	  9H),	  1.50-­‐1.61	  (m,	  1H),	  1.61-­‐1.76	  (m,	  2H),	  1.76-­‐1.85	  (m,	  1H),	  2.95	  (s,	  6H),	  3.57-­‐3.77	  (m,	  2H),	  ,	  4.58	  (dd,	  J	  =	  5.5	  Hz,	  J	  =	  7.5	  Hz,	  1H),	  6.71	  (d,	  J	  =	  9.1	  Hz,	  2H),	  7.12	  (m,	  3H),	  7.19	  (d,	  J=	  8.7	  Hz,	  2H);	  7.32	  (t,	  J	  =	  7.9	  Hz,	  2H)	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C)	  δ	  25.0,	  28.3	  (3C),	  35.6,	  40.7	  (2C),	  49.7,	  74.0,	  80.0,	  112.6	  (2C),	  125.9	  (2C),	  126.8	  (2C),	  127.1,	  128.7	  (2C),	  132.6,	  142.4,	  150.2,	  154.8;	  ESI-­‐MS:	  m/z	  =	  367.3	  [M-­‐OH]+,	  407.1	  [M+Na]+,	  791.3	  [2M+Na]+.	  
	  
General	   Procedure	   for	   the	   enantioslelectivity	   α-­‐alkylation	   benzylic	   benzydrylic	  
alcohols	  








3-­‐(4-­‐(dimethylamino)phenyl)-­‐2-­‐methyl-­‐3-­‐phenylpropanal	  (table6,	  entry	  1).	  Prepared	  according	  to	  the	  general	  procedure	  the	  compound	  was	  purified	  by	  flash	  chromatography	   column	   (SiO2,	   cyclohexane:	   diethyl	   ether,	   9:1)	   afforded	   the	  desired	  product	  as	  a	  colourless	  oil	  (80%	  yield,	  d.r-­‐-­‐-­‐,	  98maj:96min%	  ee)	  The	  ee	  was	   determined	   directly	   with	   crude	   product	   by	  HPLC	   analysis	   Daicel	   Chiralcel	  OD-­‐H	  column:	  gradient	   from	  99:1	  n-­‐hexane/i-­‐PrOH	  to	  90:10	   in	  30	  min,	   flow	  rate	  0.50	  mL/min,	  30°C,	   λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	  16.3min,	  τM(mino	  )	  r	  =	   15.5min,	  
τm(majo)r	  =	  18.1min,	  τm(min)r	  =	  24.1min.	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.58	  (d,	  2H,	  J	  =	  3.3Hz,	  2	  CHO),	  7.30-­‐7.23	  (m,	  8H,	  HAr),	  7.19-­‐7.10	  (m,	  6H,	  HAr),	  6.66	  (t,	  4H,	  J	  =	  8.9Hz),	  3.99	  (d,	  1Hmin,	  J	  =	  10.9Hz),	  3.98	  (d,	  1Hmaj,	  J	  =	  11.1Hz),	  3.29-­‐3.19	  (m,	  2H	  maj+min,	  CH),	  2.91	  (s,	  6Hmin,	  (CH3)2N),	  2.89	  (s,	  6Hmaj,	  (CH3)2N),	  1.06	  (d,	  3Hmin,	   J	  =	  6.9Hz),	  1.02	  (d,	  3H,	  J	  =	  6.65Hz)	  13C	  NMR	   (125	  MHz,	  CDCl3)	  δ	  204.7	  (2CHO),	  149.3	  (2),	  142.9	  (2),	  129.8	  (2),	  128.7,	  128.6,	  128.61(4),	  128.0	  (4),	  127.9	  (2),	  126.4,	  126.3,	  112.8	  (2),	  112.8	  (2),	  52.6	   (2),	   50.2	   (2),	   40.5	   (2),	   29.6	   (2),	   13.7maj,	   13.5min.	  HPLC-­‐MS	   calcul	   for	   (C18H21NO)	   (M+H+)	   268,	  (M+Na+)	  290	  ,	  tm	  =	  10.6min,	  tM	  =	  10.7min.	  	  	  
2-­‐((4-­‐(dimethylamino)phenyl)(phenyl)methyl)octanal	  (table	  6,	  entry2)	  	  Prepared	   according	   to	   the	   general	   procedure.	   The	   residue	   was	  purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane:	   Et2O,	   9:1)	   to	  afford	   the	   desired	   product	   as	   a	   colourless	   oil	   (	  85%	   yield,	   d.r	   -­‐-­‐,	  
89maj:81min%	   ee).	   The	   ee	   was	   determined	   directly	   with	   crude	  product	   by	  HPLC	   analysis	   Daicel	   Chiralcel	   OD-­‐H	   column:	   gradient	   from	   99:1	   n-­‐hexane/i-­‐PrOH	   to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	  17.0	  min,	  τM(mino)	  r	  =	  16.3	  min,	  τm(majo)r	  =	  18.1min,	  τm(min)r	  =	  25.6min.	  1H	  NMR	   (400	  MHz,	  CDCl3)	  δ	  9.47	  (d,	  2H,	  J	  =	  4.4Hz,	  CHO),	  7.30-­‐7.24	  (m,	  8H,	  HAr),	  7.19-­‐7.13	  (m,	  2H,	  HAr),	  7.12	  (d,	  4H,	   J	  =	  8.5Hz,	  HAr),	  6.67	  (d,	  2Hmin,	   J	  =	  8.5Hz),	  6.63	  (d,	  2Hmaj,	  J	  =	  8.9Hz),	  4.03	  (d,	  2H,	  J	  =	  11.3Hz),	  3.16-­‐3.08	  (m,	  2Hmin+maj),	  2.91	  (s,	  6Hmin),	  2.88	  (s,	  6Hmaj),	  1.59-­‐1.49	  (m,	  2H),	  1.44-­‐1.34	  (m,	  2H),	  1.33-­‐1.15	  (m,	  16H),	  0.85	  (t,	  3Hmaj,	  J	  =	  7.15Hz),	  0.84	  (t,	  3Hmin,	  J	  =	  7.0Hz).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  204.6	  (2CHO),	  149.3	  (2C),	  143.0	  (2C),	  134.6	  (2C)	  129.8	  (2CH),	  128.6	  (2CH),	  128.67	  (2CH),	  128.5	  (2CH),	  127.9	  (2CH),	  126.3	  (2CH),	  112.8	  (2CH),112.7	  (2CH),	  112.77	  (2CH),	  	  55.8	  (2CH),	  51.5	  (2CH),	  40.5	  (2CH3),	  40.4	  (2CH3),	  31.4	  (2CH2),	  29.1	  (2CH2),	  28.6	  (2CH2),	  26.8	  (2CH2),	  22.46	  (2CH2);	  13.9	  (2CH3)	  HPLC-­‐MS	  calcu.	   for	  (C23H31NO)	  (M+H)	  338	  (M+Na+)	  360	  tM	  =	  15.6	  min,	  tm	  =	  14.7min	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directly	  with	   crude	   product	   by	  HPLC	   analysis	   Daicel	   Chiralcel	   OD-­‐H	   column:gradient	   from	   99:1	   n-­‐hexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	  19.1	  min,	  
τM(mino)	  r	  =	  20.8	  min,	  τm(majo)r	  =	  21.6	  min,	  τm(min)r	  =	  23.8	  min.	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.47	  (d,	  1Hmaj,	  J	  =	  3.38Hz),	  9.33	  (d,	  1Hmin,	  J	  =	  3.3Hz),	  7.68	  (d,	  1H,	  J	  =	  8.0Hz),	  7.55	  (d,	  1H,	  J	  =	  8.0Hz);	  7.49-­‐7-­‐30	  (m,	  9H),	  7.25-­‐7.13	  (m,	  7H),	  7.03	  (d,	  2H,	  J	  =	  8.6Hz),	  6.88	  (d,	  2H,	  J	  =	  8.6Hz),	  6.64	  (d,	  2Hmin,	  J	  =	  9.1Hz),	  6.6	  (d,	  2Hmaj,	  J	  =	  9.1Hz),	  4.18	  (d,	  1Hmin,	  J	  =	  11.3Hz),	  4.05	  (d,	  1Hmaj,	  J	  =	  11.0Hz),	  3.29-­‐3.13	  (m,	  2Hmaj+min),	  2.90	  (s,	  6Hmaj),	  2,89	  (s,	  6Hmin),	  0.94	  (d,	  3Hmin,	   J	  =	  6.9Hz),	  0.88	  (d,	  3Hmaj,	   J	  =	  6.9Hz)	   13C	  NMR	   (50MHz,	  
CDCl3)	  δ	  204.7	  (2CHOmaj+min);	  149.1	  (2C);	  142.2;	  141.6;	  140.2	  (2C);	  130.3	  (2C);	  129.6	  (2C);	  129.5	  (2C);	  129.0	  (4C);	  128.7	  (4C);	  127.9	  (	  4C);	  127.8	  (4C);	  127.2	  (2C);	  127.0	  (2C);	  126.1	  (2C);	  112.6	  (4C);	  51.7	  (2C);	  47.7	  (2C);	  40.6	  (4C);	  13.5	  (2C).	  HPLC-­‐MS	  calcu.	  for	  (C24H25NO)	  (M+H)	  286	  tM	  =	  4.3min.	  	  	  
2-­‐(biphenyl-­‐2-­‐yl(4-­‐(dimethylamino)phenyl)methyl)octanal	  	  (table	  6,	  entry	  4)	  	  Prepared	   according	   to	   the	   general	   procedure.	   The	   residue	   was	  purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane:	   Et2O,	   7:3)	   to	  affor	   the	   desired	   product	   as	   a	   colourless	   oil	   (	  66%yield,	   d.r	   3:1,	  
93maj:71min%ee).	   The	   ee	   was	   determined	   directly	   with	   crude	  product	  from	  alcohol	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  (Reduction	  to	  alcohol)	  gradient	  from	  99:1	  n-­‐hexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	   19.2	   min,	   τM(mino)	   r	   =	   23.8	   min,	   τm(majo)r	   =	   28.1	   min,	   τm(min)r	   =	   26.5	   min	   1HNMR	  
(200MHz,CDCl3)	   δ	  9.38(d,	  1Hmin,J	  =	  4.8Hz);	  9.25	  (d,	  1Hmaj,	   J	  =	  4.4Hz);	  7.53-­‐7.34	  (m,	  9H);	  7.28-­‐7.14	  (m,	  9H);	  6.95	  (d,	  2Hmaj,J	  =	  8.6Hz);	  6.91(d,	  2Hmin,J	  =	  7.6Hz);	  6.63	  (d,	  2Hmin,	   J	  =	  7Hz);	  6.59	  (d,	  2Hmaj,	   J	  =	  8.8Hz);	  4.24	  (d,	  1Hmaj,	  J	  =	  11.4Hz);	  4.14	  (d,	  1Hmin,	  J	  =	  11,4Hz);	  3.0	  (m,	  2H	  maj+min);	  2.93	  (s,	  6Hmin);	  2.89	  (s,	  6Hmaj);	  1.46-­‐1.18	  (m,	  20H);	  0.871	  (t,	  6H	  maj+min,	   J	  =	  7.8Hz).	  13C	  NMR	   (50MHz,CDCl3)	   δ	  204.7	  (2CHO);	  149.2	  (2C);	  142.5	  (2C);	  141.7	  (2C);	  140.2	  (2C);	  130.2	  (2C);	  129.7	  (4C);	  128.8	  (4C);	  127.9	  (6C);	  127.5;	  127.0	   (3C);	   126.7	   (2C);	   125.8	   (2C);	   112.7	   (4C);	   57.4	   (Cmin);	   57.1	   (Cmaj);	   46.4	   (Cmin);	   46.1	   (Cmaj);	   40.5	  (4C);	  31.5	  (2C);	  29.6;	  29.1	  (2C);	  28.4	  (2C);	  26.9;	  22.5	  (2C);	  14.3	  (Cmin);	  14.0	  (Cmaj).	  HPLC-­‐MS	  calcu.from	  alcohol	  for	  (C29H37NO)	  (M+H)	  416	  tM	  =	  15.8min,	  tm=	  16.4min	  	  











d,	  2Hmaj,	  J	  =	  8.7Hz),	  6.64	  (d,	  2Hmin,	  J	  =	  8.7Hz),	  4.61	  (d,	  1Hmin,	  J	  =	  10.7Hz),	  4.46	  (d,	  1Hmaj,	  J	  =	  11.2Hz),	  3.83	  (s,	  3Hmin,	  OCH3),	  3.79	  (s,	  3Hmaj,	  OCH3),	  3.31-­‐3.24	  (m,	  1Hmin),	  3.23-­‐3.16	  (m,	  1Hmaj),	  2.91	  (s,	  6H),	  2.89	  (s,	  6H),	  1.04	  (d,	  3Hmaj,	  J	  =	  6.6Hz),	  0.99	  (d,	  3Hmin,	  J	  =	  6.6Hz)	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  205.3	  (CHOmin),	  205.1	   (CHOmaj),	   157.0	   (C),	   156.5	   (C),	   149.1	   (C),	   149.0	   (C),	   131.3	   (C),	   131.2	   (C),	   130.0	   (C),	   129.6	   (C),	  129.1	   (2CH),	   129.0	   (2CH),	   128.4	   (2CH),	   128.2	   (2CH),	   127.4	   (1CH),	   127.2	   (1CH),	   120.7	   (2CH),	   112.6	  (2CH),	  110.7	  (2CH),	  55.3	  (2CH3),	  50.1	  (CH),	  49.7	  (CH),	  44.5	  (CH),	  44.2	  (CH),	  40.5	  (4CH3),	  13.6	  (CH3min);	  13.2	  (CH3maj).	  HPLC	  –MS	  calcu.	  for	  C19H23NO2	  (M+H+)	  298	  tmin	  =	  10.7	  min,	  tmaj	  =	  10.9min.	  	  
	  
2-­‐((4-­‐(dimethylamino)phenyl)(2-­‐methoxyphenyl)methyl)octanal	  	  (table	  6,	  entry	  6)	  	  Prepared	   according	   to	   the	   general	   procedure.	   The	   residue	   was	  purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane:	   Et2O,	   7:3)	   to	  afford	   the	   desired	   product	   as	   a	   yellow	   oil	   (86%	   yield,d.r	   1:1,	  
90:88%	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  
HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:gradient	  from	  99:1	  n-­‐hexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	  17.4	  min,	  τM(mino)	  r	  =	  21.0	  min,	  τm(majo)r	  =	  19.0	  min,	  τm(min)r	  =	  25.4min.	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.4	  (d,	  1Hmin,	  J	  =	  4.2Hz),	  9.39	  (d,	  1Hmaj,	  J	  =	  4.6Hz),	  7.2-­‐7.0	  (m,	  8H),	  6.8	  (t,	  2H,	   J	  =	  7.5Hz),	  6.78	  (d,	  2H,	   J	  =	  8.3Hz),	  6.6	  (d,	  2Hmaj,	   J	  =	  7.7Hz),	  6.6	  (d,	  2Hmin,	  J	  =	  8.2Hz),	  4.6	  (d,	  1Hmin,	  J	  =	  11.9Hz),	  4.5	  (d,	  1Hmaj,	  J	  =	  11.5Hz),	  3.8	  (s,	  3Hmin),	  3.7	  (s,	  3Hmaj),	  3.2-­‐3.1	  (m,	  1Hmin),	  3.1-­‐3-­‐0	  (m,	  1Hmaj),	  2.9	  (s,	  6Hmaj),	  2.8	  (s,	  6Hmin),	  1.7-­‐1.6	  (20H,	  m),	  0.8	  (t,	  3Hmin,	  J	  =	  5.1Hz),	  0.84	  (t,	   3Hmaj,	   J	   =	   7.1Hz).	   13C	   NMR	   (50MHz,CDCl3)	   δ	   205.2	   (2CHO);	   157.0	   (2C);	   149.2	   (2C);	   131.3	   (2C);	  130.0	  (2C);	  129.1	  (2CH);	  129.0	  (2CH);	  128.4	  (CH);	  128.1	  (CH);	  127.2	  (2CH);	  120.8	  (2CH);	  112.7	  (4CH);	  110.9	  (2CH);	  55.4	   (CH3);	  55.3	   (CH3);	  43.4	   (2CH);	  43.1	   (CH);	  43.0	   (CH);	  40.6	   (4CH3);	  31.6	   (CH2);	  31.5	  (CH2);	  30.7	   (CH2);	  29.7	   (CH2);	  29.1	   (CH2);	  28.2	   (CH2);	  26.8	   (CH2);	  24.7	   (CH2);	  22.6	   (CH2);	  22.5	   (CH2);	  14.0	  (2CH3).	  HPLC	  –MS	  calcu.	  for	  C24H33NO2	  (M+H+)	  368	  (M+H+Na)	  390,	  tmaj	  =	  15.0min	  	  
3-­‐(2-­‐(benzyloxy)phenyl)-­‐3-­‐(4-­‐(dimethylamino)phenyl)-­‐2-­‐methylpropanal	  (table	  6,	  entry	  9)	  	  Prepared	  according	   to	   the	   general	  procedure.	  The	   residue	  was	  purified	  by	   flash	  chromatography	  (SiO2,	  cyclohexane:	  Et2O,	  7:3)	  to	  afford	  the	  desired	  product	  as	  a	  yellow	  oil	  (60%	  yield,	  d.r	  1:1,	  94:95%	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  gradien	  from	  99:1	  n-­‐thexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	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137.1	  (2C);	  131.6	  (C);	  131.4	  (	  C);	  129.9	  (C);	  129.5	  (C);	  129.3	  (2CH);	  129.1	  (2CH);	  128.5	  (2CH);	  128.4	  (3CH);	  128.3	  (CH);	  128.1	  (CH);	  127.8	  (CH);	  127.8	  (	  CH);	  127.5	  (2CH);	  127.4	  (2CH);	  127.2	  (CH);	  121.0	  (2CH);	   112.7	   (2CH);	   112.6	   (CH);	   112.6	   (CH);	   112.1	   (2CH);	   70.2	   (CH2);	   70.13	   (CH2);	   50.1	   (CH);	   49.6	  (CH);	  44.5	  (CH);	  44.4	  (CH);	  40.6	  (4CH3);	  13.7	  (CH3);	  13.4	  (CH3).	  HPLC-­‐MS	  calcul.	  C25H27NO2	  	  	  	  
2-­‐(biphenyl-­‐2-­‐yl(4-­‐(dimethylamino)phenyl)methyl)octanal	  (table	  6,	  entry	  10)	  Prepared	   according	   to	   the	   general	   procedure.	   The	   residue	   was	  purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane:	   Et2O,	   7:3)	   to	  affor	   the	   desired	   product	   as	   a	   yellow	   oil	   (79%	   yield,	   d.r	   1:1,	  
90:81%	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  
HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  gradient	  from	  99:1	  n-­‐hexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	  19.9	  min,	  τM(mino)	  r	  =	  23.8	  min,	  τm(majo)r	  =	  21.6	  min,	  τm(min)r	  =	  28.0	  min.	  1H	  NMR	  (400MHz,	  CDCl3)	  δ	  9.38	  (d,	  1Hmaj,	  J	  =	  4.4Hz);	  9.29	  (d,	  1Hmin,	  J	  =	  4.8Hz);	  7.31-­‐7.16	  (m,	  12H);	  7.09-­‐6.99	  (m,	  3H);	  6.84-­‐6.80	  (m,	  3	  H);	  6.81	  (d,	  2Hmaj,	   J	  =	  8.4Hz);	  6.74	  (d,	  2Hmin,	   J	  =	  8.4Hz);	  6.56	  (d,	  2Hmin,	   J	  =	  8.4Hz);	  6.52	  (d,	  2Hmaj,	   J	  =	  8.8Hz);	  4.99	  (s,	   	  2Hmaj);	  4.94	  (s,	  2Hmin);	  4.62	  (d,	  1Hmaj,	  J	  =	  10.8Hz);	  4.49	  (d,	  1Hmin,	  J	  =	  11.6Hz);	  3.07	  (m,	  1Hmaj);	  3.00	  (m,	  1Hmin);	  2.82	  (s,	  6Hmin);	  2.79	   (s,	   6Hmaj);	   1.48-­‐1.27	   (m,	   4H);	   1.18-­‐1.08	   (m,	   16H);	   0.81	   (t,	   3Hmin,	   J	   =	   7.2Hz);	   	   0.73	   (t,	   3Hmaj,	   J	   =	  7.6Hz).	  13C	  NMR	  (50MHz,CDCl3)	  δ	  205.2(CHOmaj);	  204.9	  (CHOmin);	  156.1	  (2C);	  149.2	  (2C);	  137.1	  (2C);	  131.4	  (2C);	  129.7	  (2C);	  129.3	  (2C);	  129.1	  (	  2C);	  128.5	  (2C);	  128.4	  (2C);	  128.1	  (2C);	  127.8	  (	  2C);	  127.5	  (2C);	  127.4	  (2C);	  127.2	  (2C);	  121.0	  (2C);	  112.7	  (2C);	  112.6	  (2C);	  112.1	  (C);	  112.0	  (C);	  70.1	  (2C);	  55.9	  (C);	  55.3	  (C);	  43.1	  (2C);	  40.6	  (2C);	  40.5	  (2C);	  31.5;	  30.9;	  29.7;	  29.2;	  28.5;	  28.3;	  26.9;	  26.8;	  22.6;	  22.4;	  14.0	  (2C).	  HPLC-­‐MS	  calcul.for	  C30H37NO2	  (M+H+)	  444	  (M+Na+)	  466	  tM=	  18.0min,	  tm	  =	  18.4.	  	  
3-­‐(4-­‐(dimethylamino)phenyl)-­‐2-­‐methyl-­‐3-­‐(thiophen-­‐3-­‐yl)propanal	  (table	  6,	  entry	  7)	  	  Prepared	   according	   to	   the	   general	   procedure.	   The	   residue	   was	   purified	   by	   flash	  chromatography	  (	  SiO2,	   cyclohexane:	  Et2O,	  7:3)	   to	  afford	   the	  desired	  product	  as	  a	  colourless	  oil	  (84%	  yield,	  d.r	  2:1,	  93%maj:90min%	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IA	  column	  gradient	  from	  99:1	  n-­‐hexane/i-­‐PrOH	  to	  90:10	   in	  30	  min,	   flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	   8	   nm:	  τM(majo)r	  =	  21.7	  min,	  τM(mino)	  r	  =	   24.3	  min,	  τm(majo)r	   =	   28.7	  min,	  











(CH),	   52.0	   (CHmaj),	   51.9	   (CHmin),	   48.0	   (CH),	   47.2	   (CH),	   40.5	   (2CH3),	   40.4	   (2CH3),	   13.5	   (CH3min),	   13.4	  (CH3maj).	  HPLC-­‐MS	  calcu.	  for	  C16H19NOS	  (M+H+)	  274,	  tmin	  =	  10.3min,	  tmaj	  =	  10.4min.	  	  	  
	  
2-­‐((4-­‐(dimethylamino)phenyl)(thiophen-­‐3-­‐yl)methyl)octanal	  (table	  6,	  entry	  8)	  	  Prepared	   according	   to	   the	   general	   procedure	   The	   residue	   was	  purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane:	   Et2O,	   7:3)	   to	  afford	  the	  desired	  product	  as	  a	  colourless	  oil	  (70%	  yield,d.r	  1.5:1,	  
88%maj:80%min	  ee)	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:gradient	  from	  99:1	  n-­‐hexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	   flow	  rate	  0.50	  mL/min,	  30°C,	   λ	  =	  254,	  8	  nm:	  τM(majo)r	  =	  20.4	  min,	  τM(mino)	  r	  =	   19.5	  min,	  
τm(majo)r	  =	  28.1	  min,	  τm(min)r	  =	  36.0	  min.	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.58	  (d,	  1H,J	  =	  4.3Hz),	  9.46	  (d,	  1H,	  J	  =	  4.3Hz),	  7.15-­‐7.05	  (m,	  8H),	  6.92-­‐6.86	  (m,	  2H),	  3.96	  (d,	  2H,	  J	  =	  8.8Hz),	  6.65	  (d,	  2H,	  J	  =	  8.8Hz),	  4.33	  (d,	  1Hmaj,	  J	  =	  10.4Hz),	  4.32	  (d,	  1Hmin,	  J	  =	  10.2Hz),	  3.10-­‐2.96	  (m,	  2H),	  2.93	  (s,	  6H,	  N(CH3)2),	  2.90	  (s,	  6H,	  N(CH3)2),	  1.69-­‐1.39	  (m,	  4H),	  1.39-­‐1.14	  (m,	  16H),	  0.85	  (t,	  3H,	  J	  =	  6.5Hz),	  0.84	  (t,	  3H,	  J	  =	  7.0Hz).	  13C	  
NMR	  (125	  MHz,	  CDCl3)	  δ	  204.2	  (CHOmaj),	  203.9	  (CHOmin),	  149.5	  (2C),	  147.1	  (C),	  147.0	  (C),	  129.3	  (C),	  129.2	   (C),	   128.7	   (4CH),	   126.6	   (2CH),	   124.4	   (2CH),	   124.0	   (2CH),	   112.7	   (4CH),	   57.4	   (2CH),	   46.9	   (CH),	  46.3	  (CH),	  40.4	  (2CH3),	  31.5	  (2CH2),	  29.6	  (CH2),	  29.1	  (2CH2),	  28.6	  (CH2),	  28.4	  (CH2),	  26.8	  (CH2),	  26.7	  (2CH2),	   22.4	   (2CH2),	   14.0	   (2CH3).	   HPLC-­‐MS	   calcul.for	   C21H29NOS	   (M+H+)	   344	   (M+Na+)366,	   tM	   =	  14.9min,	  tm	  =	  14.3min	  	  Prepared	  according	  to	  the	  general	  procedure.	  The	  residue	  was	  diluted	  with	  MeOH	  at	  0°C	  for	  5	  minuts	  stirring	  and	  2	  eq	  of	  NaBH4	  was	  slowly	  added.	  The	  reaction	  was	  quenched	  with	  water	   and	   concentrated	   under	   reduce	   pressure.	   The	   crude	   solution	  was	   extracted	   twice	   times	   with	   EtOAc.	   The	   collect	   organic	   layers	   were	  dried	   over	  Na2SO4	   and	   concentrated	   under	   reduce	   pressure.	   The	   residue	  was	   purified	   by	   flash	   chromatography	   (SiO2;	   cyclohexane:Et2O;	   7:3)	   to	  afford	  the	  desired	  product	  as	  a	  yellow	  oil	  (85%	  yield,	  d.r	  2:1,	  95:92	  %ee	  )	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:gradient	  from	  99:1	  n-­‐thexane/i-­‐PrOH	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  254,	  4	  nm:	  τM(majo)r	  =	  39.2	  min,	  τM(mino)	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 Prepared	  according	   to	   the	  genereal	  procedure.	  The	   residue	  was	  purified	  by	  flash	  chromatography	  (SiO2,	  cyclohexane:	  EtOAc	  =	  8:2)	  to	  afford	  the	  desired	  product	   as	   a	   yellowish	   oil;	   yield	   94%;	   d.r.=	   4.5:1	   ratio	   (anti:syn).	   Anti	  diastereisomer	  ee	  =	  98%	  :	  Syn	  diasterisomer	  ee	  =	  90%	  ee.	   	  was	  determined	  was	  determined	  by	  integration	  of	  RCHO	  1H	  NMR	  signal:	  δanti=	  9.66	  (d,	  J	  =	  3.2	  Hz,	  1H),	  δsyn=	  9.56	  (d,	  J	  =	  2.4	  Hz,	  1H).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  hexane/i-­‐PrOH	  from	  99:1	  to	  90/10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τminor	  =	  23.5	  min.,	  τmajor	  =	  31.7	  min;	  Syn	  diasteroisomer	  τmajor	  =	  27.4	  min.,	  τminor	  =	  30.8	  min.	  1H	  NMR	  (400	  
MHz,	  CDCl3,	  25°C)	  δanti	  	  0.78	  (d,	  J	  =	  6.7	  Hz,	  3H),	  0.83	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.09-­‐1.17	  (m,	  2H),	  1.19-­‐1.27	  (m,	  4H),	  1.66	  (q,	  J	  =	  7.9	  Hz,	  2H),	  1.82-­‐1.91	  (m,	  1H),	  2.33	  (m,	  1H),	  2.58-­‐2.63	  (m,	  1H),	  2.93	  (s,	  6H),	  3.44	  (dd,	  J	  =	  4.7	  Hz,	  J	  =	  5.9	  Hz,	  1H),	  3.53	  (dd,	  J	  =	  6.3	  Hz,	  J	  =	  10.6	  Hz,	  1H),	  6.70	  (dd,	  J	  =	  2.4	  Hz,	  J	  =	  9.1	  Hz,	  2H),	  7.02	  (dd,	  J	  =	  2.4	  Hz,	  J	  =	  9.1	  Hz,	  2H);	  δsyn	  =	  0.78	  (d,	  J	  =	  6.7	  Hz,	  3H),	  0.83	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.09-­‐1.17	  (m,	  2H),	  1.19-­‐1.27	  (m,	  4H),	  1.66	  (q,	  J	  =	  7.9	  Hz,	  2H),	  1.82-­‐1.91	  (m,	  1H),	  2.33	  (m,	  1H),	  2.58-­‐2.63	  (m,	  1H),	  2.93	  (s,	  6H),	  3.26	  (dd	  J	  =	  4.7	  Hz,	  J	  =	  5.9	  Hz,	  1H),	  3.45	  (dd	  J	  =	  (dd,	  J	  =	  6.3	  Hz,	  J	  =	  10.6	  Hz,	  1H),	  6.70	  (dd,	  J	  =	  2.4	  Hz,	  J	  =	  9.1	  Hz,	  2H),	  7.02	  (dd,	  J	  =	  2.4	  Hz,	  J	  =	  9.1	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	  δanti	  =14.0,	  22.8,	  30.1,	  32.8,	  40.8	  (2C),	  41.7,	  45.9,	  47.8,	  66.7,	  112.5	  (2C),	  129.3	  (2C),	  130.9,	  149.0;	  δsyn	  =	  14.0,	  22.8,	  29.7,	  31.9,	  40.8	  (2C),	  41.7,	  45.9,	  47.8,	  67.1,	  112.8	  (2C),	  128.7	  (2C),	  130.9,	  149.0;	  ESI-­‐MS:	  m/z	  =	  250.2	  [M+H]+.	  	   Prepared	   according	   at	   the	   general	   procedure	   was	   obtained	   the	   desired	  product	   as	   a	   yellowish	   oil;	   yield	   94%	   d.r.=	   2:1	   ratio	   (anti:syn)	   was	  determined	  was	   determined	   by	   integration	   of	   RCHO	   1H	  NMR	   signal	   δanti=	  9.55	  (d,	  J	  =	  4.4	  Hz,	  1H),	  δsyn=	  9.43	  (d,	  J	  =	  4.0	  Hz,	  1H).	  The	  title	  compound	  was	  isolated	  by	   flash	   column	  chromatography	   (SiO2,	   Cyclohexane:ether	  =	  8/2)	  as	   mixture	   of	   diastereoisomers.	   The	   title	   compound	  was	   isolated	   by	   flash	   column	   chromatography	  (Cyclohexane/ether	  =	  8/2)	  as	  mixture	  of	  diastereoisomers	  in	  2:1	  ratio	  (anti:syn).	  Anti	  diastereoisomer	  ee	  =	  92%;	  Syn	  diastereoisomer	  ee=	  86%.	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  hexane/i-­‐PrOH	  fron	  99/1	  to	  90/10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  
Anti	   diasteroisomer	   τminor	  =	   17.7	  min.,	   τmajor	  =	  25.4	  min;	   Syn	   diasteroisomer	   τmajor	  =	   21.6	  min.,	  










(2C),	  41.7,	  45.3,	  46.1,	  63.5,	  112.6	  (2C),	  129.2	  (2C),	  131.5,	  148.9;	  δsyn=	  14.0,	  14.1,	  22.6,	  22.8,	  27.7,	  29.8,	  30.0,	   31.9,	   32.9,	   40.7	   (2C),	   41.7,	   45.3,	   46.5,	   63.8,	   112.8	   (2C),	   128.8	   (2C),	   131.5,	   148.9;	  EI-­‐MS:	  m/z	   =	  302.9	  [M-­‐OH]+,	  320.3	  [M+H]+,	  342.4	  [M+Na]+.	  	   Prepared	   according	   at	   the	   general	   procedure	   was	   obtained	   the	   desired	  product	   as	   a	   colourless	   oil;	   yield	   90%	   d.r.=	   3:1	   ratio	   (anti-­‐5i:syn-­‐5i)	   was	  determined	  was	  determined	  by	  integration	  of	  RCHO	  1H	  NMR	  signal	  δanti=	  9.50	  (d,	   J	   =	   4.4	   Hz,	   1H),	   δsyn=	   9.39	   (d,	   J	   =	   4.0	   Hz,	   1H).	   The	   title	   compound	   was	  isolated	  by	  flash	  column	  chromatography	  (Cyclohexane/ether	  =	  8/2)	  as	  mixture	  of	  diastereoisomers	  in	  3:1	  ratio	  (anti-­‐5i:syn-­‐5i).	  Anti	  diastereoisomer	  ee	  =	  76%;	  Syn	  diastereoisomer	  ee=	  94%.	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  hexane/i-­‐PrOH	  fron	  99/1	  to	  90/10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τminor	  =	  19.9	  min.,	  τmajor	  =	  29.6	  min;	   Syn	   diasteroisomer	   τmajor	  =	   24.2	  min.,	   τminor	  =	  26.2	  min.	  1H-­‐NMR	   (400	   MHz,	   CDCl3,	   25°C):	  
δanti=	  0.77	  (t,	   J	  =	  7.3	  Hz,	  3H),	  0.89	  (t,	   J	  =	  7.1	  Hz,	  3H),	  1.19-­‐1.36	  (m,	  10H),	  1.56-­‐1.74	  (m,	  3H),	  2.59	  (m,	  1H),	  2.93	  (s,	  6H),	  3.55	  (dd,	  J	  =	  5.8	  Hz,	  J	  =	  10.0	  Hz,	  1H),	  3.67	  (dd,	  J	  =	  4.1	  Hz,	  J	  =	  10.0	  Hz,	  1H),	  6.70	  (d,	  J	  =	  8.6	  Hz,	  2H),	  7.03	  (d,	  J	  =	  8.6	  Hz,	  2H);	  δsyn=	  0.73	  (t,	  J	  =	  7.0	  Hz,	  3H),	  0.89	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.19-­‐1.36	  (m,	  10H),	  1.56-­‐1.74	  (m,	  3H),	  2.37	  (m,	  1H),	  2.93	  (s,	  6H),	  3.37	  (dd,	  J	  =	  4.4	  Hz,	  J	  =	  10.0	  Hz,	  1H),	  3.50	  (dd,	  J	  =	  4.7	  Hz,	  J	  =	  10.0	  Hz,	  1H),	  6.70	  (d,	  J	  =	  8.6	  Hz,	  2H),	  7.03	  (d,	  J	  =	  8.6	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	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=	  2.4	  Hz,	  J	  =	  9.1	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  14.0,	  22.8	  (2C),	  29,7,	  30.1	  (2C)	  ,	  32.4,	  32.8	  ,	  40.8	  (2C),	  46.0,	  47.8,	  66.7,	  112.4	  (2C),	  128.7	  (2C),	  129.3,	  149.0;	  δsyn	  =	  13.5,	  22.8	  (2C),	  29,7,	  30.1	  (2C)	  ,	  32.4,	  32.8	  ,	  40.8	  (2C),	  46.0,	  47.8,	  67.1,	  112.4	  (2C),	  128.7	  (2C),	  129.3,	  149.0;	  ESI-­‐MS:	  m/z	  =	  290.3	  [M+H]+.	  	  	   Prepared	   according	   at	   the	   general	   procedure	   was	   obtained	   the	  desired	  product	  as	  a	  yellowish	  oil;	  yield	  85%;	  d.r.=	  6:1	  ratio	  (anti:syn)	  was	   determined	   was	   determined	   by	   integration	   of	   RCHO	   1H	   NMR	  signals	  δanti=	  9.65	  (d,	  J	  =	  3.5	  Hz,	  1H),	  δsyn=	  9.56	  (d,	  J	  =	  2.4	  Hz,	  1H).	  The	  title	   compound	   was	   isolated	   by	   flash	   column	   chromatography	  (Cyclohexane/ether	  =	  8/2)	  as	  mixture	  of	  diastereoisomers	  in	  6:1	  ratio	  (anti:syn).	  Anti	  diastereoisomer	  ee	  =	  99%;	  Syn	  diastereoisomer	  ee=	  86%.	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	   hexane/i-­‐PrOH	   98/2,	   flow	   rate	   0.50	  mL/min.,	   30°C,	   λ	   =	   214,	   254	   nm:	  Anti	   diasteroisomer	  
τminor	  =	  12.3	  min.,	  τmajor	  =	  12.6	  min;	  Syn	  diasteroisomer	  τmajor	  =	  15.3	  min.,	  τminor	  =	  20.9	  min.1H	  
NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  -­‐0.03	  (s,	  6H),	  0.87	  (s,	  9H),	  0.89	  (d,	  J	  =	  7.8	  Hz,	  3H),	  1.77-­‐1.93	  (m,	  2H),	  2.48-­‐2.61	  (m,	  1H),	  2.94	  (s,	  6H),	  3.00-­‐3.06	  (m,	  1H),	  3.33-­‐3.42	  (m,	  1H),	  3.45-­‐3.55	  (m,	  1H),	  6.69	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.00	  (d,	  J	  =	  8.7	  Hz,	  2H),	  9.65	  (d,	  J	  =	  3.5	  Hz,	  1H);	  δsyn	  =	  -­‐0.02	  (s,	  6H),	  0.87	  (s,	  9H),	  1.10	  (d,	  J	  =	  7.1	  Hz,	  3H),	  1.77-­‐1.93	  (m,	  2H),	  2.48-­‐2.61	  (m,	  1H),	  2.93	  (s,	  6H),	  3.00-­‐3.06	  (m,	  1H),	  3.33-­‐3.42	  (m,	  1H),	  3.45-­‐3.55	  (m,	  1H),	  6.69	  (d,	   J	  =	  8.7	  Hz,	  2H),	  7.03	  (d,	   J	  =	  8.7	  Hz,	  2H),	  9.56	  (d,	   J	  =	  2.4	  Hz,	  1H);	  13C	  NMR	  
(100	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  -­‐5.4	  (2C),	  12.0,	  25.3	  (3C),	  29.7,	  37.2,	  40.7	  (2C),	  41.7,	  52.1,	  60.7,	  112.7	  (2C),	  128.9,	  129.0	  (2C),	  149.6,	  205.5;	  δsyn	  =	  -­‐5.4	  (2C),	  12.0,	  25.9	  (3C),	  29.7,	  37.2,	  40.7	  (2C),	  41.7,	  52.1,	  60.7,	  112.7	  (2C),	  128.9,	  129.0	  (2C),	  149.6,	  205.5;	  ESI-­‐MS:	  m/z	  =	  350.3	   [M+H]+,	  372.2	   [M+Na]+,	  721.3	  [2M+Na]+.	  	   According	  at	  the	  general	  procedure	  was	  obtained	  the	  desired	  product	  as	  a	  colourless	  oil;	  yield	  60%	  d.r.=	  3:1	  ratio	  (anti:syn)	  was	  determined	  was	  determined	  by	  integration	  of	  RCHO	  1H	  NMR	  signal	  δanti=	  9.55	  (d,	  J	  =	  4.7	  Hz,	  1H),	  δsyn=	  9.43	   (d,	   J	   =	  3.9	  Hz,	  1H).	  The	   title	   compound	  was	  isolated	  by	  flash	  column	  chromatography	  (Cyclohexane/ether	  =	  8/2)	  as	   mixture	   of	   diastereoisomers	   in	   3:1	   ratio	   (anti:syn).	   Anti	   diastereoisomer	   ee	   =	   96%;	   Syn	  diastereoisomer	   ee=	   92%.	   The	   ee	   was	   determined	   by	   HPLC	   analysis	   Daicel	   Chiralcel	   IC	   column:	  hexane/i-­‐PrOH	  98/2,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τminor	  =	  8.5	  min.,	  τmajor	  =	  9.0	  min;	  Syn	  diasteroisomer	  τmajor	  =	  12.4	  min.,	  τminor	  =	  17.8	  min.	  1H-­‐NMR	  (400	  MHz,	  









-­‐0.02	  (s,	  6H),	  0.83	  (t,	  J	  =	  7.1	  Hz,	  3H),	  0.88	  (s,	  9H),1.13-­‐1.44	  (m,	  5H),	  1.48-­‐1.70	  (m,	  3H),	  1.70-­‐1.85	  (m,	  2H),	  1.94-­‐2.10	  (m,	  1H),	  2.31-­‐2.46	  (m,	  2H),	  2.92	  (s,	  6H),	  2.95-­‐3.03	  (m,	  1H),	  3.35-­‐3.41	  (m,	  1H),	  3.50-­‐3.55	  (m,	  1H),	  6.66	  (d,	  J	  =	  8.7	  Hz,	  2H),	  6.99	  (d,	  J	  =	  9.1	  Hz,	  2H),	  9.43	  (d,	  J	  =	  3.9	  Hz,	  1H);	  13C	  NMR	  (100	  MHz,	  
CDCl3,	   25°C):	  δanti	  =	  -­‐5.4	  (2C),	  14.0,	  18.2,	  22.5,	  25.9	  (3C),	  27.1,	  27.5,	  29.1,	  31.6,	  37.4,	  40.7	  (2C),	  41.0,	  58.0,	  60.5,	  112.7	  (2C),	  127.0,	  129.0	  (2C),	  149.4,	  206.0;	  δsyn	  =	  -­‐5.4	  (2C),	  14.0,	  18.2,	  22.6,	  25.9	  (3C),	  27.2,	  27.6,	  29.3,	   	  31.6,	  37.4,	  40.7	   (2C),	  41.0,	  58.0,	  60.5,	  112.6	   (2C),	  127.0,	  129.0	   (2C),	  149.4,	  206.0;	  EI-­‐MS:	  
m/z	  =	  306.4	  [M-­‐TBS]+,	  633.3	  [(2M-­‐TBS)+Na]+.	  	   Prepared	   accordign	   at	   the	   general	   procedure	   was	   obtained	   the	   desired	  product	   as	   an	   orange	   oil;	   yield	   45%;	   d.r.=	   6:1	   ratio	   (anti:syn)	   was	  determined	  was	  determined	  by	  integration	  of	  RCHO	  1H	  NMR	  signals	  δanti=	  9.68	  (d,	  J	  =	  3.5	  Hz,	  1H),	  δsyn=	  9.52	  (d,	  J	  =	  2.4	  Hz,	  1H).	  The	  title	  compound	  was	  isolated	  by	  flash	  column	  chromatography	  (Cyclohexane/ether	  =	  7/3)	  as	   mixture	   of	   diastereoisomers	   in	   6:1	   ratio	   (anti:syn).	   Anti	   diastereoisomer	   ee	   =	   97%;	   Syn	  diastereoisomer	   ee=	   82%.	   The	   ee	   was	   determined	   by	   HPLC	   analysis	   Daicel	   Chiralcel	   IC	   column:	  hexane/i-­‐PrOH	  85/15	  for	  16	  min,	  than	  from	  85/15	  to	  70/30	  in	  14	  min,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τmajor	  =	  33.2	  min.,	  τminor	  =	  35.9	  min;	  Syn	  diasteroisomer	  τmajor	  =	  31.7	  min.,	  τminor	  =	  37.4	  min.1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  0.89	  (d,	  J	  =	  7.1	  Hz,	  3H),	  1.21	  (t,	  
J	  =	  7.1	  Hz,	  3H),	  1.83-­‐1.94	  (m,	  1H),	  1.95-­‐2.09	  (m,	  1H),	  2.10-­‐2.17	  (m,	  1H),	  2.26-­‐2.39	  (m,	  1H),	  2.51-­‐2.63	  (m,	  1H),	  2.77-­‐2.85	  (m,	  1H),	  2.94	  (s,	  6H),	  4.07	  (q,	  J	  =	  7.1	  Hz,	  2H),	  6.69	  (d,	  J	  =	  8.7	  Hz,	  2H),	  6.98	  (d,	  J	  =	  8.7	  Hz,	  2H),	  9.68	  (d,	  J	  =	  3.5	  Hz,	  1H);	  δsyn	  =	  0.88	  (d,	  J	  =	  7.1	  Hz,	  3H),	  1.22	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.83-­‐1.94	  (m,	  1H),	  1.95-­‐2.09	  (m,	  1H),	  2.10-­‐2.17	  (m,	  1H),	  2.26-­‐2.39	  (m,	  1H),	  2.51-­‐2.63	  (m,	  1H),	  2.77-­‐2.85	  (m,	  1H),	  2.73	  (s,	  6H),	  4.08	  (q,	  J	  =	  7.1	  Hz,	  2H),	  6.69	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.02	  (d,	  J	  =	  8.7	  Hz,	  2H),	  9.52	  (d,	  J	  =	  2.4	  Hz,	  1H);	  13C	  
NMR	   (100	  MHz,	   CDCl3,	   25°C):	   δanti	   =	   12.3,	   14.2,	   29.7,	   32.4,	   40.6	   (2C),	   45.0,	   52.3,	   60.2,	   112.7	   (2C),	  127.8,	  129.0	  (2C),	  149.6,	  173.4,	  205.1;	  δsyn	  =	   	  12.3,	  14.1,	  29.4,	  31.9,	  40.6	  (2C),	  45.0,	  52.3,	  60.2,	  112.8	  (2C),	   127.8,	   128.8	   (2C),	   149.6,	   173.4,	   205.0;	   ESI-­‐MS:	   m/z	   =	   	   292.3	   [M+H]+,	   314.1	   [M+Na]+,	   605.3	  [2M+Na]+.	  	   Prepared	   according	   at	   the	   general	   product	   was	   obtained	   the	   desired	  product	   as	   a	   	   colourless	   oil;	   yield	   60%	  d.r.=	   2.5:1	   ratio	   (anti:syn)	  was	  determined	   was	   determined	   by	   integration	   of	   RCHO	   1H	   NMR	   signal	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τmajor	  =	  20.8	  min.,	  τminor	  =	  22.7	  min.	  1H-­‐NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δanti=	  0.82	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.06-­‐1.18	  (m,	  2H),	  1.21	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.24-­‐1.35	  (m,	  4H),	  1.57-­‐1.70	  (m,	  2H),	  1.77-­‐1.87	  (m,	  1H),	  1.88-­‐1.97	  (m,	  1H),	  2.02-­‐2.12	  (m,	  2H),	  2.10-­‐2.16	  (m	  ,1H),	  2.35	  (t,	  J	  =	  7.5	  Hz,	  1H),	  2.38-­‐2.48	  (m,	  1H),	  2.77	  (ddd,	  
J	  =	  3.5	  Hz,	  J	  =	  5.9	  Hz,	  J	  =	  9.4	  Hz,	  1H),	  2.94	  (s,	  6H),	  4.06	  (q,	  J	  =	  7.1	  Hz,	  2H),	  6.70	  (d,	  J	  =	  9.1	  Hz,	  2H),	  6.98	  (d,	  
J	  =	  9.1	  Hz,	  2H),	  9.59	  (d,	  J	  =	  4.7	  Hz,	  1H);	  δsyn=	  0.87	  (t,	  J	  =	  7.1	  Hz,	  3H),	  1.06-­‐1.18	  (m,	  2H),	  1.22	  (t,	  J	  =	  7.1	  Hz,	  3H),	   1.24-­‐1.35	   (m,	   4H),	   1.57-­‐1.70	   (m,	   2H),	   1.77-­‐1.87	   (m,	   1H),	   1.88-­‐1.97	   (m,	   1H),	   2.02-­‐2.12	   (m,	   2H),	  2.10-­‐2.16	  (m,	  1H),	  2.35	  (t,	  J	  =	  7.5	  Hz,	  1H),	  2.38-­‐2.48	  (m,	  1H),	  2.77	  (ddd,	  J	  =	  3.5	  Hz,	  J	  =	  5.9	  Hz,	  J	  =	  9.4	  Hz,	  1H),	  2.92	  (s,	  6H),	  4.08	  (q,	  J	  =	  7.1	  Hz,	  2H),	  6.67	  (d,	  J	  =	  8.7	  Hz,	  2H),	  6.98	  (d,	  J	  =	  9.1	  Hz,	  2H),	  9.40	  (d,	  J	  =	  3.9	  Hz,	  1H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	  δanti=	  14.0,	  14.2,	  22.5,	  27.6,	  29.6,	  31.5,	  32.0,	  32.2,	  40.6	  (2C),	  44.3,	   45.0,	   58.0,	   60.2,	   112.8	   (2C),	   128.2,	   128.9	   (2C),	   149.5,	   173.3,	   205.6;	   δsyn=	  14.0,	   14.2,	   22.5,	   27.7,	  29.7,	   31.6,	   32.0,	   32.2,	   40.6	   (2C),	   44.3,	   45.0,	   58.0,	   60.2,	   112.7	   (2C),	   128.2,	   129.0	   (2C),	   149.5,	   173.5,	  205.3;	  EI-­‐MS:	  m/z	  (%)	  =	  362.3	  [M+H]+,	  384.2	  [M+Na]+,	  745.4	  [2M+Na]+.	  	   According	   at	   the	   general	  procedure	  was	  obtained	   the	  desired	  product	  as	   a	   yellow	  oil;	   yield	   88%;	  d.r.=	   5.5:1	   ratio	   (anti:syn)	  was	  determined	  was	  determined	  by	  integration	  of	  RCHO	  1H	  NMR	  signals	  δanti=	  9.68	  (d,	  J	  =	   2.8	   Hz,	   1H),	   δsyn=	   9.50	   (d,	   J	   =	   2.4	   Hz,	   1H).	   The	   title	   compound	  was	  isolated	   by	   flash	   column	   chromatography	   (EtOAc/MeOH=	   9/1)	   as	  mixture	   of	   diastereoisomers	   in	   5.5:1	   ratio	   (anti:syn).	   Anti	   diastereoisomer	   ee	   =	   90%;	   Syn	  diastereoisomer	   ee=	   71%.	   The	   ee	   was	   determined	   by	   HPLC	   analysis	   Daicel	   Chiralcel	   IC	   column:	  hexane/i-­‐PrOH	   from	  99/1	   to	  90/10	   in	  30	  min,	   flow	   rate	  0.50	  mL/min.,	   30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τminor	  =	  31.4	  min.,	  τmajor	  =	  33.8	  min;	  Syn	  diasteroisomer	  τmajor	  =	  26.8	  min.,	  τminor	  
=	  29.6	  min.;	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  0.88	  (d,	  J	  =	  7.1	  Hz,	  3H),	  1.93-­‐2.11	  (m,	  3H),	  2.12-­‐2.28	  (m,	  2H),	  2.70-­‐2.80	  (m,	  1H),	  3.02	  (s,	  6H),	  4.19	  (dd,	  J	  =	  6.7	  Hz,	  J	  =	  19.7	  Hz,	  2H),	  6.94	  (d,	  J	  =	  8.3	  Hz,	  2H),	  7.06	  (d,	  J	  =	  8.3	  Hz,	  2H);	  δsyn	  =	  1.15	  (d,	  J	  =	  6.7	  Hz,	  3H),	  1.79-­‐1.90	  (m,	  1H),	  1.93-­‐2.11	  (m,	  2H),	  2.12-­‐2.28	  (m,	  2H),	  2.50-­‐2.58	  (m,	  1H),	  3.01	  (s,	  6H),	  4.01	  (ddd,	  J	  =	  6.7	  Hz,	  J	  =	  10.6	  Hz,	  J	  =	  81.4	  Hz,	  2H),	  6.92	  (d,	  J	  =	  8.3	  Hz,	  2H),	  7.06	  (d,	  J	  =	  8.3	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  14.0,	  22.8	  (2C),	  29,7,	  30.1	  (2C)	  ,	  32.4,	  32.8	  ,	  40.8	  (2C),	  46.0,	  47.8,	  66.7,	  112.4	  (2C),	  128.7	  (2C),	  129.3,	  149.0;	  δsyn	  =	  13.5,	  22.8	  (2C),	  29,7,	  30.1	  (2C)	  ,	  32.4,	  32.8	  ,	  40.8	  (2C),	  46.0,	  47.8,	  67.1,	  112.4	  (2C),	  128.7	  (2C),	  129.3,	  149.0;	  ESI-­‐MS:	  m/z	  =	  ESI-­‐MS:	  m/z	  =	  292.3	  [M+H]+,	  314.1	  [M+Na]+,	  605.3	  [2M+Na]+.	  	  According	  at	  the	  general	  procedure	  was	  obtained	  the	  desired	  product	  as	   an	   orange	   oil;	   yield	   92%;	   d.r.=	   4.5:1	   ratio	   (anti:syn)	   was	  determined	  was	  determined	  by	   integration	  of	  RCHO	  1H	  NMR	  signals	  

















diastereoisomer	  ee	  =	  95%;	  Syn	   diastereoisomer	  ee=	  97%.	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  from	  99/1	  to	  90/10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τminor	  =	  21.3	  min.,	  τmajor	  =	  22.1	  min;	  Syn	  diasteroisomer	  
τmajor	  =	  25.0	  min.,	  τminor	  =	  27.8	  min.	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C):	  δanti	  =	  0.86	  (d,	  J	  =	  7.1	  Hz,	  3H),	  1.39	  (s,	  9H),	  1.54-­‐1.77	  (m,	  4H),	  2.27-­‐2.38	  (m,	  1H),	  2.44-­‐2.56	  (m,	  1H),	  2.73-­‐2.81	  (m,	  1H),	  2.93	  (s,	  6H),	  3.58-­‐3.70	  (m,	  2H),	  6.67	  (d,	  J	  =	  8.7	  Hz,	  2H),	  6.95	  (d,	  J	  =	  9.1	  Hz,	  2H),	  7.08	  (bd,	  J	  =	  7.5	  Hz,	  2H),	  7.17	  (tt,	  J	  =	  5.9	  Hz,	  J	  =	  7.1	  Hz,	  J	  =	  8.3	  Hz,	  1H),	  7.30	  (d,	  J	  =	  4.5	  Hz,	  2H),	  9.61	  (d,	  J	  =	  3.5	  Hz,	  1H);	  δsyn	  =	  0.88	  (d,	  J	  =	  7.1	  Hz,	  3H),	  1.39	  (s,	  9H),	  1.54-­‐1.77	  (m,	  4H),	  2.27-­‐2.38	  (m,	  1H),	  2.44-­‐2.56	  (m,	  1H),	  2.73-­‐2.81	  (m,	  1H),	  2.93	  (s,	  6H),	  3.58-­‐3.70	  (m,	  2H),	  6.67	  (d,	  J	  =	  8.7	  Hz,	  2H),	  	  6.98	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.08	  (bd,	  J	  =	  7.5	  Hz,	  2H),	  7.17	  (tt,	  J	  =	  5.9	  Hz,	  J	  =	  7.1	  Hz,	  J	  =	  8.3	  Hz,	  1H),	  	  7.30	  (d,	  J	  =	  4.5	  Hz,	  	  2H),	  9.51	  (d,	  J	  =	  2.4	  Hz,	  1H);	  13C	  NMR	  (100	  
MHz,	  CDCl3,	  25°C):	  δanti	  =	  12.1,	  14.1,	  22.7,	  28.3	  (3C),	  31.2,	  40.7	  (2C),	  45.1,	  52.4,	  77.2,	  80.0,	  112.7	  (2C),	  125.9	  (2C),	  128.6	  (2C),	  128.8,	  129.0	  (2C),	  142.4,	  149.4,	  154.7,	  205.4;	  δsyn	  =	  12.1,	  14.1,	  22.7,	  28.3	  (3C),	  31.2,	   40.7	   (2C),	   45.1,	   52.4,	   77.2,	   80.0,	   112.7	   (2C),	   125.9	   (2C),	   128.6	   (2C),	   128.8,	   129.0	   (2C),	   142.4,	  149.4,	  154.7,	  205.4;	  ESI-­‐MS:	  m/z	  =	  447.2	  [M+Na]+,	  871.4	  [2M+Na]+.	  	   According	  at	  the	  general	  procedure	  was	  obtained	  the	  desired	  product	  as	   a	   dark	   yellow	   oil;	   yield	   75%	   d.r.=	   2.5:1	   ratio	   (anti:syn)	   was	  determined	  was	   determined	   by	   integration	   of	   RCHO	   1H	   NMR	   signal	  
δanti=	  9.52	   (d,	   J	   =	   4.7	  Hz,	   1H),	  δsyn=	  9.39	   (d,	   J	   =	   3.9	  Hz,	   1H).	  The	   title	  compound	   was	   isolated	   by	   flash	   column	   chromatography	  (Cyclohexane/ether	   =	   8/2)	   as	   mixture	   of	   diastereoisomers	   in	   2.5:1	   ratio	   (anti:syn).	   Anti	  diastereoisomer	  ee	  =	  96%;	  Syn	   diastereoisomer	  ee=	  91%.	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  fron	  99/1	  to	  90/10	  in	  30	  min,	  flow	  rate	  0.50	  mL/min.,	  30°C,	  λ	  =	  214,	  254	  nm:	  Anti	  diasteroisomer	  τminor	  =	  17.3	  min.,	  τmajor	  =	  18.1	  min;	  Syn	  diasteroisomer	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(4S)-­‐4-­‐benzyl-­‐3-­‐((2R)-­‐3-­‐(4-­‐methoxyphenyl)-­‐2-­‐methyl-­‐3-­‐(thiophen-­‐2-­‐yl)propanoyl)oxazolidin-­‐
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Chapter	  3.	  Catalytic	  stereoselective	  benzylic	  C-­‐H	  functionalization	  by	  oxidative	  C-­‐H	  activation	  and	  organocatalysis.	  	  	  
I.	  Introduction	  	  









Scheme	  1.	  Alternative	  way	  for	  the	  C-­‐C	  bond	  formation	  	  The	   development	   of	   various	   transition	   metal	   catalyzed	   coupling	   reactions	   was	   studied	   for	   the	  approach	  in	  the	  stereoselective	  intermolecular	  C-­‐H	  functionalization	  methods.	  Sames	  and	  co	  workers1	  reported	   a	   review	   where	   they	   described	   the	   functionalization	   of	   C-­‐H	   bond	   in	   complex	   organic	  substrates	   catalyzed	   by	   transition	   metal	   catalyst.	   Two	   types	   of	   transition	   metal	   mediated	  transformations	   have	   appeared	   as	   innovative	   methodologies	   for	   selective	   C-­‐H	   functionalization	   in	  complex	  organic	  substrates.2	  The	  first	  method	  described	  as	  C-­‐H	  activation	  involves	  insertion	  of	  a	  metal	  into	  a	  C-­‐H	  bond.3	  The	  second	  method	  is	  the	  C-­‐H	  insertion	  of	  metal	  bound	  carbenes	  or	  nitriles.	  [4]	  On	  the	  other	   hand,	   metal	   free	   coupling	   reactions	   has	   emerged	   as	   interesting	   synthetic	   methodologies.5	  Several	   groups	  have	  developed	  various	   cross-­‐dehydrogenative-­‐coupling	   (CDC)	   reactions	   for	   forming	  C-­‐C	  bonds	   through	   two	  different	   C-­‐H	  bonds.	   Zhang	   and	   co-­‐workers6	   reported	   a	   highly	   efficient	   CDC	  reaction	   between	   benzyl	   ether	   and	   ketone	  mediated	   by	  DDQ	  without	  metal,	   the	   role	   of	   DDQ	   in	   the	  reaction	   was	   a	   dehydrogenating	   reagent	   and	   the	   reagent	   was	   also	   able	   to	   activate	   the	   carbonyl	  towards	  the	  addition.	  (Scheme2)	  

















































Scheme	  3.	  Oxidative	  C-­‐H	  bond	  activation.	  	  
Over	  the	  past	  years,	  my	  group	  was	  involved	  in	  the	  development	  of	  stereoselective	  SN1	  type	  reactions,	  merging	  two	  concepts	  enamine	  catalysis	  and	  Mayr’s	  electophilicity	  scale	  to	  generated	  stereoselective	  
α-­‐alkylation	  of	  aldehydes.8	  This	  allowed	  to	  use	  stabilized	  carbocations	  generated	  by	  benzylic	  alcohols	  in	   situ	   that	   reacted	   with	   the	   enamine	   catalyst	   	   that	   generated	   enantioselective	   α-­‐alkylation	   of	  aldehydes.9 However, the	  carbocation	  can	  be	  generated	  under	  oxidative	  conditions	  by	  a	  benzylic	  C-­‐H	  bond	   activation	   and	   the	   organocatalytic	   reactions	   can	   be	   merged	   with	   oxidants.	   With	   these	   two	  concepts	   a	   new	   approach	   in	   the	   stereoselective	   α-­‐alkylation	   of	   aldehydes	   is	   developed	   with	   C-­‐H	  functionalization.	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Scheme	  4.	  Hypothesis	  about	  the	  cycle	  organocatalytic	  
The	  model	   reaction	  was	  performed	  under	   inert	  atmosphere	  using	  1eq.	  of	  xanthene,	  3	  eq.	  of	  octanal,	  20mol%	   of	   secondary	   amine	   as	   catalyst	   and	   1.3eq.	   of	   DDQ	   as	   oxidant	   in	   the	   reaction.	   As	   already	  mentioned	   before	   DDQ	  mediate	   the	   cross	   dehydrogenation	   coupling	   reaction	   between	   nucleophiles	  and	  benzylic	  substrates.	  On	  the	  other	  hand,	  the	  scope	  of	  organocatalysis	  mediated	  reactions	  is	  expanding	  in	  the	  last	  years	  and	  new	  chiral	  organocatalysts	  have	  been	  developed	  by	  several	  groups10	  The	  chiral	  diphenylprolinol	  TBS	  ether	   catalyst	   developed	   by	   two	   groups	   independently,	   on	   of	   them	   Jørgensen	   group	   and	   other	  was	  Hayashi	  and	  co-­‐workers,	  did	  not	  prove	  good	  stereoselectivity	  in	  the	  reaction	  conditions.11	  MacMillan	  group12	   developed	   a	   new	   type	   of	   catalyst	   imidazolidinone	   derivatives	   that	   promoted	   a	   good	  stereoselectivity	   for	   our	   reaction.	   The	   catalyst	   a	   (2S,	   5R)-­‐5-­‐benzyl-­‐2-­‐(tert-­‐butyl)-­‐3-­‐methylimidazolidin-­‐4-­‐one	  ·	  TFA	  performed	  better	  than	  other	  MacMillan	  type	  catalysts	  studied	  in	  the	  reaction.	   Furthermore	   the	   reaction	  was	   efficiently	   promoted	   by	   using	   polar	   aprotic	   solvent	   such	   as	  nitromethane	   or	   dichloromethane.	   The	   rule	   played	   by	   DDQ	  was	   crucial.	   In	   fact	   DDQ	  was	   powerful	  enough	  as	  oxidant	  to	  generate	  the	  carbocation,	  but	  no	  enough	  to	  oxidize	  the	  transient	  enamine	  formed	  by	  the	  MacMillan	  catalyst	  during	  the	  catalytic	  cycle:	  In	  catalysis	  is	  well	  know	  that	  strong	  oxidant	  used	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Entry Temp (°C) Solvent Time(h) Y (%)a ee (%)b 
1 r.t CH3CN 1 Traces --- 
2 r.t DMF 1 --- --- 
3 r.t DCM 0.5 62 45 
4 r.t CH3NO2 0.5 50 70 
5 0 DCM 3 81 69 
6 0 CH3NO2 3 55 56 
8 -25 DCM 4 65 77 
9c -25 DCM 4 90 79 
10d -25 DCM 4 52 70 
11e -25 DCM 4 74 70 
a	  Isolated	  yield	  after	  chromatographic	  purification.	  b	  Evaluated	  by	  chiral	  HPLC	  analysis.	  c	  The	  reaction	  was	  performed	  under	  nitrogen	  with	  degassed	  solvents	  and	  adding	  portion	  wise	  the	  oxidant.	  d	  the	  reaction	  was	  carried	  out	  using	  15mol%	  of	  MacMillan	  catalyst.	  e	  The	  reaction	  was	  carried	  out	  without	  TFA	  as	  additive.	  	  
Table	  1	  	  Organocatalytic	  functionalization	  C-­‐H	  activation	  with	  compound	  1	  
When	   the	   reaction	   was	   performed	   at	   low	   temperature	   (-­‐25	   °C)	   it	   was	   observed	   an	   increase	   in	  enantioselectivity	  and	  moderated	  decrease	  in	  yield	  (table1,	  entry	  8,	  65%	  yield,	  77%	  ee).	  The	  addition	  of	  DDQ	  in	  two	  portions	  increased	  the	  yield,	  but	  without	  compromising	  the	  enantioselectivity	  (table	  1,	  entry	  9).	  The	  addition	  of	  oxidant	  by	  syringe	  pump	  stopped	  the	  reaction,	  and	  no	  conversion	  of	  product	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Ar = Ph; 5
Ar = o-NO2Ph; 6 
Ar = p-MeOPh; 7 




R = OMe, NMe2
N
Me




Figure	  1.	  Substrates	  tested	  in	  the	  stereoselective	  benzylic	  C-­‐H	  functionalization	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1.3 eq DDQ 
cat (20mol%)






























































50%, d.r 1:1 
82 anti: 62 syn % ee 
 
40%, d.r 1:1  
69 anti: 59 syn % ee 
 
57%, d.r 1:9  






















57%, d.r 1:9 
60 anti: 77 syn % ee 
 
33%, d.r 1:1 
66 anti: 65 syn % ee 
 
55%, d.r 3:1  







40%, d.r 1:1 
86 anti: 79 syn % ee 
  
All	  the	  reactions	  were	  performed	  at	  -­‐25°C	  under	  nitrogen	  with	  anhydrous	  solvents.	  DDQ	  was	  added	  in	  portions.	  The	   Yield	   after	   chromatography	   purification.	   For	   all	   the	   reactions	   the	   d.r	   ratio	   was	   determined	   by	   1HNMR	  spectroscopic	  analysis.	  The	  enantiomeric	  excess	  determined	  by	  chiral	  HPLC	  analysis	  of	  the	  isolated	  products	  or	  of	  the	  corresponding	  alcohol.	  
Table	   2.	   Representative	   Stereoselective	   C-­‐H	   functionalization	   by	   oxidative	   CH	   activation	   and	  organocatalysis	  .	  	  Oxidation	   of	   1,3,5-­‐cycloheptatrienene	   2	   gave	   the	   stable	   tropylium	   cation,	   but	   in	   performing	   the	  reaction	  using	  20	  mol%	  TFA	  as	  co-­‐catalyst	   the	  enantioselectivity	  decreased	  to	  16%	  ee.	  However	  the	  counter	  ion	  of	  the	  catalyst	  was	  crucial	  in	  order	  to	  obtain	  a	  good	  enantiomeric	  excess,	  and	  by	  the	  use	  of	  MacMillan	   catalyst	   with	   p-­‐NO2PhCOOH	   as	   co-­‐catalyst,	   the	   alkylation	   of	   product	   was	   isolate	   in	  moderated	  yield	  and	   low	  enantioselectivity	   (table	  3,	   entry	  1-­‐3,	  90-­‐30,	  38-­‐70	  %	  ee).	  The	   substrate	  3	  was	   prepared	   according	   at	   the	   literature	   by	   a	   reduction	   of	   the	   corresponding	   flavylium	   salt,15	  The	  procedure	  led	  to	  the	  formation	  of	  a	  mixture	  of	  two	  products,	  one	  the	  desired	  product	  and	  the	  other	  the	  specie	  reduce	  from	  flavylium	  salt:	  Is	  important	  to	  note	  that	  the	  separation	  by	  chromatography	  of	  the	  two	  products	  was	  difficult,	  possibly	  due	  to	  π-­‐stacking	  interaction	  between	  aromatic	  system	  of	  the	  two	  products.	   Using	   the	   mixture	   obtained	   by	   a	   partial	   purification	   as	   a	   starting	   material,	   the	   desired	  product	  was	  obtained	  in	  moderated	  enantioselectivity	  and	  poor	  yield	  (table	  3,	  entry	  4,	  30%,	  d.r.	  3:1,	  74	  anti:	  50	  syn	  %	  ee).	  	  



























1.3 eq DDQ 
cat (20mol%)







	   	   	   	   	  
1	   O 	  30%,	  38%	  ee	  
2	   O 	  90%,	  46%	  ee	  
3	   O 	  30%,	  70%	  ee	  
4	   O Ph
O
	  30%,	  d.r	  3:1	  74	  anti:	  50	  syn	  %	  ee	  All	  the	  reactions	  were	  performed	  at	  -­‐25°C	  under	  nitrogen	  with	  anhydrous	  solvents.	  DDQ	  was	  added	  in	  portions.	  	  
Table	  3.	  Organocatalytic	  C-­‐H	  activation	  with	  compounds	  2-­‐3	  
Determination	  of	  absolute	  configuration	  	  The	   absolute	   configuration	   of	   the	   products	   derivatives	   from	   xanthene	   1	   and	   from	   1,3,5-­‐cycloheptatriene	  (table	  2,	  entry	  2;	  table	  3,	  entry	  1)	  were	  established	  by	  chemical	  correlation	  through	  alkylation	   of	   oxazolidinone	   derivatives.16	   From	   the	   enolization	   procedure	   of	   chiral	   oxazolidinone	  described	   by	   of	   Evans,	   the	   9H-­‐xanthen-­‐9-­‐ol	  was	   treated	  with	   titanium	   enolate	   derived	   from	   the	  N-­‐propionyl	  oxazolidinone,	  and	  the	  product	  was	  reduced	  with	  Super	  Hydride	   in	  THF	  to	  afford	  the	  (R)-­‐	  alcohol	  14.17	   (Scheme	   6)	   The	   absolute	   configuration	   for	   the	   product	   derivative	   from	   alcohol	  2	   was	  assigned	  by	  correlation	  to	  know	  derivatives	  obtain	  using	  a	  methodology	  reported	  by	  Evans.	  The	  (S)-­‐	  
	  101	  























15 16; 54% yield
i) NaN(SiMe3)2, THF, -78C
ii) EtI, -20°C
iii) LiHBEt3, THF, 0°C
Et OH
(S)- 17; 15% yield
ii) LiOH, THF, MeOH
	  
	  
Scheme	  6.	  Assignment	  of	  absolute	  configuration	  by	  chemical	  correlation	  	  
	  The	  absolute	  configuration	  of	   the	  product	  derived	  from	  alcohols	  5-­‐8	  was	  assigned	  by	  comparison	  of	  the	  elution	  order	  of	  the	  product	  from	  a	  chiral	  phase	  HPLC	  column	  reported	  by	  Melchiorre	  group.18	  The	  major	  diastereoisomer	  obtained	   in	   the	  reaction	  was	   the	  syn	   isomer.	   In	  all	   cases	   the	  configuration	  of	  the	  isolated	  products	  were	  in	  agreement	  with	  the	  addition	  of	  carbocation	  from	  the	  less	  hindered	  face	  of	  the	  enamine.	  (Scheme	  7)	  
	  
	  
































































The	   development	   of	   stereoselective	   intermolecular	   dehydrogenation	   α-­‐alkylation	   of	   aldehyde	   via	  benzylic	   C-­‐H	   bond	   activation	   has	   emerged	   as	   a	   new	   strategy	   in	   the	   building	   of	   active	   organic	  compounds,	   merging	   enamine	   catalysis	   with	   oxidative	   C-­‐H	   activation.	   The	   limitations	   in	   this	   new	  reaction	   have	   been	   the	   small	   arrange	   of	   substrates	   that	   can	   perform	   the	   reaction,	   an	   only	   alkyl	  aromatic	  compound	  with	  weak	  C-­‐H	  was	  tolerance	  in	  the	  reaction	  conditions.	  In	  addition	  tnother	  weak	  point	   is	   the	   stoichiometric	   amount	  of	  oxidant	  necessary	   to	  activated	   the	  C-­‐H	  bond.	  Quite	   recently,	   a	  group	  reported	  the	  use	  of	  oxygen	  in	  these	  reactions.	   On	   the	   other	   hand,	   the	   tolerance	   of	   DDQ	   with	   enamine	   catalysts	   emerge	   a	   new	   approach	   in	   the	  catalytic	   stereoselective	   α-­‐alkylation	   of	   aldehydes	   with	   the	   use	   of	   oxidants.	   The	   possibility	   in	   the	  future	  to	  use	  catalytic	  amount	  of	  oxidant	  or	  inexpensive	  and	  simple	  oxidants	  has	  been	  studying	  in	  our	  group.	  Recently,	   Jiao	  and	  co-­‐workers	   19	  reported	   the	  stereoselective	  dehydrogenation	  α-­‐alkylation	  of	  aldehydes	  using	  molecule	  of	  oxygen	  as	  oxidant	  with	  efficiently	  enantioselectivity	  up	  to	  93%	  ee.	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IV.	  Experimental	  section	  
	  

















	  	  entry	   substrate	   Product	  
1	  
N
Me 	   Not	  characterized	  by-­‐products	  2	   O 	   Starting	  material	  
3	  
Me2N NMe2 	   Not	  characterized	  by	  products	  
4	   OMe




Me2N 	   Me2N OMe
O
(63%)	  




H 	   NH
O
(61%)	  9	   	   Starting	  material	  
10	   	   Starting	  material	  	  
Table	  4.	  Stereoselective	  α-­‐alkylation	  with	  aldehydes	  via	  benzylic	  C-­‐H	  bond	  activation.	  	  	  
O














	  	  entry	   T(°C)	   Additive,	  20mol%	   Yield	  (%)	   ee	  (%)	  1	   RT	   TFA	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  2	   -­‐25	   TFA	   91	   16	  3	   -­‐25	   p-­‐NO2PhCO2H	   90	   46	  4	   -­‐25	   1,3,5-­‐MeOPhCOOH	   27	   44	  5	   -­‐25	   -­‐-­‐-­‐	   82	   40	  6	   -­‐25	   CF3CH2OH	   32	   20	  7	   -­‐25	   N-­‐Boc-­‐Phe-­‐OH	   n.d	   20	  8	   -­‐25	   proline	   -­‐-­‐-­‐	   0	  	  
Table	  5.	  Reaction	  of	  n-­‐octanal	  with	  1,3,5-­‐cycloheptatriene	  performed	  with	  different	  co-­‐catalysts.	  	  
	  
Synthetic	  procedures	  	  Procedure	  A.	  Substrates	  1	  and	  3.	  	  In	  a	  two-­‐necked	  flask	  containing	  degassed	  DCM	  (1	  mL),	  the	  organocatalyst	  a	  (20	  mol	  %),	  the	  aldehyde	  (3	  eq.,	  0.3	  mmol)	  and	  compound	  1	  or	  3	   (0.1mmol)	  are	  added	  under	  nitrogen	  at	  r.t.	  and	  the	  solution	  was	  stirred	  at	  r.t.	  for	  5	  min.	  After	  cooling	  to	  -­‐25°C,	  DDQ	  (1.3	  eq.)	  was	  added	  portion	  wise	  (3	  portions)	  during	  1	  hour,	  and	  the	  solution	  was	  stirred	  at	   -­‐25°C	  for	  4	  h.	  The	  reaction	  was	  quenched	  with	  water,	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and	  the	  organic	  phase	  was	  separated.	  The	  aqueous	  phase	  was	  extracted	  twice	  with	  DCM;	  the	  organic	  phases	  were	  dried	  over	  Na2SO4	  and	  evaporated	  under	  reduced	  pressure	  to	  afford	  the	  crude	  reaction	  mixture,	   that	  was	   purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane/Et2O	   =	   9/1	   for	   the	   product	  from	  1,	  n-­‐hexane/	  Et2O	  =	  95/5	  for	  the	  producst	  from	  3).	  	  	  Procedure	  B.	  Substrate	  2.	  In	  a	  two-­‐necked	  flask	  containing	  degassed	  DCM	  (1	  mL),	  the	  organocatalyst	  b	  (20	  mol	  %),	  the	  aldehyde	  (3	  eq.,	  0.3	  mmol)	  and	  compound	  2	   (0.1mmol)	  are	  added	  under	  nitrogen	  at	   r.t.	   and	   the	  solution	  was	  stirred	   at	   r.t.	   for	   5	  min.	   After	   cooling	   to	   -­‐25°C,	   DDQ	   (1.3	   eq.)	   was	   added	   portion	  wise	   (3	   portions)	  during	  1	  hour,	  and	  the	  solution	  was	  stirred	  at	   -­‐25°C	  for	  4	  h.	  The	  reaction	  was	  quenched	  with	  water,	  and	  the	  organic	  phase	  was	  separated.	  The	  aqueous	  phase	  was	  extracted	  twice	  with	  DCM;	  the	  organic	  phases	  were	  dried	  over	  Na2SO4	  and	  evaporated	  under	  reduced	  pressure	  to	  afford	  the	  crude	  reaction	  mixture,	  that	  was	  purified	  by	  flash	  chromatography	  (SiO2;	  cyclohexane/Et2O	  =	  9/1).	  	  	  Procedure	  C.	  Substrates	  5-­‐8.	  In	  a	  two-­‐necked	  flask	  containing	  degassed	  DCM	  (1	  mL),	  the	  organocatalyst	  a	  (20	  mol	  %),	  the	  aldehyde	  (3	  eq.,	  0.3	  mmol),	  MeOH	  (2eq.,	  0.2	  mmol)	  and	  compound	  5-­‐8	  (0.1	  mmol)	  are	  added	  under	  nitrogen	  at	  r.t.	  and	  the	  solution	  was	  stirred	  at	  r.t.	   for	  5	  min.	  After	  cooling	  to	  -­‐25°C,	  DDQ	  (1.3	  eq.)	  was	  added	  and	  the	  solution	  was	  stirred	  at	  -­‐25°C	  for	  4	  h.	  The	  reaction	  was	  quenched	  with	  water,	  and	  the	  organic	  phase	  was	  separated.	  The	  aqueous	  phase	  was	  extracted	  twice	  with	  DCM;	  the	  organic	  phases	  were	  dried	  over	  Na2SO4	  and	  evaporated	  under	  reduced	  pressure	  to	  afford	  the	  crude	  reaction	  mixture,	  that	  was	  purified	  by	  flash	  chromatography	  (SiO2;	  cyclohexane/AcOEt,	  gradient	  from	  9/1	  to	  8/2).	  	  	  
2-­‐(9H-­‐xanthen-­‐9-­‐yl)octanal	  (table	  2,	  entry	  1)	  	  C21H24O2	  FW	  =	  308.41	  [a]D	  =	  +	  17.1	  (c	  0.35,	  CHCl3)	  According	   at	   the	   procedure	   A	   was	   afforded	   the	   desired	   product	   in	   90%	  yield,	  79%	  ee.	  1H	  NMR	  (CDCl3,	  200MHz)	  δ	  0.83	  (3H,	  t,	  J	  =	  6.6Hz),	  0.98-­‐1.60	  (10H,	  m),	  2.51-­‐2.57	  (1H,	  m),	  4.49	  (1H,	  d,	  J	  =	  4.8Hz),	  7.04-­‐7.32	  (8H,	  m),	  9.65	  (1H,	  d,	  J	  =	  2.6Hz).	  13C	  NMR	  (CDCl3,	  50MHz)	  δ	  13.9,	  22.4,	  25.4,	  25.4,	  27.4,	  29.1,	  31.4,	  40.1,	  60.6,	  116.7,	  116.8,	  123.4,	  123.5,	  128.2	  (2C),	   128.3	   (2C),	   128.7	   (2C),	   128.9	   (2C),	   204.0.	   ESI-­‐MS:	   r.t:	   15.1	   min;	   m/z:	   331	   (M+Na+),	   HPLC	  




2-­‐(9H-­‐xanthen-­‐9-­‐yl)propanal	  (table	  2,	  entry	  2)	  C16H14O2	  	  	  Fw	  =	  238.28	  [α]D	  =	  +7.6	  (c	  1.1,	  CHCl3).	  	  Colorless	  oil.	  According	  at	  the	  procedure	  A	  was	  afforded	  the	  desired	  product	  in	  75%	  yield,	  68	  %	  ee.	  1H	  NMR	  (CDCl3,	  200	  MHz)	  δ	  0.93	  (3H,	  d,	  J	  =	  7.4	  Hz),	  2.67-­‐2.76	  (1H,	  m),	  4.64	  (1H,	  d,	  J	  =	  4.0	  Hz),	  7.02-­‐7.32	  (8H,	  m);	  9.78	  (1H,	  s).	  13C	  NMR	  (CDCl3,	  50	  MHz)	  δ:	  9.4,	  39.7,	  55.8,	  116.6,	  118.0,	  121.5,	  123.3,	  123.4,	  123.6,	   128.2,	   128.3,	   128.6,	   129.0,	   152.9,	   153.1,	   203.7.	   GC-­‐MS:	   rt:	   19.2	   min;	  m/z:	   238(5),	   183(12),	  182(146),	   181(1000),	   180(12),	   165(13),	   153(15),	   152(112),	   151(39),	   150(14),	   127(15),	   126(15),	  77(10),	  76(11),	  63(7).	  HPLC	   analysis:	  Chiracel	   IC:	  99:1	   (n-­‐hexane:	   i-­‐PrOH),	   flow	  0.7mL/min.	   tm:12.2	  min;	  TM:	  11.7	  min.	  HRMS	  Calcd	  for	  C17H16O2:	  238.09938,	  [M]+,	  found:	  238.0991.	  	  
2-­‐(9H-­‐xanthen-­‐9-­‐yl)butanal	  (table	  2,	  entry	  3)	  C17H16O2	  	  	  Fw	  =	  252.31	  [α]D	  =	  +19.5	  (c	  1.2,	  CHCl3).	  	  Colorless	  oil.	  According	   at	   the	   procedure	   A	   was	   afforded	   the	   desired	   product	   in	   50%	   yield,	  78%ee.	  1H	  NMR	  (CDCl3,	  200	  MHz)	  δ	  0.84	  (3H,	  t,	  J	  =	  7.5	  Hz),	  1.45-­‐1.65	  (2H,	  m),	  2.42-­‐2.53	  (1H,	  m),	  4.49	  (1H,	  d,	  J	  =	  4.4	  Hz);	  7.04-­‐7.32	  (8H,	  m);	  9.67	  (1H,	  d,	  J	  =	  2.6	  Hz).	  13C	  NMR	  (CDCl3,	  50	  MHz)	  δ	  12.0,	  18.7,	  40.0,	  62.3,	  116.7,	  116.8,	  122.2,	  123.2,	  123.4,	  123.5,	  128.2,	  128.3,	  128.7,	  128.9,	  152.9,	  153.0,	  204.5.	  GC-­‐
MS:	   rt:	   22.7	   min;	   m/z:	   252(5),	   207(9),	   205(7),	   196(5),	   183(17),	   182(18),	   181(1000),	   180(13),	  165(10),	   153(18),	   152(116),	   151(38),	   150(14),	   139(6),	   91(9),	   77(9),	   76(15),	   75(9),70(9),	   69(9),	  63(10).	  HPLC	   analysis	   (derivatized	   to	   alcohol):	   Chiracel	  OF:	   gradient	   from	  99:1	   (hexane:	   i-­‐PrOH)	   to	  90:10	   in	  30min,	   flow	  0.5mL/min.	   tm:23.3	  min;	  TM:	  21.4	  min.	  HRMS	   Calcd	   for	   C17H16O2:	   252.11503,	  [M]+,	  found:	  252.1151.	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127(12),	  126(10),	  76(8),	  63(7).	  HPLC	  analysis:	  Chiracel	  IC:	  gradient	  from	  99:1	  (n-­‐hexane:	   i-­‐PrOH)	  to	  90:10	  in	  30min,	  flow	  0.5mL/min.	  tm:14.8	  min;	  TM:	  15.9	  min.	  HRMS	  Calcd	  for	  C18H18O2:	  266.13068,	  [M]+,	  found:	  266.1307.	  	  	  
2-­‐(9H-­‐xanthen-­‐9-­‐yl)hex-­‐5-­‐enal	  (table	  2,	  entry5)	  C19H18O2	  	  	  	  Fw	  =	  278.35	  [α]D	  =	  +	  2.3	  (c	  0.48,	  CHCl3).	  	  Colorless	  oil.	  According	   at	   the	   same	   procedure	   A	  was	   afforded	   the	   desired	   product	   in	   90%	  yield,	  78%	  ee	  1H	  NMR	  (CDCl3,	  400	  MHz)	  δ	  1.43-­‐1.49	  (1H,m),	  160-­‐1.69	  (1H,	  m),	  1.85-­‐1.91	  (1H,	  m),	  1.96-­‐2.02	  (1H,	  m),	  2.60	  (1H,	  ddt,	  J=	  2.4,	  4.4,	  9.6	  Hz),	  4.50	  (1H,	  d,	  J=	  4.4	  Hz),	  4.84	  (1H,	  d,	  J=17.2	  Hz),	  4.89	  (1H,	  d,	   J=10.4	  Hz),	  5.57	  (1H,	  ddt,	   J=	  3.2,	  10.4,	  17.2	  Hz),	  7.04-­‐7.12	  (4H,	  m),	  7.21-­‐7.28	  (4H,	  m),	  9.67	  (1H,	  d,	  J=2.4	  Hz).	  13C	  NMR	   (CDCl3,	  100	  MHz)	  δ	  24.4,	  31.3,	  39.9,	  59.9,	  115.5,	  116.7,	  116.8,	  122.9	   (2C),	  123.4,	  123.6,	  128.3,	  128.4,	  128.7,	  128.9,	  137.3,	  152.8	  (2C),	  204.2.	  	  GC-­‐MS:	  rt:	  30.2	  	  min;	  m/z:	  278(4),	  207(14),	  183(11),	   182(138),	   181(1000),	   180(10),	   153(14),	   152(86),	   151(23),	   127(10),	   126(9),	   77(7).	  HPLC	  analysis	  (derivatized	  to	  alcohol)	  Chiracel	  IC:	  gradient	  from	  99:1	  (n-­‐hexane:	  i-­‐PrOH)	  to	  90:10	  in	  30min,	  flow	  0.5mL/min.	  tm:27.8	  min;	  TM:	  29.0	  min.	  	  
HRMS	  Calcd	  for	  C19H18O2:	  278.13068,	  [M]+,	  found:	  268.1308.	  	  	  






(2S)-­‐(2-­‐phenyl-­‐4H-­‐chromen-­‐4-­‐yl)	  octanal	  (table	  3,	  entry	  4)	  C23H26O2	  	  	  	  Fw	  =	  334.45	  Colorless	  oil.	  	  According	   at	   the	   procedure	   A	   was	   afforded	   the	   desired	   product	   in	   30%	  yield,	  d.r	  2:1,	  10%maj:	  62%min	  ee	  1H	  NMR	  (CDCl3,	  400	  MHz)	  δ	  	  0.82	  (3H	  M,	  t,	  J	  =	  7.2	  Hz),	  0.88	  (3H	  m,	  t,	  J	  =	  7.2	  Hz),	  0.91-­‐1.45	  (16H,	  m),	  1.61-­‐1.73	  (2H	  m,	  m),	  1.73-­‐1.80	  (2H	  M,	  m),	  2.58-­‐2.62	  (1H	  m,	  m),	  2.62-­‐2.66	  (1H	  M,	  m),	  4.06	  (1H	  m,	  t,	  J=4.4Hz),	  4.22	  (1H	  M,	  t,	  J=4.4Hz),	  5.38	  (1H	  M,	  d,	  J=	  4.8Hz),	  5.55	  (1H	  m,	  d,	  J=	  4.8Hz),	  7.07-­‐7.26	  (6H,	  m),	  7.24	  (1H	  M	  +	  1H	  m,	  t,	  J=5.8Hz),	  7.33-­‐7.40	  (6H,	  m),	  7.69	  (4H,	  d,	  J=6.8Hz),	  9.72	  (1H	  m,	  d,	  J=2.4Hz),	  9.84	  (1H	  M,	  d,	  J=2.4Hz).	  13C	  NMR	  (CDCl3,	  100	  MHz)	  δ	  (major)	  13.9,	  24.9(2C),	  27.8,	   29.1,	   31.4,	   35.0,	   59.5,	   96.6,	   116.7,	   116.8,	   121.3,	   123.7,	   124.7,	   124.8,	   127.9,	   128.3,	   128.4,	   128.7,	  133.8,	   150.6,	   152.5,	   204.4.	   ESI-­‐MS:	   rt:	   17.3	   	   min;	   m/z:	   335	   (M+1),	   357	   (M+Na+).	   HPLC	   analysis:	  Chiracel	  IC:	  gradient	  from	  99:1	  (hexane:	  i-­‐PrOH)	  to	  90:10	  in	  30min,	  flow	  0.5mL/min.	  tm	  (major):12.8	  min;	   TM	   (major):	   14.6	  min.	   tm	   (minor):15.7	  min;	   TM	   (minor):	   13.8	  min.	  HRMS	   Calcd	   for	   C24H26O2:	  334.19328,	  [M]+,	  found:	  334.1935.	  	  
(S)-­‐2-­‐	  (cyclohepta	  -­‐2,4,6-­‐trien-­‐1-­‐yl)	  (table	  3,	  entry	  2)	  C15H22O	  	  	  	  Fw	  =	  218.33	  [α]D	  =	  +	  8.4	  (c	  0.90,	  CHCl3).	  	  Colorless	  oil.	  According	   the	   procedure	   B	   was	   afforded	   the	   desired	   product	   in	   90	   %	  yield,	  46%	  ee.	  1H	  NMR	   (CDCl3,	  200	  MHz)	  δ:	  0.88	  (3H,	  t,	   J	  =	  6.6	  Hz),	  1.09-­‐1.44	  (8H,	  m),	  1.53-­‐1.81	  (2H,	  m),	  1.81-­‐2.07	  (1H,	  m),	  2.52-­‐2.69	  (1H,	  m),	  5.23	  (2H,	  pseudo	  t,	  J	  =	  7.2	  Hz),	  6.24	  (2H,	  m),	  6.69	  (2H,	  pseudo	  t,	  J	  =	  2.8	  Hz),	  9.64	  (1H,	  d,	  J	  =	  3.4Hz).	  13C	  NMR	  (CDCl3,	  100	  MHz)	  δ:	  14.1,	  23.6,	  29.1,	  29.3,	  31.8,	  34.4,	  38.8,	  54.0,	  122.2,	  123.1,	  125.6,	  125.7,	  131.0,	  131.1,	  204.7.	  GC-­‐MS:	  rt:	  14.7	  min;	  m/z:	   218(5),	   147(7),	   133(45),	   129(19),	   128(10),	   118(6),	   117(28),	   116(9),	   115(32),	   105(40),	  104(12),	   103(17),	   92(92),	   91(1000),	   90(6),	   79(17),	   78(29),	   77(34),	   69(6),	   65(46),	   55(22),	   51(11).	  
HPLC	  analysis:	  Chiracel	  OD-­‐H:	  99:1	  (n-­‐hexane:	   i-­‐PrOH),	   flow	  0.6mL/min.	  tm:21.1	  min;	  TM:	  19.2	  min.	  
HRMS	  Calcd	  for	  C15H22O2:	  218.16706,	  [M]+,	  found:	  218.1672.	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According	  at	  the	  procedure	  B	  was	  afforded	  the	  desired	  product	  30%	  yield,	  38	  %	  ee.	  1H	  NMR	   (CDCl3,	  400	  MHz)	  δ	  0.94	  (3H,	  t,	  J	  =	  7.2	  Hz),	  1.74-­‐1.84	  (2H,	  m),	  1.97-­‐2.02	  (1H,	  m),	  2.54-­‐2.60	  (1H,	  m),	  5.24	  (2H,	  dt,	  J	  =	  5.6,	  10.0	  Hz),	  6.25	  (2H,	  tt,	  J	  =	  2.8,	  10.0	  Hz),	  6.69	  (2H,	  pseudo	  t,	  J	  =	  2.8	  Hz),	  9.65	  (1H,	  d,	  J	  =	  3.6Hz).	  
13C	  NMR	  (CDCl3,	  100	  MHz)	  δ	  11.5,	  20.2,	  38.5,	  55.1,	  122.1,	  123.1,	  125.6,	  125.8,	  131.0,	  131.1,	  204.5.	  GC-­‐
MS:	  rt:	  9.3	  min;	  m/z:	  162(3),	  133(16),	  131(7),	  128(7),	  117(14),	  115(29),	  105(40),	  104(10),	  103(20),	  92(85),	   91(1000),	   89(20),	   79(18),	   78(57),	   77(55),	   65(77),	   63(28),	   62(9),55(24),	   51(29).	   HPLC	  analysis:	  Chiracel	  OD-­‐H:	  99:1	  (n-­‐hexane:	   i-­‐PrOH),	  flow	  0.6mL/min.	  tm:	  28.6min;	  TM:	  26.9min.	  HRMS	  Calcd	  for	  C11H14O:	  162.10447,	  [M]+,	  found:	  162.1045.	  
 
(S)-­‐2-­‐	  (cyclohepta-­‐2,4,6-­‐trien-­‐1-­‐yl)-­‐3-­‐methylbutanal	  (table	  3,	  entry	  3)	  C12H16O	  	  	  	  Fw	  =	  176.25	  [α]D	  =	  +	  8.8	  (c	  0.51,	  CHCl3).	  	  Colorless	  oil.	  According	  to	  the	  procedure	  B	  was	  afforded	  the	  desired	  product	  in	  30%yield,	  79%	  ee.	  1H	  
NMR	   (CDCl3,	  400	  MHz)	  δ	  0.95	  (3H,	  d,	   J	  =	  7.2	  Hz),	  1.06	  (3H,	  d,	   J=7.2Hz),	  2.05-­‐2.12	  (1H,	  m),	  2.25-­‐2.33	  (1H,	  m),	  2.50	  (1H,	  m),	  5.21	  (2H,	  dd,	  J=6.0,	  9.2	  Hz),	  6.24	  (2H,	  pseudo	  tt,	  J=2.8,	  9.2	  Hz),	  6.70	  (2H,	  dd,	  J=2.8	  Hz),	   9.78	   (1H,	   d,	   J	   =	   4.4	  Hz).	   13C	   NMR	   (CDCl3,	   100	  MHz)	  δ	   18.6,	   21.2,	   21.5,	   37.3,	   59.0,	   122.0,	   122.7,	  125.4,	  125.5,	  130.9,	  131.0,	  205.7.GC-­‐MS:	  rt:	  10.2	  min;	  m/z:	  176(5),	  174(6),	  134(10),	  133(94),	  131(20),	  129(11),	   128(17),	   117(18),	   116(11),	   115(50),	   105(59),	   104(12),	   92(114),	   91(1000),	   90(9),	   89(21),	  79(39),	   78(59),	   77(70),	   65(80),	   63(24),	   55(38),	   53(17),	   52(14),	   51(38),	   50(12).	   HPLC	   analysis:	  Chiracel	   OD-­‐H:	   99:1	   (hexane:	   i-­‐PrOH),	   flow	   0.6mL/min.	   tm:29.0min;	   TM:	   24.9min.	  HRMS	   Calcd	   for	  C12H16O:	  176.12012,	  [M]+,	  found:	  176.1200.	  
	  






348	  (M+H+);	  370	  (M+Na+).	  HPLC	  analysis	  Chiracel	  IC:	  gradient	  from	  99:1	  (hexane:	  i-­‐PrOH)	  to	  90:10	  in	  30min,	   flow	  0.5mL/min.	  TM	  (anti):	  31.6	  min;	  tm	  (anti):	  23.8	  min;	  TM	  (syn):	  21.0	  min;	  tm	  (syn):	  24.5	  min;	  HRMS	  Calcd	  for	  C17H16O2:	  347.22491,	  [M]+,	  found:	  347.2247.	  	  






Ph 	  According	  at	  the	  procedure	  C	  was	  afforded	  the	  desired	  product	  in	  40%	  yield,	  d.r	  1:1,	  69%syn:	  59%	  anti	  ee.	  Analysis	  data	  are	  reported	  in	  ref.	  18	  	  
(S)-­‐2-­‐((R)-­‐(2-­‐methyl-­‐1H-­‐indol-­‐3-­‐yl)(2-­‐nitrophenyl)methyl)octanal	  (table	  2,	  entry	  9)	  C24H28N2O3	  	  	  	  Fw	  =	  392.49	  [α]D	  =	  +113.0	  (c	  0.60,	  CHCl3).	  	  Yellow	  oil.	  According	   at	   the	   procedure	   C	   was	   afforded	   the	   desired	   product	   in	  57%yield,	  d.r	  1:9;	  86%	   syn	   ee.	   1H	   NMR	   (CDCl3,	   400	  MHz)	  δ	   (syn)	  0.86	  (3H,	  t,	  J=7.2Hz),1.17-­‐1.32	  (8H,	  m),	  1.49-­‐1.57	  (1H,	  m),	  1.73-­‐1.80	  (1H,m),	  2.38	  (3H,	  s),	  3.45-­‐3.52	  (1H,m),	  5.22	   (1H,	   d,	   J	   =	   10.8	   Hz),	   7.00-­‐7.09	   (2H,	   m),	   7.18	   (1H,	   d,	   J=7.2Hz),	   7.30	   (1H,	   t,	   J=8.0Hz),	   7.49-­‐7.59	  (2H,m),	  7.63	  (1H,	  dd,	  J=1.2,	  8.0Hz),	  7.85	  (1Hsyn,	  bs),	  7.87	  (1H,	  d,	  J=8.0Hz),	  9.38	  (1H,	  d,	  J	  =	  4.4	  Hz).	  13C	  
NMR	   (CDCl3,	  100	  MHz)	  δ	   (syn):	  12.4,	  14.0,	  22.5,	  26.9,	  28.8,	  29.1,	  31.5,	  37.3,	  54.6,	  110.0,	  110.6,	  118.7,	  119.8,	  121.3,	  124.4,	  127.1,	  127.2,	  129.3,	  132.3,	  132.7,	  135.3,	  136.5,	  150.3,	  203.2.	  ESI	  MS:	  rt:	  12.9	  min	  (syn);	  m/z:	  393	  (M+H+);	  415	  (M+Na+).	  HPLC	  analysis:	  Chiracel	  IC:	  gradient	  from	  99:1	  (hexane:	  i-­‐PrOH)	  to	   90:10	   in	   30min,	   flow	   1.0mL/min.	   TM	   (syn):	   24.1	   min;	   tm	   (syn):	   17.7min.	   HRMS	   Calcd	   for	  C24H28N2O3:	  392.20999,	  [M]+,	  found:	  392.2098.	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J=	  10.8	  Hz),	  6.97-­‐7.26	  (9H,	  m),	  7.34	  (1H,	  t,	  J=8.0Hz),	  7.56	  (1H,	  t,	  J=8.0	  Hz),	  7.66	  (1H,	  d,	  J=8.0	  Hz),	  7.82	  (1H,	  bs),	  7.99	  (1H,	  d,	   J=	  8.0Hz),	  9.43	  (1H,	  d,	   J=	  3.6Hz).	  13C	  NMR	   (CDCl3,	  100	  MHz)	  δ	  12.2,	  35.0,	  37.8,	  55.6,	  109.4,	  110.7,	  118.6,	  119.9,	  121.3,	  124.5,	  126.5,	  127.0,	  128.5,	  128.6	  (2C),	  128.8	  (2C),	  129.3,	  132.3,	  132.9,	  135.4,	  136.2,	  138.4,	  150.5,	  203.0.	  
ESI	  MS:	   rt:	  10.9(syn)	  min;	  m/z:	  399	  (M+H+);	  421	  (M+Na+).	  HPLC	  analysis	  Chiracel	   IC:	  gradient	   from	  99:1	  (hexane:	  i-­‐PrOH)	  to	  90:10	  in	  30min,	  flow	  0.5mL/min.	  TM	  (syn):	  40.4	  min;	  tm	  (syn):	  33.9min;	  TM	  (anti):	  43.0	  min;	  tm	  (anti):	  28.7min.	  HRMS	  Calcd	  for	  C25H22N2O3:	  398.16034,	  [M]+,	  found:	  398.1602.	  	  
(S)-­‐2-­‐((R)-­‐(4-­‐methoxyphenyl)(2-­‐methyl-­‐1H-­‐indol-­‐3-­‐yl)methyl)octanal	  (table	  2,	  entry	  11)	  C25H31NO2	  	  	  	  Fw	  =	  377.52	  Colorless	  oil.	  According	   at	   the	  procedure	  C	  was	   affored	   the	  desired	  product	   in	  33%	  yield,	  d.r	  1:1,	  66%	  anti:	  65%	   syn	   ee.	   1H	   NMR	   (CDCl3,	  400	  MHz)	  δ	   0.79	  (3Hanti,	   t,	   J=7.2Hz),	   0.86	   (3Hsyn,	   t,	   J=7.2Hz),1.09-­‐1.28	   (16H,	  m),	   1.46-­‐1.66	   (4H,	  m),	   2.42	   (3Hsyn,	   s),	   2.44	   (3Hanti,	   s),	   3.43-­‐3.55	   (2H,m),	   3.72	  (3Hanti,	  s),	  3.75	  (3Hsyn,	  s),	  4.28	  (1Hsyn,	  d,	  J	  =	  11.6	  Hz),	  4.40	  (1Hanti,	  d,	  J	  =	  11.6	  Hz),	  6.76	  (2Hanti,	  d,	  J=8.4Hz),	  6.81	  (2Hsyn,	  d,	  J=8.4Hz),	  7.02-­‐7.11	  (4H,	  m),	  7.19-­‐7.31	  (6H,m),	  7.62	  (1Hanti,	  d,	  J=7.6Hz),	  7.67	  (1Hsyn,	  d,	  J=7.6Hz),	  7.74	  (1Hsyn,	  bs),	  7.79	  (1Hanti,	  bs),	  9.40	  (1Hsyn,	  d,	  J	  =	  4.4	  Hz),	  9.60	  (1Hanti,	  d,	  J	  =	  4.4	  Hz).	  13C	  NMR	  (CDCl3,	  100	  MHz)	  δ	  (anti+syn)	  12.4,	  12.8,	  14.0	  (2C),	  22.5	  (2C),	  26.7,	  27.0,	  28.7	  (2C),	  29.2,	  29.3,	  31.5,	  31.6,	  42.2,	  43.1,	  54.5,	  54.6,	  55.1,	  55.2,	  110.3,	  110.4,	  112.4	  (2C),	  112.6	  (2C),	  113.8	  (2C),	  113.9	  (2C),	  118.7,	  119.0,	  119.4,	  119.5,	  121.0,	  121.1,	  127.4	  (2C),	  128.9	  (2C),	  129.0	  (2C),	  131.1,	  131.4,	  134.8,	  135.4,	  157.9	  (2C),	  204.3,	  205.6.	  ESI	  MS:	  rt:	  12.5	  and	  13.0	  min;	  m/z:	  400	  (M+Na+).	  HPLC	  analysis:	  Chiracel	   IC:	  gradient	   from	  99:1	  (n-­‐hexane:	   i-­‐PrOH)	  to	  8:2	   in	  30min,	   flow	  0.5mL/min.	  TM	  (anti):	  22.2	  min;	  tm	  (anti):	  20.4min;	  TM	  (syn):	  24.0min;	  tm	  (syn):	  25.8min.	  HRMS	  Calcd	  for	  C25H31NO2:	  377.23548,	  [M]+,	  found:	  377.2353.	  	  	  












13C	   NMR	   (CDCl3,	   100	  MHz)	   δ	   (syn+anti)	   12.3,	   12.5,	   35.3,	   35.4,	   42.6(2C),	   43.5(2C),	   55.7,	   56.4,	   110.5,	  110.6,	  111.9,	  112.2,	  113.9(2C),	  114.1(2C),	  118.9,	  119.0,	  119.5,	  119.6,	  121.0,	  121.1,	  126.2,	  126.3,	  126.4,	  127.2,	  127.4,	  128.2,	  128.3(4C),	  128.4,	  128.5	  (2C),	  128.9,	  129.0,	  129.1,	  131.2,	  131.8,	  134.3,	  134.5,	  135.3,	  135.5,	  138.6,	  139.0,	  157.9,	  158.0,	  204.5,	  205.5.ESI	  MS:	   rt:	  10.8	  and	  11.2	  min;	  m/z:	  384	   (M+H+);	  406	  (M+Na+).	   HPLC	   analysis	   IC:	   gradient	   from	   99:1	   (n-­‐hexane:	   i-­‐PrOH)	   to	   90:10	   in	   30min,	   flow	   0.5	  mL/min.	  TM	  (anti):	  45.8	  min;	  tm	  (anti):	  48.0	  min;	  	  TM	  (syn):	  42.8	  min;	  tm	  (syn):	  34.1	  min.	  HRMS	  Calcd	  for	  C26H25NO2:	  383.18853,	  [M]+,	  found:	  383.1884.	  	  
(S)-­‐2-­‐((R)-­‐	  (2-­‐methyl-­‐1H-­‐indol-­‐3-­‐yl)(4-­‐nitrophenyl)methyl)octanal	  (table	  2,	  entry	  13)	  C24H28N2O3	  	  	  	  Fw	  =	  392.49	  Yellow	  oil.	  According	  at	  the	  same	  procedure	  C	  was	  afforded	  the	  desired	  product	  in	  40%	  yield,	  d.r	  1:1	  and	  86%	  anti:	  79%	  syn	  ee.	  1H	  NMR	  (CDCl3,	  400	  MHz)	  
δ	   0.77-­‐0.91	   (6H,	  m),	   1.34-­‐1.45	   (16H,	  m),	   1.46-­‐1.51	   (2H,	  m),	   1.52-­‐1.62	  (2H,	  m),	   2.42	   (3Hsyn,	   s),	   2.44	   (3Hanti,	   s),	   3.49-­‐3.58	   (1Hsyn,	  m),	   3.61-­‐3.68	  (1Hanti,	  m),	  4.45	  (1Hsyn,	  d,	   J	  =	  11.2	  Hz),	  4.56	  (1Hanti,	  d,	   J	  =	  11.2	  Hz),	   7.03-­‐7.14	   (4H,	  m),	   7.18-­‐7.34	   (4H,m),	   7.50	   (2Hanti,	   d,	   J=8.8	  Hz),	   7.54	   (2Hsyn,	   d,	   J=8.8	  Hz),	   7.89	  (1Hsyn,	  bs),	  7.93	  (1Hanti,	  bs),	  8.07	  (2Hanti,	  d,	  J=8.8	  Hz),	  8.13	  (2Hsyn,	  d,	  J=8.8	  Hz),	  9.44	  (1Hsyn,	  d,	  J	  =	  4.0	  Hz),	  9.68	  (1Hanti,	  d,	  J	  =	  4.0	  Hz).13C	  NMR	  (CDCl3,	  100	  MHz)	  δ	  (syn+anti)	  12.7	  (2C),	  14.0	  (2C),	  22.6	  (2C),	  26.4,	  26.9,	  29.1,	  29.3,	  29.4,	  29.7,	  31.5,	  31.6,	  42.4,	  43.9,	  53.8,	  54.0,	  110.7	  (2C),	  118.4,	  118.5,	  119.9,	  120.0,	  121.4,	  121.5,	  123.8	  (2C),	  123.9	  (2C),	  128.7	  (4C),	  127.0	  (2C),	  131.8	  (2C),	  132.0	  (2C),	  135.3	  (2C),	  150.2	  (2C),	  150.4	  (2C),	  203.3,	  204.5.	  ESI	  MS:	  rt:	  12.4	  and	  12.7	  min;	  m/z:	  393	  (M+H+).	  HPLC	  analysis	  IC:	  gradient	   from	  99:1	  (n-­‐hexane:	   i-­‐PrOH)	   to	  90:10	   in	  30min,	   flow	  1.0	  mL/min.	  TM	  (anti):	  40.9	  min;	   tm	  (anti):	  31.8	  min;	  TM	  (syn):	  29.3	  min;	  tm	  (syn):	  27.7	  min.	  HRMS	  Calcd	  for	  C24H28N2O3:	  392.20999,	  [M]+,	  found:	  392.2098	  .	  	  
Determination	  of	  the	  absolute	  configuration	  
Synthesis	  of	  (R)-­‐2-­‐(9H-­‐xanthen-­‐9-­‐yl)propanol	  (14)	  
OH
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then	   quenched	  with	  water	   and	   diluted	  with	   Et2O	   (6	  mL).	   The	   TiO2	  formed	  was	   filtered	   off	   and	   the	  organic	  phase	  was	  separated.	  The	  aqueous	  phase	  was	  extracted	  with	  ether,	   then	   the	  organic	  phases	  were	  reunited,	  dried	  over	  Na2SO4	  and	  evaporated	  under	  reduced	  pressure.	  The	  crude	  reaction	  mixture	  containing	  9H-­‐Xanthen-­‐9-­‐ol,	  propionyl	  oxazolidinone	  and	  the	  desired	  products	  were	  transferred	  to	  a	  flask	  and	  THF	  (3mL)	  was	  added.	  The	  solution	  was	  stirred	  at	  0	  °C	  for	  5	  minutes	  then	  was	  treated	  with	  SuperHydride	  (0.20mL	  of	  a	  solution	  1M	  in	  THF).	  After	  60	  min,	  the	  reaction	  was	  quenched	  with	  water	  and	  diluted	  with	  AcOEt.	  The	  separated	  organic	  phase	  was	  dried	  over	  sodium	  sulfate	  and	  concentrated	  in	  vacuo.	  Purification	  by	  preparative	  TLC	  (5:5	  cyclohexane/Et2O)	  afforded	  14	  (3	  mg,	  yield=12%	  over	  2	  steps).	  	  
1H	  NMR	   (CDCl3,	  200MHz)	  δ 	  0.65	  (3H,	   t,	   J=7.0	  Hz),	  1.50	  (1H,	  bs),	  2.0	  (1H,	  m),	  3.40-­‐3.59	  (2H,m),	  4.23	  (1H,	  J=4.2	  Hz),	  7.03-­‐7.12	  (4H,m)	  7.19-­‐7.29	  (4H,	  m).	  HPLC	   	  analysis	  IC:	  gradient	  from	  99:1	  (hexane:	  i-­‐PrOH)	  to	  90:10	  in	  30min,	  flow	  0.5mL/min:	  TM=	  27.5min,	  tm=30.5min	  (ee=99%).	  	  
Synthesis	   of	   (S)-­‐4-­‐benzyl-­‐3-­‐(2-­‐((2Z,4Z,6Z)-­‐cyclohepta-­‐2,4,6-­‐trienyl)acetyl)oxazolidin-­‐2-­‐one	  (16)	   To	  a	  solution	  of	  diisopropylamine	  (185	  mL,	  1.32	  mmol)	   in	  12	  mL	  of	  dry	  THF	  under	   nitrogen,	   n-­‐butyllithium	   (492	   mL	   of	   a	   2.5M	   solution	   in	   hexanes,	   1.23	  mmol)	   was	   added	   at	   0°C	   and	   the	   resulting	   solution	   was	   stirred	   for	   10	   min.	  	  Then	  the	  flask	  was	  cooled	  to	  -­‐78°C,	  EtOAc	  (119	  mL,	  1.2	  mmol)	  was	  added	  and	  the	  solution	  was	  stirred	  at	  the	  same	  temperature	  for	  60min.	  In	  a	   second	   flask,	   tropylium	   tetrafluoroborate	  15	   (178mg,	  1mmol)	  and	  TEA	   (139	  mL,	  1mmol)	  were	  suspended	  in	  1.5mL	  of	  dry	  THF	  and	  the	  mixture	  was	  cooled	  to	  -­‐78°C.	  Then	  the	  content	  of	  this	  second	  flask	   was	   slowly	   transferred	   by	   cannula	   into	   the	   solution	   of	   the	   preformed	   lithium	   enolate,	   while	  keeping	  the	  temperature	  at	  -­‐78°C.	  The	  reaction	  was	  allowed	  to	  warm	  during	  1h,	  then	  it	  was	  quenched	  with	  water	  and	  extracted	  with	  EtOAc.	  The	  combined	  organic	  phases	  were	  dried	  on	  sodium	  sulfate	  and	  concentrated	  in	  vacuo.	  The	  crude	  product	  was	  the	  dissolved	  in	  a	  mixture	  of	  THF/MeOH/H2O	  (3.6/1/1,	  total	  volume:	  15mL)	  and	  lithium	  hydroxyde	  (114mg,	  3	  mmol)	  was	  added	  at	  r.t.	  After	  1h,	  the	  reaction	  was	  diluted	  with	  EtOAc	  and	  acidified	  with	  1M	  HCl.	  After	  the	  extraction,	  the	  organic	  fraction	  was	  dried	  over	   sodium	   sulfate	   and	   concentrated	   in	   vacuo	   affording	   81mg	   of	   2-­‐((2Z,4Z,6Z)-­‐cyclohepta-­‐2,4,6-­‐trienyl)acetic	  acid	  (Y=54%	  over	  2	  steps).	  The	   carboxylic	   acid	   (81	  mg,	   0.54	  mmol)	   was	   dissolved	   in	   dry	   THF	   (4.0	  mL)	   and	   TEA	   (139	   μL,	   1.0	  mmol)	  and	  cooled	  to	  –78	  °C	  according	  to	  the	  procedure	  described	  by	  MacMillan	  at	  al.	  in	  Science,	  2007,	  






sodium	   sulfate	   and	   concentrated	   in	   vacuo.	   Purification	   by	   flash	   chromatography	   (SiO2,	   9:1	  cyclohexane/EtOAc)	  afforded	  16	  (90	  mg,	  Y=54%).	  	  
1H	  NMR	   (CDCl3,	  200MHz)	  δ	  2.30-­‐2.42	  (1H,	  m),	  2.80	  (1H,	  dd,	  J=9.6,	  13.2	  Hz),	  3.24-­‐3.45	  (3H,	  m),	  4.08-­‐4.27	  (2H,	  m),	  4.65-­‐4.76	  (1H,	  m),	  5.29	  (2H,	  pseudo	  t,	  J=7.0	  Hz),	  6.25	  (2H,	  d,	  J=9.0Hz),	  6.70	  (2H,	  pseudo	  t,	  J=2.6	  Hz),	  7.20-­‐7.35	  (5H,	  m).	  	  
Synthesis	  of	  (S)-­‐2-­‐((2Z,4Z,6Z)-­‐cyclohepta-­‐2,4,6-­‐trienyl)butan-­‐1-­‐ol	  (17)	  Compound	  16	  was	  dissolved	  in	  THF	  (4	  mL)	  and	  cooled	  to	  –78	  °C.	  NaN(SiMe3)2	  (700	  μL,	  0.7	  mmol)	   was	   added	   and	   the	   reaction	   was	   stirred	   for	   1	   h.	   Iodoethane	   (150	   μL,	   1.88	  mmol)	  was	   then	   added	   and	   the	   reaction	  was	  warmed	   to	   –20	   °C	   over	   4	   h,	   then	   it	  was	  quenched	  with	  a	  saturated	  NH4Cl	  aqueous	  solution	  (5	  mL).	  The	  reaction	  was	  diluted	  with	  EtOAc	  and	  the	  organic	  phase	  was	  washed	  with	  brine,	  dried	  over	  sodium	  sulfate	  and	  concentrated	   in	  vacuo.	  The	  crude	  mixture	  obtained	  was	  diluted	  with	  400	  μL	  of	  dry	  THF,	  cooled	  to	  0°C	  and	  treated	  with	  SuperHydride	  (0.29mL	  of	  a	  solution	  1M	  in	  THF).	  After	  30	  min,	  the	  reaction	  was	  quenched	  with	  water	  and	  diluted	  with	  EtOAc.	  The	  separated	  organic	  phase	  was	  dried	  over	  sodium	  sulfate	  and	  concentrated	  in	  vacuo.	  Purification	  by	  preparative	  TLC	  (7:3	  cyclohexane/EtOAc)	  afforded	  17	  (7	  mg,	  Y=15%	  over	  2	  steps).	  	  
1H	  NMR	   (CDCl3,	  200MHz)	  δ	  0.96	  (3H,	   t,	   J=7.4	  Hz),	  1.39-­‐1.70	  (3H,	  m),	  1.70-­‐1.88	  (1H,	  m),	  3.81	  (2H,	  d,	  J=4.8	  Hz),	  5.28-­‐5.37	  (2H,	  m),	  6.21-­‐6.25	  (2H,	  m),	  6.68	  (2H,	  pseudo	  t,	  J=3.4	  Hz).	  	  HPLC	  analysis	  OD-­‐H	  99:1	  (n-­‐hexane:	  i-­‐PrOH),	  flow	  0.6mL/min.	  Tm	  =	  28.6	  min,	  TM	  =	  26.9min	  (ee	  =	  90	  %)	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Chapter	   4.	   Stereoselective	   α-­‐alkylation	   of	   aldehydes	   with	   1.3-­‐benzodithiolylium	  tetrafluoroborate	  salt.	  	  	  
I.	  Introduction	  	  	  1,3-­‐benzodithiole	  heterocycle	   is	   a	   substrate	   that	   can	  offer	   considerable	  appeal	   in	   terms	  of	  C-­‐C	  bond	  forming	  because	  of	  the	  relative	  ease	  with	  which	  both	  corresponding	  carbanionic	  2	  and	  carbocationic	  3	  forms	  can	  be	  designed.1	  The	  stability	  of	  carbocation	  3	   is	  between	  that	  of	  the	  tropylium	  and	  tritylium	  carbenium	  salts.2	   
SS SS SS
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Scheme	  1	  
	  In	   1976,	   Hoshino	   and	   co-­‐workers3	   reported	   the	   synthesis	   of	   1,3-­‐benzodithiolylium	   salts,	   through	  treatment	  of	  a	  solution	  of	  2-­‐isopentyloxy-­‐1,3-­‐benzodithiole	  in	  acetic	  anhydride	  and	  the	  correspondent	  HX	   acid	   to	   give	   the	   1,3-­‐benzothiolylium	   salt.	   The	   behaviour	   of	   1,3-­‐benzodithiolylium	   salts	   with	  nucleophiles	  has	  been	  studied	  with	  secondary	  amine	  such	  as	  dibenzylamine	  that	  react	  with	  the	  salt	  to	  give	  the	  compound	  4.	  The	  treatment	  of	  tetrafluoroborate	  salt	  with	  triethyl	  amine	  in	  acetonitrile	  gave	  the	   compound	  5,	   where	   the	   reaction	   was	   performed	   through	   a	   base	   –catalyzed	   deprotonation	   and	  subsequent	   reaction	   of	   the	   carbene	   with	   the	   tetrafluoroborate	   salt	   followed	   by	   deprotection.	   The	  electrophilic	   substitution	  with	  electron	  rich	  aromatic	   compounds	   reacted	  with	  1,3-­‐benzodithiolyium	  to	   give	   the	   correspondent	   products	   in	   good	   yields.	   These	   studies	   about	   the	   reactivity	   of	   1,3-­‐benzodithiolylium	  tetrafluoroborate	  toward	  a	  wide	  variety	  of	  nucleophiles	  reagents	  demonstrated	  the	  stability	  and	  solubility	  in	  polar	  solvent	  of	  the	  tetrafluoroborate	  salt.	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Scheme	  3.	  Hypothesis	  about	  the	  functionalization	  of	  1,3-­‐benzodithiol	  group	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II.	  Results	  and	  discussion	  	  The	  direct	  α-­‐alkylation	  reaction	  of	  propionaldehyde	  with	  1,3-­‐benzodithiolylium	  tetrafluoroborate	  salt	  and	  stoichiometric	  amount	  of	  base,	  which	  capture	  the	  HBF4	  liberated	  by	  the	  reaction	  of	  the	  carbenium	  ion	  was	  selected	  as	  the	  model	  reaction.	  Different	  base	  and	  organocatalysts	  were	  tested	  in	  the	  reaction.	  The	   nature	   of	   the	   base	   was	   important	   in	   the	   reaction,	   the	   use	   of	   organic	   base	   such	   as	   1,6-­‐dimethylpyridine,	  DABCO	  or	  triethylamine	  afforded	  the	  desired	  product	  in	  poor	  yields	  because	  of	  side	  reactions,	   formation	   of	   the	   tetrathioflulvalene	   5	   induce	   by	   the	   formation	   of	   the	   correspondent	  carbene.	  Therefore	  the	  use	  of	  inorganic	  bases	  were	  more	  suitable	  for	  the	  reaction.	  NaH2PO4	  was	  found	  the	  most	   efficiently	   base	   in	   yielding.	   Then,	   different	   catalysts	   and	   solvents	   were	   tested	   in	   order	   to	  improve	  both	  yield	  and	  enantiomeric	  excesses.	  Proline	  derivatives	  in	  general	  gave	  poor	  results	  in	  this	  reaction.	  Meanwhile,	  the	  use	  of	  imidazolidinone	  derivatives	  8	  and	  10	  were	  found	  to	  catalyze	  the	  direct	  
α-­‐alkylation	  of	  aldehydes	   in	  moderated	  yield	  and	  enantioselectivity	   (table1,	  entry	  1,3).	  The	  reaction	  was	  further	  optimized	  by	  screening	  of	  different	  solvents,	  using	  imidazolidinone	  derivatives	  as	  catalyst	  into	  the	  reaction.	  The	  water	  as	  solvent	  gave	  the	  optimal	  results	  in	  enantioselectivity.	  (table	  1,	  entry	  6-­‐9).	   Delighted	   by	   these	   initials	   results,	   a	   mixture	   of	   solvents	   were	   tested	   using	   the	   catalyst	   8.	   The	  desired	  product	  7	  was	  produced	  with	  96%	  enantioselectivity	  and	  96	  %	  yield	  in	  a	  1:1	  mixture	  of	  CH3CN	  and	  H2O.	  (table	  1,	  entry	  12).	  	  The	   stability	   of	   the	   1,3-­‐benzodithiolyium	   carbenium	   is	   high	   in	   the	   presence	   of	   water	   and	   no	  decomposition	  was	  observed	  in	  the	  reaction.	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1)    8, 20mol %
    PhCOOH, 20mol %
solvent, 0°C
  NaH2PO4
2) NaBH4, MeOH, 0°C 	  	  
1	   S S
OH 	  
2	   S S
OH
Ph 	  
3	   S S
OH4 	  	   96%,	  96	  %	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   61%,	  97%	  ee	   	   90%,	  92%	  ee	   	   84%,	  96%	  ee	  All	  the	  reaction	  were	  performed	  at	  0°C	  with	  1	  eq	  of	  1,3-­‐benzodithiozolylium	  salt,	  3	  eq	  of	  aldehyde	  in	  presence	  of	  20	  mol	  %	  of	  catalyst,	  and	  1	  eq	  of	  NaH2PO4,	  20	  mol	  %	  benzoic	  acid	  was	  used	  as	  co-­‐catalyst	  and	  the	  reactions	  were	  run	  until	  completion	  as	  determined	  by	  TLC.	  Yield	  after	  chromatographic	  purification.	  Determined	  by	  analysis	  of	  isolated	  products	  by	  HPLC	  on	  chiral	  phase.	  	  
Table2.	  Organocatalytic	  alkylation	  of	  functionalized	  aldehydes	  with	  1,3-­‐benzodithiolylium	  salt	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Me1) n-BuLi, THF 






     (98%, 92%ee)
[α]D = + 2.9 (CHCl3) 






























        96%, 93%ee95%, 93% ee 	  	  
Scheme	  6.	  Synthesis	  of	  (R)-­‐2-­‐methyloctanol	  	  Other	  potential	  agent	  possible	   to	  prepared	   from	  the	  stereoselective	  α-­‐methylation	  of	  aldehydes	  was	  the	  Arundic	  acid	  which	  was	  discovered	  by	  Minase	  Research	  Institute	  of	  Ono	  Pharmaceutical	  CO-­‐Ltd.,	  Osaka,	  during	  a	  screening	  process	  and	  was	  called	  the	  name	  Ono-­‐2506	  the	  (R)-­‐Arundic	  acid	  is	  currently	  undergoing	   phase	   II	   development	   for	   the	   treatment	   of	   acute	   ischemic	   stroke	   as	   well	   as	   clinical	  development	   for	   other	   neurodegenerative	   diseases	   including	   Alzheimer’s	   disease	   and	   Parkison’s	  disease.11 
To	   synthesize	   the	   (R)-­‐	  Arundic	   acid	  was	   treated	  1,3-­‐benzodithiozolylium	   salt	  with	  hexanal	   and	   (R)-­‐MacMillan	   catalyst	   followed	   by	   a	   reduction	   of	   aldehyde	   with	   NaBH4	   /MeOH	   to	   afford	   the	   desired	  alcohol	  20	   in	  91%	  yield,	   93%ee.	  Then	   the	   alcohol	  20	  was	   treated	  with	  NaH	  and	  BnBr	   to	   afford	   the	  intermediated	  21	  with	   93%	  ee.	   Then	   the	   derivative	  21	  was	  metalated	  with	  n-­‐BuLi	   at	   0°C	   and	   then	  alkylated	   to	   obtain	   22	   in	   91%	   yield	   and	   93%ee	   After	   successive	   treatment	   with	   Raney	   Ni/H2	   and	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Scheme	  7.	  The	  enantioselective	  synthesis	  of	  arundic	  acid,	  with	  organocatalytic	  formylation	  	  a)NaH,	  BnBr	   in	  THF;	  b)	  n-­‐BuLi	   in	  THF,	  0°C	   ;	  c)	  EtI,	  98%	  (two	  steps);	  d)	  Raney	  Ni/H2	   in	  EtOH;	  e)	  H2,	  Pd/C,	  91%	  (two	  steps);	   f)	  NaClO2,	  NaClO	  (cat.),	  TEMPO	  (cat.)	   in	  MeCN/buffer	  pH	  6.7,	  98%.	  TEMPO	  =	  2,2,6,6-­‐tetramethylpiperidin-­‐1-­‐yloxyl.	  	  	  










R = C6H13, 96% ee , 14
R = Ph, 93%,  24
R = C6H13, (85% yield), [α]D =  -9.8 (EtOH)
      (S)-2-methyloctanol, [α]D =  -13.1 (EtOH); Ref. 14
R = Ph, (96%, 93% ee)  
      (S)- 2- phenylpropanal, Ref.15 	  
Scheme	  8.	  Determination	  of	  absolute	  configuration	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III. Conclusion	  	  The	  SN1	  type	  reaction	  has	  appeared	  as	  a	  new	  methodology	  in	  the	  asymmetric	  organocatalysis.	  In	  this	  this	  work	  was	   reported	   a	   simple	   and	  practical	   asymmetric α-­‐alkylation	   using	   1,3-­‐benzodithiolylium	  salt	  commercially	  available.	  This	  novel	  methodology	  has	  opened	  new	  frontiers	  in	  the	  stereoselective	  α	  addition	  of	  a	  formyl	  group	  to	  aldehyde.	  The	  novelty	  in	  this	  method	  has	  been	  the	  tolerance	  of	  the	  1,3-­‐benzodithiolylium	  into	  the	  reaction	  conditions	  and	  the	  capacity	  of	  transformation	  of	  1,3-­‐benzodithiol	  group	   by	   either	  metalation	  with	   n-­‐BuLi	   and	   successive	   alkylation,	   or	   the	   possibility	   to	   reduce	  with	  Raney	  Ni	  affording	  stereoselective	  α	  methylation	  of	  aldehydes.	  Quite	   remarkably,	   the	   reaction	   was	   tolerance	   a	   broad	   range	   of	   functionalized	   aldehydes	   and	   was	  applied	  successfully	   to	   the	  synthesis	  of	   chiral	   compounds.	  Furthermore	   the	  possibility	   to	   induce	   the	  formation	  of	  carbocation	  in	  presence	  of	  water,	  merging	  metal	  catalysis	  and	  organocatalysis	  can	  open	  new	  frontiers	  in	  the	  field	  of	  organocatalysis.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  127	  
IV. Experimental	  section	  	  
	  
Enantioselective	  α-­‐alkylation	  of	  aldehydes	  
General	  procedure	  A	   vial	   was	   charged	   with	   (S)-­‐8	   catalyst	   (0.02	   mmol,	   0.005	   g),	   benzoic	   acid	   (0.02	   mmol,	   0.002	   g),	  acetonitrile	   (0.25	  mL)	   and	   water	   (0.25	  mL).	   The	  mixture	   was	   cooled	   at	   0°C,	   1,3-­‐benzodithiolylium	  tetrafluoroborate	  (0.1	  mmol,	  0.024	  g),	  NaH2PO4	  (0.1	  mmol,	  0.012	  g)	  and	  propanal	  (0.3	  mmol,	  11	  mL)	  were	  added.	  The	  mixture	  was	  stirred	  for	  24	  hours	  at	  the	  same	  temperature,	  the	  organic	  solvent	  was	  evaporated	  and	   the	  mixture	  was	  diluted	  with	  Et2O	   (3mL).	  The	  organic	   layer	  was	   separated,	   and	   the	  aqueous	   layer	  was	   extracted	  with	   Et2O	   (2	   x	   3	  mL).	   The	   collected	   organic	   layers	  were	  washed	  with	  brine	  (5	  mL),	  dried	  over	  Na2SO4	  and	  concentrated	  under	  reduce	  pressure.	  The	   residue	  was	  diluted	   in	  MeOH	  (1	  mL)	  and	  NaBH4	   (0.4	  mmol,	  0.015	  g)	  was	   slowly	  added	  at	  0	   °C.	  After	   30	  minutes,	   the	   reaction	  was	   quenched	  with	   water	   (0.2	  mL)	   and	   concentrated	   in	   vacuo.	   The	  residue	   was	   extracted	   with	   AcOEt	   (3	   x	   5	   mL),	   dried	   over	   Na2SO4	   and	   concentrated.	   Flash	  chromatography	  (SiO2,	  cyclohexane/ethyl	  acetate)	  of	  the	  residue	  affording	  the	  desired	  product.	  	  
(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)propan-­‐1-­‐ol.	  (table	  2,	  entry	  1)	  According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	  (85%	  yield,	  96%	  ee).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  n-­‐hexane/i-­‐PrOH	  95:5,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	  τmajor	  =	  20.7	  min.,	  
τminor	  =	  19.1	  min;	  [α]D20=+4.6	  (c=0.9	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  1.06	  (d,	  J	  =	  6.8	  Hz,	  3H),	  2.11	  (m,	  1H),	  3.69	  (d,	  J	  =	  5.2	  Hz,	  2H),	  5.13	  (d,	  J	  =	  6.0	  Hz,	  1H),	  7.01	  (dd,	  J	  =	  3.3	  Hz,	  J	  =	  5.8	  Hz,	  2H),	  7.21	  (dd,	   J	  =	  3.1	  Hz,	   J	  =	  5.9	  Hz,	  2H);	  13C	  NMR	   (25	  MHz,	   CDCl3,	   25°C)	  δ	  13.2,	  43.6,	  56.5,	  64.8,	  121.9,	  122.0,	  125.4	  (2C),	  137.7	  (2C);	  HMRS	  calcd	  for	  C10H12OS2	  :	  212.0330;	  found	  346.2327.	  
	  
(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐3-­‐phenylpropan-­‐1-­‐ol.	  (table	  2,	  entry	  2)	  	  According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	  (85%	  yield,	  96%	  ee)	  ;	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  hexane/i-­‐PrOH	  95:5,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	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126.4,	   128.5,	   128.7	   (2C),	   129.3,	   137.7,	   137.8,	   139.4;	  HMRS	   calcd	   for	   C16H16OS2	   :	   288.0643;	   found	  288.0640.	  	  
(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)octan-­‐1-­‐ol.	  (table	  2,	  entry	  3)	  According	   at	   the	   same	   procedure	   the	   desired	   product	   was	   isolated	   by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	  (96%ee,	  94%	  ee).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	  hexane/i-­‐PrOH	  95:5,	   flow	   rate	  0.50	  mL/min,	   30°C,	   λ	  =	  254,	   262	  nm:	  
τmajor	  =	  16.6	  min.,	  τminor	  =	  15.5	  min;	  [α]D20=+17.7	  (c=1.1	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  	  0.89	  (t,	  J	  =	  7.0	  Hz,	  3H),	  2.25-­‐1.32	  (m,	  8H),	  139-­‐1.46	  (m,	  1H),	  1.53-­‐1.60	  (m,	  1H),	  1.77	  (bs,	  1H),	  1.92	  (m,	  1H),	  3.74	  (dd,	  J	  =	  5.6	  Hz,	  J	  =	  11.3	  Hz,	  1H),	  3.83	  (dd,	  J	  =	  4.1	  Hz,	  J	  =	  11.3	  Hz,	  1H),	  5.20	  (d,	  J	  =	  6.5	  Hz,	  1H),	  7.01	  (dd,	   J	  =	  3.3	  Hz,	   J	  =	  5.8	  Hz,	  2H),	  7.20	  (dd,	   J	  =	  3.1	  Hz,	   J	  =	  5.8	  Hz,	  2H);	  13C	  NMR	   (100	  MHz,	   CDCl3,	  








(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐5-­‐chloropentan-­‐1-­‐ol.	  (table	  2,	  entry	  5)	  According	   at	   the	   same	   procedure	   the	   desired	   product	   was	   isolated	   by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   7/3)	   as	   colourless	   oil	  (93%	  yield,	  94%	  ee);	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  80:20,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	  τmajor	  =	  15.9	  min.,	  τminor	  =	  12.3	  min;	   [α]D20=+21.5	   (c=1.3	   in	  CHCl3);	   1H	  








(S)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐3-­‐(benzyloxy)propan-­‐1-­‐ol	  (table	  2,	  entry	  4)	  According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	  (62%	  yield,	  92%	  ee	  ).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  90:10,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	  τmajor	  =	  28.5	  min.,	  τminor	  =	  23.0	  min;	  [α]D20=+27.5	  (c=0.4	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  
25°C)	  δ	  2.18	  (m,	  1H),	  2.32	  (bs,	  1H),	  3.74	  (dd,	  J	  =	  4.0	  Hz,	  J	  =	  9.7	  Hz,	  1H),	  3.87-­‐3.91	  (m,	  2H),	  3.97	  (dd,	  J	  =	  4.9	  Hz,	  J	  =	  11.2	  Hz,	  1H),	  4.52	  (s,	  2H),	  5.21	  (d,	  J	  =	  8.6	  Hz,	  1H),	  7.00-­‐7.04	  (m,	  2H),	  7.20-­‐7.23	  (m,	  2H),	  7.31-­‐7.34	  (m,	  2H),	  7.36-­‐7.39	  (m,	  3H);	  13C	  NMR	  (25	  MHz,	  CDCl3,	  25°C)	  δ	  47.6,	  52.9,	  62.9,	  70.3,	  73.7,	  122.2,	  122.4,	   125.5	   (2C),	   127.0,	   127.7,	   127.9,	   128.5	   (2C),	   137.5,	   137.6	   (2C);	  HMRS	   calcd	   for	   C17H18O2S2	   :	  318.0748;	  found	  346.2327.	  	  
(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐2-­‐phenylethanol.	  (table	  2,	  entry	  6)	  According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	  (90%	  yield,	  97%	  ee).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	   column:	  hexane/i-­‐PrOH	  96:4,	   flow	  rate	  0.50	  mL/min,	  30°C,	   λ	  =	  232,	  254	  nm:	  τmajor	  =	  34.5	  min.,	  
τminor	  =	  35.7	  min;	  [α]D20=+22.6	  (c=0.2	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  3.33	  (ddd,	  J	  =	  4.9	  Hz,	  J	  =	  6.1	  Hz,	  J	  =	  9.5	  Hz,	  1H),	  4.00-­‐4.08	  (m,	  2H),	  5.34	  (d,	  J	  =	  9.5	  Hz,	  1H),	  6.97-­‐7.02	  (m,	  2H),	  7.10-­‐7.13	  (m,	   1H),	   7.19-­‐7.21	   (m,	   1H),	   7.26-­‐7.36	   (m,	   5H);	   13C	   NMR	   (25	   MHz,	   CDCl3,	   25°C)	   δ	   54.9,	   56.2,	   64.4,	  122.2,	   122.3,	   125.4,	   125.6,	   127.7	   (2C),	   128.4,	   128.6,	   128.8	   (2C),	   137.2,	   139.1;	   HMRS	   calcd	   for	  C15H14OS2	  :	  274.0486;	  found	  346.2327.	  	  
(R)-­‐tert-­‐butyl	  (2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐3-­‐hydroxypropyl)(methyl)carbamate.	  (table	  2,	  enty	  7)	   According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   7/3)	   as	   colourless	   oil	  (61%	  yield,	  97%	  ee).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  85:15,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	  τmajor	  =	  14.6	  min.,	  τminor	  =	  10.9	  min;	  [α]D20=-­‐63.7	  (c=1.1	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  
25°C)	  δ	  1.47	  (s,	  9H),	  2.05	  (m,	  1H),	  2.83	  (s,	  3H),	  3.22	  (dd,	  J	  =	  4.1	  Hz,	  J	  =	  14.1	  Hz,	  1H),	  3.52	  (d,	  J	  =	  14.1	  Hz,	  1H),	  3.73-­‐3.85	   (m,	  2H),	  5.00	   (d,	   J	   =	  9.5	  Hz,	  1H),	  7.02-­‐7.04	   (m,	  2H),	  7.22-­‐7.24	   (m,	  2H);	   13C	   NMR	   (25	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(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐3-­‐isocyanopropan-­‐1-­‐ol.	  (table	  2,	  entry	  8)	  According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	  chromatography	  (cyclohexane/ethyl	  acetate	  =	  8/2)	  as	  colourless	  oil	   (	  90%	  yield,	  92%	  ee).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  80:20,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	  τmajor	  =	  21.2	  min.,	  τminor	  =	  18.1	  min;	  [α]D20=+10.4	  (c=0.6	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  
25°C)	  δ	  1.57	  (bs,	  1H),	  2.25-­‐2.33	  (m,	  1H),	  2.61	  (dd,	  J	  =	  8.7	  Hz,	  J	  =	  16.7	  Hz,	  1H),	  2.77	  (dd,	  J	  =	  4.5	  Hz,	  J	  =	  17.1	  Hz,	  1H),	  3.88-­‐3.97	  (m,	  2H),	  5.06	  (d,	  J	  =	  6.9	  Hz,	  1H),	  7.06	  (dd,	  J	  =	  3.2	  Hz,	  J	  =	  5.7	  Hz,	  2H),	  7.24	  (dd,	  J	  =	  3.1	  Hz,	  J	  =	  5.9	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C)	  δ	  16.2,	  45.6,	  53.5,	  61.0,	  118.2,	  122.4,	  122.5,	  126.0	  (2C),	  136.3,	  136.7;	  HMRS	  calcd	  for	  C11H11NOS2	  :	  237.282;	  found	  346.2327	  	  
(R)-­‐2-­‐(benzo[d][1,3]dithiol-­‐2-­‐yl)-­‐4,4-­‐dimethoxybutan-­‐1-­‐ol.	  (table	  2,	  entry	  	  9)	  According	  at	   the	  general	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	   chromatography	   (cyclohexane/ethyl	   acetate	   =	   8/2)	   as	   colourless	   oil	  (84%	  yield,	  96%	  ee)	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  OD-­‐H	  column:	  hexane/i-­‐PrOH	  90:10,	  flow	  rate	  0.50	  mL/min,	  30°C,	  λ	  =	  232,	  254	  nm:	  τmajor	  =	  22.7	  min.,	  τminor	  =	  17.7	  min;	   [α]D20=+3.0	  (c=0.7	   in	  CHCl3);	  1H	  NMR	   (400	  MHz,	   CDCl3,	  
25°C)	  δ	  1.81	  (ddd,	  J	  =	  5.4	  Hz,	  J	  =	  8.8	  Hz,	  J	  =	  14.3	  Hz,	  1H),	  1.99-­‐2.05	  (m,	  1H),	  2.10	  (m,	  1H),	  3.32	  (s,	  3H),	  3.35	  (s,	  3H),	  3.74	  (m,	  1H),	  3.82	  (m,	  1H),	  4.49	  (t,	  J	  =	  5.3	  Hz,	  1H),	  5.16	  (d,	  J	  =	  6.8	  Hz,	  1H),	  7.01	  (dd,	  J	  =	  3.3	  Hz,	  J	  =	  5.7	  Hz,	  2H),	  7.20	  (d,	  J	  =	  3.3	  Hz,	  J	  =	  5.6	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C)	  δ	  31.5,	  44.5,	  52.6,	   54.0,	   56.2,	   62.7,	   103.5,	   122.0,	   122.1,	   125.4,	   125.5,	   137.5,	   137.6;	  HMRS	   calcd	   for	   C13H18O3S2	   :	  286.0697;	  found	  346.2327.	  	  












(dd,	  J	  =	  5.6	  Hz,	  J	  =	  9.5	  Hz,	  1H),	  3.65	  (dd,	  J	  =	  4.4	  Hz,	  J	  =	  9.5	  Hz,	  1H),	  4.48	  (d,	  J	  =	  12.1	  Hz,	  1H),	  4.54	  (d,	  J	  =	  12.1	  Hz,	  1H),	  	  5.27	  (d,	  J	  =	  7.2	  Hz,	  1H),	  7.00	  (dd,	  J	  =	  2.8	  Hz,	  J	  =	  5.6	  Hz,	  2H),	  7.31-­‐7.40	  (m,	  2H),	  6.98-­‐7.02	  (m,	  5H);	  13C	  NMR	   (100	  MHz,	   CDCl3,	   25°C)	  δ	  14.1,	  22.5,	  27.2,	  27.8,	  29.3,	  31.6,	  46.3,	  56.3,	  69.3,	  73.2,	  121.8,	   121.9,	   125.2	   (2C),	   127.5,	   127.6,	   128.3,	   137.8,	   138.2,	   138.8;	   HMRS	   calcd	   for	   C22H28OS2	   :	  372.1582;	  found	  346.2327.	  	  
(R)-­‐	  15	  :	  [a]D20=-­‐29.5	  (c=1.0	  in	  CHCl3);	  NMR	  spectra	  were	  identical	  to	  those	  of	  (S)-­‐(16).	  
	  
	  	  
General	  Procedure	  for	  Alkylation	  A	  solution	  of	  nBuLi	  (0.022	  mmol,	  88	  mL,	  2.5	  M	  in	  hexanes)	  was	  added	  dropwise	  to	  a	  solution	  of	  (S)-­‐
(15)	  (0.2	  mmol,	  0.076	  g)	  in	  anhydrous	  in	  THF	  (2	  mL)	  at	  0°C.	  The	  mixture	  turns	  to	  orange	  colour.	  After	  5	  minutes	  methyl	  iodide	  (0.4	  mol,	  20	  mL)	  was	  added	  and	  the	  solution	  became	  colourless.	  The	  solution	  was	  stirred	  for	  5	  minutes	  and	  then	  water	  (1	  mL)	  was	  added.	  The	  organic	  layer	  was	  separated,	  and	  the	  aqueous	   layer	  was	   extracted	  with	   Et2O	   (2	   x	   5	  mL).	   The	   collected	   organic	   layers	  were	  washed	  with	  brine	   (5	   mL),	   dried	   over	   Na2SO4	   and	   concentrated	   under	   reduce	   pressure.	   Flash	   chromatography	  (cyclohexane/ethyl	  acetate)	  affording	  the	  product	  	  	   The	   desired	   product	   was	   isolated	   by	   flash	   column	   chromatography	  (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	   (S)-­‐16	   (93%	   yield)	  [α]D20=+12.5	  (c=1.7	  in	  CHCl3);	  1H	  NMR	   (400	  MHz,	   CDCl3,	   25°C)	  δ	  0.91	  (t,	   J=	  6.6	  Hz,	  3H),	  1.29-­‐	  1.39	  (m,	  8H),	  1.54-­‐	  1.63	  (m,	  1H),	  1.66-­‐1.72	  (m,	  1H),	  1.88	  (s,	  3H),	  2.35-­‐2.41	   (m,	  1H),	  3.66	   (d,	   J=4.5	  Hz,	  2H),	  4.55	   (AB,	   J=8.6Hz,	   J=	  11.9	  Hz,	  2H),	  7.00-­‐	  7.02	   (m,2H),	  7.19	   (d,	   J=	  5.7	  Hz,	  1H),	  7.20	   (d,	   J=	  5.7	  Hz,	  1H),	  7.28-­‐7.34	   (m,	  1H);	  7.35-­‐7.41	   (m,	  4H);	  13C	   NMR	   (100	  
MHz,	  CDCl3,	   25°C)	  δ	  14.1,	  22.6,	  28.2,	  28.3,	  29.3,	  30.2,	  31.7,	  48.5,	  70.4,	  73.1,	  73.7,	  122.4,	  122.5,	  125.2	  (2C),	  127.5	  (2C),	  127.6	  (2C),	  128.3,	  137.6,	  138.2,	  138.3;	  HMRS	  calcd	   for	  C23H30OS2	  :	  386.1738;	  found	  386.1737.	  	  The	  desired	  product	  was	  isolated	  by	  flash	  column	  chromatography	  (cyclohexane/ethyl	  acetate	  =	  9/1)	  as	   colourless	   oil	   (92%	  yield).	   [α]D20=+10.6	   (c=1.05	   in	   CHCl3);	   1H	   NMR	   (400	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7.28-­‐7.42	  (m,	  8H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C)	  δ	  14.1,	  22.6,	  28.4,	  29.4,	  30.6,	  31.7,	  46.2,	  27.6,	  70.7,	  73.1,	  8.0,	  121.7	  (2C),	  124.8,	  126.6,	  127.2	  (2C),	  127.6,	  127.7,	  128.4	  (2C),	  128.7,	  129.0,	  130.4	  (2C),	  136.3,	  126.3,	  138.2,	  138.3;	  HMRS	  calcd	  for	  C29H34OS2	  :	  465.2051;	  found	  346.2327.	  	   The	   desired	   product	   was	   isolated	   by	   flash	   column	   chromatography	  (cyclohexane/ethyl	   acetate	   =	   9/1)	   as	   colourless	   oil	   (91%	  yield)	   [α]D20=-­‐22.1	  (c=1.0	   in	  CHCl3);	  1H	  NMR	   (400	  MHz,	   CDCl3,	   25°C)	   δ	  0.90	   (t,	   J=	  6.6	  Hz,	  3H),	  1.08	  (t,	  J=	  7.2	  Hz,	  3H),	  1.24-­‐1.37	  (m,	  7H),	  1.40-­‐1.49	  (m,	  1H),	  1.53-­‐1.62	  (m,	  1H),	  1.77-­‐1.85	  (m,	  1H),	  2.12	  (q,	   J=	  7.1	  Hz,	  2H),	  2.23-­‐2.28	  (m,	  1H),	  3.62	  (dd,	   J=	  4.0	  Hz,	   J=	  10.4	  Hz,	  1H),	  3.77	  (dd,	   J=	  4.5	  Hz,	   J=	  9.8	  Hz,	  1H),	  4.52	  (s,	  2H),	  6.95-­‐6.98	  (m,	  2H),	  7.11-­‐7.14	  (m,	  2H),	  7.29-­‐7.38	  (m,	  5H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  25°C)	  δ	  9.9,	  14.1,	  22.6,	  28.3,	  29.4,	  30.3,	  31.7,	  34.6,	  47.3,	   70.5,	   73.1,	   78.6,	   121.6,	   121.7,	   124.9	   (2C),	   127.5	   (2C),	   127.6,	   128.3	   (2C),	   138.2,	   138.3,	   138.6;	  
HMRS	  calcd	  for	  C24H32OSi2	  :	  400.1895;	  found	  400.1896.	  	  
Reductive	  removal	  of	  benzothiol	  group	  General	  Procedure	  To	   a	   solution	   of	  16	   (0.05	  mmol,	   0.020	   g)	   in	   ethanol	   (3	  mL),	  Ni-­‐Raney	   (0.450g	   slurry	   in	  water)	  was	  added	   and	   the	   reaction	  was	   keep	   under	  H2	   atmosphere	   (1	   atm).	   After	   3h	   the	   reaction	  mixture	  was	  filtered	  through	  a	  Celite	  pad	  and	  the	  organic	  solvent	  was	  removed	  under	  reduce	  pressure.	  The	  residue	  was	  diluited	  with	  AcOEt,	   the	  organic	   layer	  was	  separated,	  and	  the	  aqueous	   layer	  was	  extracted	  with	  AcOEt	  (2	  x	  5	  mL).	  The	  collected	  organic	  layers	  were	  washed	  with	  brine	  (5	  mL),	  dried	  over	  Na2SO4	  and	  concentrated	  under	  reduce	  pressure.	  Flash	  chromatography	  (Cyclohexane/diethyl	  ether,	  9/1)	  of	  the	  residue	  afforded	  the	  desired	  product.	  	  	  
(S)-­‐	  2-­‐methyloctanol	  and	  (R)-­‐	  were	  already	  reported16	  	  	  	  Absolute	  configuration	  was	  assigned	  by	  comparison	  of	  retention	  time	  with	  the	  reference	  literature18	  	  














6H),	  1.24-­‐1.34	  (m,	  14H),	  1.48	  (m,	  1H),	  1.58	  (bs,	  1H),	  3.54	  (d,	  J=	  5.5	  Hz,	  2H);	  13C	  NMR	  (100	  MHz,	  CDCl3,	  
25°C)	   δ	   14.1,	   14.4,	   20.0,	   22.6,	   26.8,	   29.7,	   30.9,	   31.8,	   33.2,	   40.2,	   65.7;	   HMRS	   calcd	   for	   C11H24O	   :	  172.1827;	  found	  400.1896.	  	  
Oxidative	  removal	  of	  benzothiol	  group	  General	  procedure20	  To	  a	  suspension	  of	  HgO	  (0.1	  mmol,	  0.022	  g)	  in	  THF	  (2	  mL)	  a	  40%	  solution	  of	  HBF4	  in	  water	  (0.05	  mL)	  was	   added.	   After	   2	   minutes	   a	   solution	   of	   16	   (0.05	   mmol,	   0.020	   g)	   was	   slowly	   added	   and	   the	  precipitated	  dissolved.	  After	  30	  minutes	  a	  saturated	  solution	  of	  NaHCO3	  was	  slowly	  added	  at	  0°C	  until	  basic	  pH.	  The	  solid	  was	   filtered	  through	  a	  pad	  of	  Celite,	   the	  organic	  solvent	  was	  evaporated	  and	  the	  residue	  was	  diluted	  with	  AcOEt.	  The	  organic	  layer	  was	  separated,	  and	  the	  aqueous	  layer	  was	  extracted	  with	  AcOEt	  (2	  x	  5	  mL).	  The	  collected	  organic	  layers	  were	  washed	  with	  brine	  (5	  mL),	  dried	  over	  Na2SO4	  and	  concentrated	  under	  reduce	  pressure.	  Flash	  chromatography	  (	  SiO2,	  cyclohexane/ethyl	  acetate)	  of	  the	  residue	  gave	  the	  product.	  	   According	  with	   the	  procedure	   the	  desired	  product	  was	   isolated	  by	   flash	  column	  chromatography	  (SiO2,	  cyclohexane/ethyl	  acetate	  =	  8/2)	  as	  colourless	  oil	  (S)-­‐	  18	  (	  89%	  yield,	  92%	  ee).	  The	  ee	  was	  determined	  by	  HPLC	  analysis	  Daicel	  Chiralcel	  IC	  column:	   hexane/i-­‐PrOH	   95:5,	   flow	   rate	   0.50	   mL/min,	   30°C,	   λ	   =	   210,	   254	   nm:	   τmajor	  =	   13.1	   min.,	  
τminor	  =	  13.8	  min;	  [α]D20=-­‐90.9	  (c=0.4	  in	  CHCl3);	  1H	  NMR	  (400	  MHz,	  CDCl3,	  25°C)	  δ	  1.16	  (t,	  J=	  6.7	  Hz,	  3H),	  1.43-­‐1.62	  (m,	  6H),	  1.64-­‐1.73	  (m,	  2H),	  1.82-­‐1.92	  (m,	  2H),	  2.46	  (s,	  3H),	  3.07-­‐3.13	  (m,	  1H),	  3.80	  (dd,	  J=	  5.0	  Hz,	  J=	  9.0	  Hz,	  1H),	  3.89	  (t,	   J=	  8.7	  Hz,	  1H),	  4.76	  (s,	  2H),	  7.54-­‐7.64	  (m,	  5H);	  13C	  NMR	  (100	  MHz,	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Oxidation	  to	  arundic	  acid21	  A	  1	  mL	  flask	  equipped	  with	  a	  magnetic	  stir	  bar	  was	  charged	  with	  an	  alcohol	  23	  (0.5mmol,	  0.009	  g)	  in	  CH3CN	  (0.25	  mL).	  A	  solution	  of	  NaClO2	  (0.1	  mmol,	  0.009	  g),	  TEMPO	  (0.01mmol,	  0.001g)	  in	  H2O	  (0.05	  mL),	  0.67	  M	  sodium	  phosphate	  buffer	  (pH	  6.7,	  0.200	  mL)	  and	  a	  solution	  of	  dilute	  NaOCl,	  prepared	  by	  diluting	   household	   bleach	  with	   25	   μL	   of	  water,	  were	   added.	   The	  mixture	  was	   stirred	   at	   35°C.	   for	   7	  hours	   and	   was	   cooled	   to	   0°C.	   Water	   (0.25	   mL)	   and	   NaHCO3	   aq.	   were	   added	   until	   pH	   8.0.	   Na2SO3	  (0.12mmol,	  0.015	  g)	  was	  added	  and	  the	  mixture	  was	  vigorously	  stirred	  30	  min.	  The	  organic	  layer	  was	  separated,	  and	  the	  aqueous	  layer	  was	  extracted	  with	  AcOEt	  (2	  x	  5	  mL).	  HCl	  (0.1M)	  was	  added	  to	  the	  aqueous	  phase	  until	  pH=	  2	  and	  AcOEt	  was	  added.	  The	  organic	   layer	  was	  separated,	  and	  the	  aqueous	  layer	  was	  extracted	  with	  AcOEt	   (2	  x	  5	  mL).	  The	  collected	  organic	   layers	  were	  washed	  with	  brine	   (5	  mL),	   dried	   over	   Na2SO4	   and	   concentrated	   under	   reduce	   pressure	   to	   give	   (R)-­‐arundic	   acid	   in	   98%	  yield.	  Spectroscopical	  data	  are	  in	  according	  with	  the	  literature22	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Chapter	  5.	  Stereoselective	  α-­‐alkylation	  of	  ketone	  via	  SN1	  Type.	  	  
I. Introduction	  	  The	   asymmetric	   alkylation	   of	   ketone	   enolate	   represented	   one	   of	   the	   most	   challenging	   reactions	   in	  asymmetric	  catalysis.	  The	  use	  of	  auxiliars	  chirals	  in	  α-­‐alkylation	  of	  ketone	  was	  a	  goal	  in	  the	  synthesis	  of	  chiral	  compounds	  and	  product	  naturals.	  The	  asymmetric	  alkylation	  of	  ketone	  enolate	  represented	  one	   of	   the	   most	   challenging	   reactions	   for	   asymmetric	   catalysis.	   1Several	   groups	   have	   studied	   the	  stereoselective	  alkylation	  of	  ketone	  with	  performed	  or	  in	  situ	  generated	  metal	  enolate.2	  Organocatalysis	  has	  opened	  new	  frontiers	  in	  the	  world	  of	  organic	  chemistry.3	  New	  mode	  of	  activation	  has	  set	  up	  such	  as	  enamine	  catalysis4a,	  iminium	  catalysis4b,	  SOMO	  catalysis4c,	  hydrogen	  bonding4d	  and	  new	  reactions	  have	  been	  discovered.	  Several	  groups	  have	  studied	  the	  stereoselective	  α-­‐alkylation	  of	  aldehydes	  with	  enamine	  catalysis.5	  But	   limiting	  process	   in	  organocatalysis	  have	  studied	  the	  catalytic	  alkylation	  of	  ketone	  because	  of	  side	  reactions	  such	  as	  N,O-­‐alkylation,	  Cannizzaro	  reaction6	  or	  enolation	  reaction	   can	   take	   place	   so	   fast	   in	   acidic	   conditions	   to	   promoted	   the	   racemization	   of	   the	   product.	  Furthermore	  ketone	  again	  the	  aldehydes	  are	  less	  reactive.	  Only	  few	  strategies	  in	  organocatalysis	  have	  reported	   the	  alkylation	  of	  ketones,	  one	  of	   them	  was	   the	  asymmetric	  phase	   transfer	  catalyzed7	  other	  the	   intramolecular	  alkylation	  of	  aldehydes	  with	  alkyl	  halides	  promoted	  by	  a	  chiral	  amine	  catalyst	  by	  List	  group.8	  MacMillan	  group	  with	  SOMO	  catalysis	  introduced	  the	  direct	  stereoselective	  α-­‐allylation	  of	  ketones	  with	  allyl	  silanes.9	  	  	  















up to 81 % yield 










up to 98 % yield 






1. Cinchone derived catalyst. O'Donnell
2. Spiro aminonium salt as organocatalyst. Maruoka and co-workers
	  	  
Scheme	  1.	  Phase	  transfer	  catalysts	  	  Recently	  our	  group	  has	   reported	  a	   simple	  and	  practical	   asymmetric	  α-­‐alkylation	  of	   aldehydes	  using	  1,3-­‐benzodithiolylium	  salt	  obtaining	  high	  stereoselectivity.10	  	  In	   view	   of	   this	   approach	   for	   the	   development	   of	   α-­‐methylation	   of	   aldehydes	   using	   1,3-­‐benzodithiolylium	  salt	  was	  realized	  in	  an	  indirect	  way;	  by	  the	  use	  of	  a	  stabilized	  carbenium	  ions	  and	  by	   the	   successive	   reduction	   with	   Raney	   Ni.	   We	   were	   interested	   in	   developing	   the	   same	  straightforward	  alkylation	  of	  ketone,	  and	  we	  try	  to	  use	  similar	  reaction	  conditions	  and	  investigate	  the	  same	   reagents.	   Preliminary	   studies	   with	   1,3-­‐benzodithiolyium	   salt	   give	   unsatisfactory	   results	   with	  ketones	   using	   the	   same	   conditions	   that	  were	   used	   in	   the	  α-­‐alkylation	  with	   aldehydes.	   After	   several	  trials	  and	  attempts	  we	  discovered	  a	  major	  problem	  in	  the	  use	  of	  the	  benzodithiolylium	  tetrafluoborate	  with	  ketone.	  Traces	  of	  fluoroboric	  acid	  liberates	  during	  the	  reaction	  or	  by	  storing	  the	  carbocation	  were	  active	  in	  promoting	  the	  reaction	  with	  the	  ketone.	  The	  easy	  formation	  of	  the	  corresponding	  enol	  form	  of	   the	  ketone	  was	  responsible	   for	   the	   fast	  background	  reaction.	  The	  reaction	  was	  settled	  with	  many	  organocatalysts	  and	  in	  the	  presence	  of	  bases,	  but	  the	  reaction	  conditions	  found	  were	  not	  reproducible.	  	  Therefore,	  we	  have	  investigated	  the	  possibility	  to	  use	  other	  carbenium	  ions	  for	  the	  stereoselective	  α-­‐alkylation	   of	   ketone.	   We	   have	   prepared	   many	   formylation	   reagents	   based	   on	   different	   stabilized	  carbenium	  and	  we	  have	  tested	  them	  in	  reaction	  with	  cyclopentanone.	  	  Finally,	  we	  have	  demonstrated	  that	   3-­‐methyl	   benzothiazolium	   iodide	   was	   the	   most	   efficient	   carbenium	   ion	   providing	   the	   desired	  alkylation	  product	  in	  moderate	  yields.	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X 	  	  
Figure	  1.	  Stabilized	  carbeniums	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   140	  
II. Results	  and	  discussion	  	  











1 210 eq neat 	  	   entrya	   Base	  1eq	   Yieldb	  %	   d.rc	   ee	  %majd	   ee	  %	  mind	  1	   DABCO	   70	   3:1	   30	   0	  2	   lutidine	   70	   4:1	   21	   0	  3	   DBU	   60	   7:1	   30	   0	  4	   TEA	   75	   8:1	   36	   0	  5	   K2CO3	   60	   10:1	   21	   0	  6	   Na2CO3	   70	   10:1	   31	   0	  aAll	   the	   reaction	   were	   performed	   under	   air	   with	   1	   eq	   of	   1,	   10	   eq	   of	   ketone,	  20mol%	   L-­‐proline	   and	   1	   eq	   of	   base	   at	   r.t.	   b	   Determined	   after	   chromatographic	  purification	  c	  for	  all	  the	  reactions	  the	  d.r	  ratio	  measured	  by	  1NMR	  spectroscopy.	  d	  Determined	  by	  HPLC	  analysis.	  	  
Table	  1.	  Stereoselective	  α-­‐alkylation	  of	  ketone	  with	  L-­‐proline	  and	  different	  base	  	  According	   to	   the	   previous	   results	  was	   examined	   the	   reaction	  with	   different	   secondary	   and	   primary	  amine	   catalysts,	   and	  decrease	   the	   amount	   of	   ketone.	  The	   reaction	  was	  performing	  using	  5	   equiv.	   of	  cyclopentanone,	   1	   eq	   of	   1,	   20	   mol	   %	   of	   catalyst	   and	   1	   eq	   Na2CO3	   as	   base.	   The	   secondary	   amine	  catalysts	  afforded	  the	  product	  in	  low	  yields	  or	  without	  conversion	  into	  the	  product.	  (table	  2,	  entry	  1-­‐5).	  On	  the	  other	  hand,	  the	  use	  of	  primary	  amine	  catalyst	  derivative	  from	  cinchona	  alkaloids	  produced	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   3	   NH NH N
NN 	  	   3;	  10%	  yield,	  d.r	  4:1	  racemic	   	   4;	  10%	  yield,	  d.r	  4:1	  racemic	   	   5;	  5%	  yield,	  d.r	  3:1	  racemic	  
4	   N
H




	  	   6;	  0%	  yield	   	   7;	  15%	  yield,	  d.r	  4:1	  25%	  maj:	  0%	  min	  ee	   	   8;	  25%	  yield,	  d.r	  8:1	  95%	  maj:	  64%	  min	  ee	  All	  the	  reaction	  were	  performed	  under	  air	  with	  1	  eq	  of	  1,	  5	  eq	  of	  ketone,	  20mol%	  of	  catalyst	  and	  1	  eq	  of	  base	  at	  r.t.	  Determined	  after	  chromatographic	  purification.	  For	  all	  the	  reactions	  the	  d.r	  ratio	  measured	  by	  1NMR	  spectroscopy.	  Determined	  by	  HPLC	  analysis	  .	  
Table	  2.	  Model	  reaction	  tested	  with	  primary	  and	  secondary	  amine	  catalysts.	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toluene (0.5M)1 2X eq 	  	  entrya	   X	  eq	  ketone	   d.rb	   ee	  %c	  1	   1	   2:1	   23:00	  2	   5	   6:1	   57:00	  3	   10	   4:1	   97:63	  4	   20	   4:1	   96:18	  5	   neat	   10:1	   92:00	  aAll	  the	  reaction	  were	  performed	  under	  air	  with	  1	  eq	  of	  
1,	   X	   eq	   of	   ketone,	   20mol%	   8,	   1	   eq	   Na2CO3	   and	   0.5M	  toluene	   at	   r.t.	   b	   for	   all	   the	   reactions	   the	   d.r	   ratio	  measured	   by	   1NMR	   spectroscopy.	   c	   Determined	   by	  HPLC	  analysis.	  
	  












       X NaOHaq 0.5M
1 210eq toluene 0.5M 	  	  entrya	   eq	  of	  Base	   Yieldb	  %	   d.rc	   ee	  %	  majd	   ee%	  mind	  1	   1	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	   -­‐-­‐-­‐	  2	   0.5	   60	   8:1	   93	   56	  3	   -­‐-­‐-­‐	   30	   8:1	   97	   0	  aAll	  the	  reaction	  were	  performed	  under	  air	  with	  1	  eq	  of	  1,	  10	  eq	  of	  ketone,	  20mol%	  8	  and	  X	  eq	  of	  NaOH	  aq	  0.5M,	  at	  r.t.	   b	  Determined	  after	  chromatographic	  purification	  c	  for	  all	  the	  reactions	  the	  d.r	  ratio	  measured	  by	  1NMR	  spectroscopy.	  d	  Determined	  by	  HPLC	  analysis.	  
	  
Table	  4.	  Test	  of	  solution	  aq.	  NaOH	  0.5M	  as	  base	  	  The	   limitation	   in	   this	   reaction	   was	   the	   conversion	   that	   was	   around	   30-­‐60%	   yield.	   To	   increase	   the	  conversion,	  higher	  temperatures	  were	  applied.	  Unfortunately,	  no	  increase	  in	  conversion	  was	  observed	  and	   the	   carbocation	   seemed	   to	   degrade.	   At	   lower	   reaction	   temperatures,	   the	   conversion	   dropped	  drastically.	  Using	  polar	  solvents	  such	  as	  iPrOH,	  H2O,	  and	  MeOH	  resulted	  in	  a	  decrease	  in	  conversion.	  	  Further	   investigations	   were	   conducted	   by	   studying	   the	   behaviour	   of	   benzothiazolium	   iodide	   at	  different	  pH	  range,	  using	  different	  buffer	  solutions	  (controlled	  by	  1H	  NMR	  in	  CDCl3)	  demonstrated	  that	  the	   stability	   of	   the	   carbocation	   was	   quite	   high.	   In	   fact,	   after	   24	   hours	   stirring	   in	   an	   acid	   or	   base	  solution,	  the	  carbocation	  was	  stable	  The	  stability	  of	  carbocations	  in	  polar	  and	  apolar	  solvents	  was	  also	  controlled	  by	  NMR,	  and	  no	  degradation	  after	  24	  hours	  occurred	  by	  stirring	  in	  the	  different	  solvents.	  	  Finally	   the	   α	   alkylation	   of	   ketones	   using	   3-­‐methylbenzothiazolium	   iodide	   was	   applied	   with	   a	   large	  range	   of	   ketones,	   but	   only	   limited	   to	   unfunctionalized	   cyclic	   ketones	   gave	   the	   desired	   product	   in	  moderate	  yield	  and	  stereoselectivity.	  (table	  5,	  enrty	  1-­‐8,	  d.r.	  up	  to	  8:1,	  up	  to	  93%	  maj	  and	  56%min	  ee)	  Linear,	  functionalized	  ketones	  were	  unreactive	  in	  the	  reaction	  conditions.	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O 	  	   40%	  yield,	  d.r	  3:1	  88%maj:7%	  min	  ee	   	   20%	  yield,	  d.r	  4:1	  95%maj:	  36%	  min	  ee	   	   27%	  yield,	  d.r	  5:1	  85%maj:	  13%min	  ee	  




	   	  
	  
	   	   	   30%	  yield,	  d.r	  8:1	  87%maj	  ee	   	   	  All	  the	  reaction	  were	  performed	  under	  air	  with	  1	  eq	  of	  1,	  10	  eq	  of	  ketone,	  20mol%	  8,	  50%mol	  of	  NaOH	  aq	  0.5M	  and	  0.5M	  of	  toluene	  at	  r.t.	  The	  yield	  were	  determined	  after	  chromatographic	  purification	  	  For	  all	  the	  reactions	  the	  d.r	  ratio	  measured	  by	  1NMR	  spectroscopy.	  The	  excess	  enantiomerics	  were	  determined	  by	  HPLC	  analysis.	  	  
Table	  5	  Stereoselective	  α-­‐alkylation	  of	  cycle	  ketones	  with	  3-­‐methylbenzothiazolium	  iodide	  	  Remarkably,	   the	  possibility	   to	   remove	   the	  benzothiazoline	  group	   could	  adopt	   a	  new	  approach	   to	  α-­‐methylation	  of	  ketones.	  The	  hydrolysis	  of	  benzothiazoline	  was	  accomplished	  under	  neutral	  conditions	  using	  AgNO3	  in	  a	  solution	  of	  CH3CN-­‐phosphate	  buffer	  (pH	  =	  7,	  0.05M)-­‐	  H2O	  (15:3:5)	  at	  0	  °C.18	  In	  such	  a	  conditions	   the	  benzothiazoline	   is	   transformed	   in	   the	   corresponding	  aldehyde.	  Before	   to	   liberate	   the	  aldehyde	   the	   ketones	   was	   reduced	   to	   alcohol	   with	   NaBH4	   in	   MeOH	   at	   0°C,	   in	   order	   to	   avoid	   the	  racemization	  and	  degradation	  of	  the	  product.	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Absolute	  configuration	  	  
	  The	   major	   diastereoisomer	   was	   afforded	   the	   products	   in	   excellent	   enantiomeric	   excess,	   while	   the	  minor	   diastereoisomer	  was	   isolated	  with	   low	   or	   no	   entamieric	   exess.	   The	   diastereoselection	   of	   the	  reaction	  is	  dependant	  by	  the	  approaching	  mode	  of	  the	  cation	  to	  the	  enamine.	  However,	  is	  still	  difficult	  suggesting	  a	  preferential	  conformation	  of	  the	  enamine	  derived	  by	  Cinchona	  alkaloids.	  Thus,	  we	  have	  	  performed	  analysis	  through	  NMR	  studies.	  1H	  NMR	  analysis	  on	  the	  product	  (table	  5,	  entry	  3)	  in	  order	  to	  attribute	  the	  relative	  configuration	  of	  the	  majoritary	  diastereoisomer.	  From	  the	  multiplicity	  of	  the	  H2	   proton	   signal	   it	   was	   possible	   stablished	   the	   equatorial	   position	   of	   the	   benzothiazole	   group.	   The	  positive	  NOE	   response	   experienced	  by	   the	   four	  H3	   and	  H5	  protons,	  when	   the	  methyl	   frequency	  was	  irradiated	   confirmed	   the	   syn	   relative	   configuration	   between	   the	   methyl	   in	   γ	   position	   and	   the	  benzothiazole.	  (	  Figure	  2,	  see	  E.P	  for	  further	  details)	  	  	  
	  	  
Figure	  2.	  Observed	  NOEs	  for	  the	  analyzed	  diasteroisomer	  	  Unfortunately,	  the	  direct	  long	  range	  NOEs	  between	  the	  H2	  and	  H4	  in	  1,3-­‐diaxial	  position	  was	  not	  clear,	  due	   to	   the	  overlapping	  with	   the	  H3eq	   and	  H5eq	   signals.	  The	  analysis	  was	   less	   clear	   for	   the	   compound	  (table	  5,	  entry	  4),	  in	  which	  some	  protons	  were	  overlapping	  in	  the	  1H	  NMR	  spectra,	  due	  to	  the	  presence	  of	   the	   tertbutyl	   substituent.	   Considering	   the	   partial	   results	   obtained	   and	   that	   the	   tertbutyl	   group	   is	  more	  bulky	  compare	  to	  the	  methyl,	  we	  can	  assume	  that	  also	  for	  the	  compound	  (table	  5,	  entry	  4),	  a	  syn	  product	  was	  obtained	  where	  the	  terbutyl	  and	  benzothiazolyl	  group	  are	  both	  in	  equatorial	  position.	  For	  the	  derivatives	  (table5,	  entry	  3,	  4)	  only	  two	  of	  the	  possible	  four	  diasteroisomers	  were	  observed,	  and	  the	  more	  stable	  syn	  diequatorial	  diastereoisomer	  was	  obtained	  in	  both	  cases.19	  We	  have	  followed	  the	  reaction	  by	  sampling	  amounts	  of	  the	  crude	  reaction	  mixture	  over	  the	  time	  and	  studying	  the	  dr	  of	  the	  reaction	   by	   1H	   NMR	   and	   HPLC	   analysis.	   We	   had	   no	   evidence	   of	   diastereoisomers	   equilibration	   or	  changes	  in	  the	  dr	  over	  the	  reaction	  time.	  The	   stereochemical	   outcome	   of	   the	   reaction	   was	   probably	   determined	   by	   the	   hindrance	   of	   the	  N-­‐methylbenzothiazolium	   iodide	   in	   the	   approach	   to	   the	   primary	   enamine.	   At	   this	   time	   we	   can	   only	  suggest	  a	  speculative	  model	  for	  interpreting	  the	  result	  of	  the	  reaction	  that	  is	  represented	  in	  the	  Figure	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IV.	  Experimental	  section	  	  
Starting	  materials	  
Ketone:	   cyclopentanone,	   cyclohexanone,	   4,4-­‐dimethylcyclohexanone,	   4-­‐dimethylcyclohexanone,	   4-­‐tert-­‐buthylcyclohexanone,	   1,4-­‐cyclohexanedione	   monoethylen	   acetal,	   cycloheptanone	   are	  commercially	  availables.	  
3-­‐methylbenzothiazolium	   iodide	   salt.	   A	   flash	   with	   benzothiazole	   (1eq,	   10	   mmol)	   and	   (1.2eq,	  12mmol)	  iodomethane	  was	  stirred	  24	  hours	  at	  room	  temperature	  until	  observe	  a	  yellow	  precipitate.	  The	   yellow	   solid	   was	   collected	   by	   filtration	   and	   washed	   several	   times	   with	   ether:	   DCM	   (1:1),	   and	  finally	  dried	  in	  a	  vacuum	  obtain	  the	  compound	  3-­‐methylbenzothiazolium	  iodide	  salt	  in	  90%	  yield.	  23	  	  	  
Catalysts	  8	  used	  in	  the	  screening	  are	  commercially	  availables.	  	  
	  	  
9-­‐amino-­‐(9-­‐dioxy-­‐epi-­‐quinidine)	   (9-­‐epiQDA)	   the	   catalyst	  was	  prepared	   from	  quinidine	   according	  to	   the	   procedure	   of	   Connon’s15.	   The	   crude	   was	   purified	   by	   chromatographic	   column	   (SiO2,	  DCM:MeOH:NH3,	  9:1:1)	  to	  obtain	  9-­‐epiQDA	  as	  yellowish	  viscous	  oil.	  	  
	  
Racemic	  samples	  Direct	  reaction	  of	  lithium	  enolates	  with	  3-­‐methylbenzothiazolium	  iodide	  salt	  gave	  the	  racemic	  α-­‐alkylation	  of	  ketones.	  24	  
	  	  A	   freshly	   solution	   of	   LDA	   (1.1eq,	   0.11mmol)	   in	   anhydrous	   THF	   (0.1M)	   in	   a	   flask	   equipped	   with	   a	  magnetic	  stir	  bar	  under	  inert	  atmosphere	  was	  cooled	  at	  -­‐78°C	  for	  5minuts	  and	  ketone	  (1eq,	  0.1mmol)	  was	  added.	  The	  mixture	  was	  stirred	  for	  30	  minuts,	  then	  the	  solution	  was	  cooled	  at	  0°C	  and	  stirring	  for	  10	   minuts,	   and	   3-­‐methylbenzothiazolium	   iodide	   salt	   (1eq,	   0.1mmol,	   27.7mg)	   was	   added	   and	   the	  mixture	  was	  warmed	  at	  r.t	  and	  stirring	  until	  no	  further	  conversion	  took	  place	  (controlled	  by	  TLC).	  The	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reaction	  was	  quenched	  with	   saturated	  NH4Cl	   aq.	   solution.	  The	  organic	   layer	  was	   separated,	   and	   the	  aqueous	   layer	  was	  extracted	   twice	  with	  EtOAc.	  The	  collected	  organic	   layers	  were	  dried	  over	  Na2SO4	  and	   concentrated	   under	   reduce	   pressure	   to	   give	   an	   orange	   oil.	   The	   residue	   was	   purified	   by	   flash	  chromatography.	  	  	  
General	   procedure	   for	   the	   asymmetric	   α-­‐	   alkylation	   of	   ketone	   with	   3-­‐
methylbenzothiazolium	  iodide	  salt	  	  
	  A	  vial	   equipped	  with	  magnetic	   stir	   bar	   and	   charged	  with	  3-­‐methylbenzothiazolium	   iodide	   salt	   (1eq,	  0.1mmol,	  27.7mg),	  20	  mol%	  of	  freshly	  prepared	  chincona	  primary	  amine,	  ketone	  (10eq,	  10mmol)	  and	  0.2	  mL	  of	   anhydrous	   toluene	   (0.5M).	  Then	  a	   solution	  of	  NaOH	  aq	   (0.5M,	  100μL)	  was	  added	  and	   the	  mixture	  was	  stirred	   for	  24	  hours	  at	   room	  temperature.	  The	  reaction	  was	  quenched	  with	  water.	  The	  organic	  layer	  was	  separated,	  and	  the	  aqueous	  layer	  was	  extracted	  twice	  times	  with	  DCM.	  The	  collected	  organic	   layers	   were	   washed	   with	   brine	   (5	  mL),	   dried	   over	   Na2SO4	   and	   concentrated	   under	   reduce	  pressure.	   The	   enantioselectivity	   was	   determined	   either	   by	   chiral	   HPLC	   analysis,	   using	   the	   crude	  product.	  The	  product	  was	  purified	  by	  flash	  chromatography	  silica	  gel	  to	  give	  yield/	  conversion.	  	  	  
(S)-­‐2-­‐((R)-­‐3-­‐methyl-­‐2,3-­‐dihydrobenzo[d]thiazol-­‐2-­‐yl)cyclopentanone	  (table	  5,	  entry	  1)	  According	   at	   the	   same	   procedure.	   The	   product	   was	   purified	   by	   flash	  chromatography	  column	  (SiO2,	  cyclohexane:	  acetone=7/3)	  to	  give	  a	  yellow	  solid	  (60%	  yield,	  d.r	  8:1,	  94	  %	  maj:	  55	  %	  min	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  HPLC	  analysis	  Daciel	  Chiralcel	  IC	  column	  hexane/i-­‐PrOH	  gradient	  from	  99:1	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.5mL/min,	  35°C,	  λ	  =	  230nm,	  TM(maj)	  =	  32.2.min,	  TM(min)	  =	  40.8	  min,	  tm(maj)	  =	  27.2	  min,	  tm(min)	  =	  24.5	  min	  .	  HPLC-­‐MS	  calcul	  for	  (C13H15NOS)	  (M+H+	  234),	  (M+Na	  255)	  tMaj	  =	  9.9	  min	  
1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  6.98	  (d,	  1H,	  J	  =	  7.5Hz,	  1ArH),	  6.95	  (t,	  1H,	  J	  =	  7.6Hz,	  1ArH),	  6.63	  (t,	  1H,	  J	  =	  7.6Hz,	  1ArH),	  6.31	  (d,	  1H,	   J	  =	  7.6Hz,	  1ArH),	  5.60	  (d,	  1H,	   J	  =	  3.8Hz,	  NCHS),	  2.87-­‐2.82	  (m,	  1H,	  0=CCH),	  2.85	  (s,	  3H,	  NCH3),	  2.32	  (dd,	  1H,	   J	  =	  18.2,	  6.8Hz,	  CH2),	  2.18-­‐2.01	  (m,	  3H,	  CH2CH2),	  1.97-­‐	  1.90	  (m,	  1H,	  CH2),	   1.82-­‐1.68	   (m,	  1H,	  CH2),	   13C	   NMR	   (125	  MHz,	   CDCl3)	   δ	   218.0	   (CO),	   147.9	   (C),	   125.5	   (C);	   125.6	  (CH),	  121.2	  (CH),	  118.4	  (CH),	  106.6	  (CH),	  71.9	  (CH),	  53.5	  (CH),	  39.0	  (CH2),	  33.4	  (CH3),	  23.4	  (CH2),	  20.4	  (CH2).	  	  	  
2	  -­‐(S)-­‐	  (N-­‐methylbenzothiazolium)cyclohexanone	  (table	  5,	  entry	  2)	  According	   at	   the	   same	   procedure	   the	   product	   was	   purified	   by	   flash	  chromatography	  column	  (SiO2,	  cyclohexane:	  acetone=7/3)	  to	  give	  a	  yellow	  oil	  (54%	  yield,	  d.r	  4:1,	  89	  %	  maj:	  0	  %	  min	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  by	  HPLC	  analysis	  Daciel	  Chiralcel	  IC	  column	  hexane/i-­‐PrOH	  gradient	  from	  99:1	  to	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90:10	   in	   30	  min,	   flow	   rate	   0.5mL/min,	   40°C,	   λ	   =	   254nm,	  TM(maj)	   =	   37.1.min,	  TM(min)	   =	   39.9	  min,	  
tm(maj)	  =	  28.8	  min,	  tm(min)	  =	  25.5	  min	   .	  HPLC-­‐MS	  calcul	  for	  (C14H17NOS)	  (M+H+	  )	  248,	  tMaj	  =	  9.76	  1H	  
NMR	  (400	  MHz,	  CDCl3)	  δ	  6.97	  (d,	  1H,	  J	  =	  7.4Hz,	  1HAr),	  6.92	  (t,	  1H,	  J	  =	  7.8Hz,	  1HAr),	  6.61	  (t,	  1H,	  J	  =	  7.8Hz,	  1HAr),	  6.33	  (d,	  1H,	   J	  =	  7.8Hz,	  1HAr),	  5.55	  (d,	  1H,	   J	  =	  3.5Hz,	  NCHS),	  2.94-­‐2.88	  (m,	  1H,	  O=CCH),	  2.84	  (s,	  3H,	  NCH3),	  2.46	  (dm,	  1H,	  J	  =	  12.7Hz,	  O=CCH2),	  2.33-­‐2.25	  (m,	  1H,	  CH2),	  2.11-­‐2.00	  (m,	  2H,	  CH2),	  1.97-­‐1.89	  (m,	  2H,	  CH2),	  1.73	  -­‐1.62	  (m,	  2H,	  CH2).13C	  NMR	   (125	  MHz,	   CDCl3)	   δ	  211.2	  (CO),	  148.5	  (C),	  126.9	  (C),	  124.1	  (CH),	  120.8	  (CH),	  118.3	  (CH),	  106.9	  (CH),	  71.8	  (CH),	  54.4	  (CH),	  42.2	  (CH2),	  34.7	  (CH3),	  26.9	  (CH2),	  26.1	  (CH2),	  24.2	  (CH2).	  	  	  
(2S,4S)-­‐4-­‐methyl-­‐2-­‐((R)-­‐3-­‐methyl-­‐2,3-­‐dihydrobenzo[d]thiazol-­‐2-­‐yl)cyclohexanone	   (table	   5,	  entry	  3)	  	   Prepared	  according	  to	  the	  general	  procedure.	  The	  product	  was	  isolated	  by	  flash	  chromatography	   (SiO2,	   cyclohexane:	   acetone=7/3)	   to	   give	   a	   yellow	   oil	   (30%	  yield,	   d.r	   4:1,	   81%	   maj:	   65	   %min	   ee).	   The	   ee	   was	   determined	   directly	   with	  crude	   product	   by	   HPLC	   analysis	   Daciel	   Chiralcel	   IC	   column	   hexane/i-­‐PrOH	  90:10,	   flow	   rate	   0.5mL/min,	   35°C,	   λ	   =	   230nm,	   TM(maj)	   =	   23.6min,	   TM(min)	   =	   25.2min,	   tm(maj)	   =	  26.5min,	   tm(min)	   =	   28.8min.	  HPLC-­‐MS	   calcul	   for	   (C15H19NOS)	   (M+H+)	   261;	   tMaj	   =	   11.0	  min	   1H	   NMR	  
(400	  MHz,	   CDCl3)	  δ	  6.97	  (	  d,	  1H,	  J	  =	  7.6	  Hz,	  1ArH),	  6.93	  (t,	  1H,	  J	  =	  7.6,	  1ArH),	  6.61	  (t,1H,	  J	  =	  7.6	  Hz,	  1HAr),	  6.34	  (d,	  1H,	  J	  =7.6Hz,	  1HAr),	  5.53	  (d,	  1H,	  J	  =	  3.5	  Hz,	  NCHS),	  2.97	  (dt,	  1H,	  J	  =	  12.8,	  4.0	  Hz,	  O=CCH),	  2.82	  (s,	  3H,	  NCH3),	  2.42-­‐2.32	  (m,	  2H,	  O=CCH2CH2),	  2.04-­‐1.93	  (m,·2H,	  CH3CH,CH2),	  1.70	  (t,1H,	  J	  =	  13Hz,	  CH2),	  1.48-­‐1.35	  (m,	  2H,	  CH2),	  1.03	  (d,	  3H,	  J	  =	  6.2Hz,	  CH3CH)	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  211.3	  (CO),	  148.5	  (C),	  126.9	  (C),	  125.0	  (CH),	  120.9	  (CH),	  118.6	  (CH),	  107.1	  (CH),	  71.8	  (CH),	  53.1	  (CH),	  41.6	  (CH2),	  35.0	  (CH2),	  34.8	  (CH3),	  34.1	  (	  CH2),	  31.2	  (CH),	  21.4	  (CH3).	  	  	  	  
4-­‐tert-­‐butyl-­‐2-­‐(3-­‐methyl-­‐2,3-­‐dihydrobenzo[d]thiazol-­‐2-­‐yl)cyclohexanone	  (table	  5,	  entry	  4)	  According	   at	   the	   same	   procedure.	   The	   product	   was	   purified	   by	   flash	  chromatography	   column	   (SiO2,	   cyclohexane:	   acetone=7/3)	   to	   give	   a	   yellow	  oil.(40%	  yield,	  d.r	  3:1,	  88	  %	  maj:	  7	  %	  min	  ee)	  The	  ee	  was	  determined	  directly	  with	   crude	  product	   	   by	  HPLC	  analysis	  Daciel	   Chiralcel	   IC	   column	  hexane/i-­‐PrOH	   gradient	   from	   99:1	   to	   90:10	   in	   30	   min,	   flow	   rate	   0.5mL/min,	   35°C,	   λ	   =	   230nm,	   TM(maj)	   =	  37.2.min,	   TM(min)	   =	   34.6	   min,	   tm(maj)	   =	   28.0	   min,	   tm(min)	   =	   23.9	   min	   .	   HPLC-­‐MS	   calcul	   for	  (C18H25NOS)	   (M+H+	  304),	   (M+Na	  326)	   tMaj	   =	   15.8	  min	   1H	   NMR	   (400	  MHz,	   CDCl3)	   δ	   6.99	   (t,	   1H,	   J	   =	  7.6Hz,	  1HAr),	  6.93	  (t,	  1H,	  J	  =	  7.6Hz,	  1HAr),	  6.63	  (	  t,	  1H,	  J	  =	  7.6Hz,	  1HAr),	  6.36	  (d,	  1H,	  J	  =	  7.9Hz;	  1HAr),	  5.51	  (d,	  1H,	  J	  =	  3.6Hz,	  NCHS),	  2.94	  (ddd,	  1H,	  J=	  12.5,	  4.2,	  4.2	  Hz,	  O=CCH),	  2.81	  (s,	  3H,	  NCH3),	  2.48	  (ddd,	  1H,	  J	  =	  14.2,	  4.1,	  4.1	  Hz,	  CH),	  2.33	  (td,	  1H,	  J	  =	  14.0,	  6	  Hz,	  CH),	  2.13-­‐2.04	  (m,	  2H,CH2),	  1.73-­‐1.63	  (m,	  1H,	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CH),	  1.61-­‐1.42	  (m,	  2H,	  CH2),	  0.88	  (s,	  9H,	  CCH3).13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  211.6	  (CO),	  148.7,	  127.0,	  125.0,	  121.0,	  118.6,	  107.3,	  72.3,	  53.3,	  46.4,	  41.7,	  34.9,	  32.6,	  30.9,	  29.7,	  27.8,	  27.6,	  27.3.	  	  	  
(R)-­‐4,4-­‐dimethyl-­‐2-­‐((S)-­‐3-­‐methyl-­‐2,3-­‐dihydrobenzo[d]thiazol-­‐2-­‐yl)cyclohexanone	  (table	  5,	  entry	  5)	   Prepared	  according	  at	  the	  same	  procedure.	  The	  product	  was	  isolated	  by	  flash	  chromatography	  column	  (SiO2,	  cyclohexane:	  acetone=7/3)	  to	  give	  a	  yellow	  oil	  (20%	  yield,	  d.r	  4:1,	  95	  %	  maj:	  36	  %	  min	  ee).The	  ee	  was	  determined	  directly	  with	   crude	   product	   	   by	   HPLC	   analysis	   Daciel	   Chiralcel	   IA	   column	   hexane/i-­‐PrOH	   gradient	   from	   99:1	   to	   90:10	   in	   30	   min,	   flow	   rate	   0.5mL/min,	   35°C,	   λ	   =	   230nm,	   TM(maj)	   =	  20.9.min,	   TM(min)	   =	   19.8	   min,	   tm(maj)	   =	   15.8	   min,	   tm(min)	   =	   14.6	   min.	   .	   HPLC-­‐MS	   calcul	   for	  (C16H21NOS)	  (M	  275),	  tMaj	  =	  11.8min,	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  6.97	  (d,	  1H,	  J	  =	  7.3Hz,	  1ArH),	  6.92	  (t,	  1H,	  J	  =	  7.3Hz,	  1HAr),	  6.61	  (t,	  1H,	  J	  =	  7.3Hz,	  1HAr),	  6.32	  (d,	  1H,	  J	  =	  7.7Hz,	  1HAr),	  5.58	  (d,	  1H,	  J	  =	  3.5Hz,	  NCHS),	   3.07	   (dd,	   1H,	   J	   =	   7.6,	   3.8Hz,	   0=CCH),	   2.81	   (s,	   3H,	   NCH3),	   2.51-­‐2.42	   (m,	   1H,	   O=CCH2),	   2.33	  (ddd,1H,	  J	  =	  15,	  4.7,	  2.9	  Hz,	  O=CCHCH2),	  1.92	  (t,	  1H,	  J	  =	  13.4Hz,	  O=CHCCH2),	  1.74-­‐	  1.63	  (m,	  3H,	  CH2CH2,	  O=CCH2),	  1.21	  (s,	  3H,	  CCH3),	  1.02	  (s,	  3H,	  CCH3)	  13C	  NMR	   (125	  MHz,	   CDCl3)	   δ	  211.7	  (CO),	  148.5	  (C),	  126.8	  (C),	  125.0	  (CH),	  121.0	  (CH),	  118.3	  (CH),	  106.8	  (CH),	  71.8	  (CH),	  49.7	  (CH),	  38.9	  (CH2),	  38.3	  (CH2),	  34.4	  (CH3),	  31.5	  (CH3),	  30.2	  (CH2),	  29.6	  (C),	  24.6	  (CH3).	  	  
	  
	  
(R)-­‐7-­‐((S)-­‐3-­‐methyl-­‐2,3-­‐dihydrobenzo[d]	  thiazol-­‐2-­‐yl)-­‐1.4-­‐dioxaspiro	  [4.5]decan-­‐8-­‐one	  (table	  5,	  entry	  6)	   According	   at	   the	   same	   procedure	   the	   compound	   was	   purified	   by	   flash	  chromatography	  	  (SiO2,	  cyclohexane:	  acetone	  =	  9:1)	  to	  give	  a	  yellow	  oil	  (27%	  yield,	   d.r	   5:1,	   85%maj;	   13%min	   ee).	   The	   ee	   was	   determined	   directly	   with	  crude	   product	   by	   HPLC	   analysis	   Daciel	   Chiralcel	   IC	   column	   hexane/i-­‐PrOH	  90:10	   ,	   flow	  rate	  0.5mL/min,	  35°C,	   λ	  =	  232nm,	  TM(maj)	   =	  30.0	  min,	  TM(min)	   =	  25.3	  min,	  tm(maj)	   =	  16.5	  min,	  tm(min)	  =	  19.0	  min	   .	  HPLC-­‐MS	  calcul	   for	  (C16H19NO3S)	  (M+H+	  306),	  (M+Na	  328)	  tMaj	  =	  10.0	  min	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  6.96	  (d,	  1H,	  J	  =	  7.5Hz,	  1HAr),	  6.92	  (t,	  1H,	  J	  =	  7.5Hz,	  1HAr),	  6.60	  (t,	  1H,	  J	  =	  7.5	  Hz,	  1HAr),	  6.32	  (d,	  1H,	  J	  =	  7.8Hz,	  1HAr),	  5.59	  (d,	  1H,	  J	  =	  3.4Hz,	  SCHN),	  4.05-­‐4.02	  (m,	  2H,	  OCH2),	  4.00-­‐3.96	   (m,	  2H,	  OCH2),	  3.29	   (dt,	  1H,	   J	  =	  12.8,	  5.4Hz,	  O=CCH),	  2.83	   (s,	  3H,	  NCH3),	  2.70-­‐2.61	   (m,	  1H,	  CH2),	  2.43	  (dt,	  1H,	  J	  =	  14.9,	  4.5Hz,	  CH2),	  2.30	  (t,	  1H,	  J	  =	  13.0	  Hz,	  CH2),	  2.04-­‐1.93	  (m,	  3H,	  CH2CH).13C	  NMR	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2-­‐(3-­‐methyl-­‐2,3-­‐dihydrobenzo[d]thiazol-­‐2-­‐yl)cycloheptanone	  (table	  5,	  entry	  7)	  According	   at	   the	   same	   procedure.	   The	   compound	   was	   purified	   by	   flash	  chromatography	  	  (SiO2,	  cyclohexane:	  acetone	  =	  9:1)	  to	  give	  a	  yellow	  oil	  (	  30%	  yield,	  d.r	  8:1,	  87%maj	  ee).	  The	  ee	  was	  determined	  directly	  with	  crude	  product	  to	  reduction	  to	  alcohol	  by	  HPLC	  analysis	  Daciel	  Chiralcel	  IC	  column	  hexane/i-­‐PrOH	  gradient	  from	  99:1	  to	  90:10	  in	  30	  min,	  flow	  rate	  0.5mL/min,	  35°C,	  λ	  =	  230nm,	  TM(maj)	  =	  32.8	  min,	  TM(min)	  =	  29.2	  min.	  HPLC-­‐MS	  calcul	  for	  (C15H19NOS)	  (M+H+	  262	  )	  tMaj	  =	  10.6	  min	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  7.01	  (d,	  1H,	  J	  =	  7.8Hz),	  6.94	  (t,	  1H,	  J	  =	  7.8Hz),	  6.69	  (t,	  1H,	  J	  =	  7.4Hz),	  6.47	  (d,	  1H,	  J	  =	  8.1Hz),	  5.12	  (d,	  1H,	  J	  =	  5.5Hz);	  4.21	  (bs,	  1H),	  2.80	  (s,	  3H),	  2.03-­‐1.99	  (m,	  1H),	  1.83-­‐1.75	  (m,	  2H),	  1.71-­‐1.27	  (m,	  6H).	  	  	  	  
Absolut	  configuration	  	  
The	  absolute	  configuration	  was	  assigned	  by	  comparation	  of	  [α]	  in	  literature19	  	  
(1S,	  2R)-­‐2-­‐((S)-­‐3-­‐methyl-­‐2,3	  –dihydrobenzo[d]thiazol-­‐2-­‐yl)cyclohexanol	  (10)	  The	   residu	   of	   2	   -­‐(S)-­‐	   (N-­‐methylbenzothiazolium)cyclohexanone	   was	   diluted	   in	  MeOH	  at	  0°C	  and	  NaBH4	  (2eq)	  was	  added	  slowly.	  The	  mixture	  was	  stirred.	  After	  30	  min	   the	   reaction	  was	  worked	   up	  with	   H2O	   and	   concentrated	   in	   vacuo.	   The	  residue	   was	   extracted	   twice	   times	   with	   AcOEt,	   dried	   over	   Na2SO4	   and	  concentrated	   The	   crude	   was	   purified	   by	   flash	   chromatography	   (SiO2,	   cyclohexane/Et2O	   =	   7:3)	   to	  isolate	  the	  maj.	  diasterisomer	  (90%	  yield).	  HPLC-­‐MS	  calcul	  for	  (C14H19NOS)	  (M+H+	  250)	  tM	  =	  9.9min	  1H	  
NMR	  (400	  MHz,	  CDCl3)	  δ	  7.05	  (d,	  1H,	  J	  =	  7.5Hz,	  1HAr),	  6.96	  (t,	  1H,	  J	  =	  7.7Hz,	  1HAr),	  6.72	  (t,	  1H,	  J	  =	  7.4Hz,	  1HAr),	  6.54	  (d,	  1H,	  J	  =	  7.7Hz,	  1HAr),	  4.99	  (d,	  1H,	  J	  =	  6.2H,	  NCHS),	  4.23	  (bs,	  1H,	  CHOH),	  2.94	  (s,	  3H,	  NCH3),	  2.11	  (s,	  1H,	  OH),	  2.08-­‐	  2.01	  (m,	  1H,	  CH2CHOH),	  1.85	  -­‐1.74	  (	  m,3H,	  CHCHOH,	  CH2),	  1.68-­‐1.57	  (m,	  3H,	  CHCH2,	  CH2),	  1.54-­‐1.45	  (m,	  2H,	  CH2CHOH,	  CH2CH)	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  147.4,	  125.5,	  125.0,	  121.2,	  120.3,	  110.8,	  78.1,	  67.5,	  47.5,	  39.3,	  33.5,	  25.3,	  22.9,	  20.2.	  	  	  




in	  solution	  and	  stirring	  was	  continued	  for	  5	  minuts.	  satured	  aq	  NaCl	  solution	  was	  added	  to	  the	  reaction	  mixture	   and	   filtered	   through	   Celite.	   The	   filtrated	   was	   extracted	   with	   Et2O.	   Removal	   solvent	   afford	  almost	  pure	  but	  unstable	  aldehyde	  over	  extended	  time	  periode	  at	  r.t.	  	  
1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  9.73	  (s,	  1H,	  CHO),	  4.28	  (bs,	  1H,	  0=CCH),	  2.47-­‐2.48	  (m,	  1H,	  CHOH),	  1.84-­‐1.66	  (m,	  4H,	  CH2CH2),	  1.84-­‐1.66	  (m,	  1H,	  CH2),	  1.49-­‐1.35	  (m,	  3H,	  CH2,	  CH2)	  	  The	  crude	  product	  was	  dissolved	  in	  MeOH	  and	  1.5	  eq	  of	  NaBH4	  was	  slowly	  added	  at	  0°C.	  The	  reaction	  was	  controlled	  by	  TLC	  until	  total	  conversion	  and	  followed	  by	  aqueous	  work-­‐up.	  The	  organic	  layer	  was	  separated,	  and	   the	  aqueous	   layer	  was	  extracted	   twice	   times	  with	  EtOAc.	  The	  collected	  organic	  were	  dried	  over	  Na2SO4	   and	   concentrated	  under	   reduce	  pressure	   to	  obtain	   a	  pure	  dialcohol.	  The	  mixture	  was	   purified	   by	   flash	   chromatography	   	   (SiO2,	   cyclohexane:	   ethyl	   acetate	   =	   7:3)	   to	   give	   the	   product	  (80%	  yield)	  [α]D20	  =	  -­‐21	  (c=	  0.24	  in	  CHCl3)	  1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  4.16	  (s,	  1H,	  CHOH),	  3.76	  (bs,	  2H,	   CH2OH),	   2.17	   (s,	   2H,	   OH),	   1.82	   -­‐1.76	   (m,	   1H,	   CHCH2OH),	   1.71-­‐1.21	   (m,	   8H,	   CH2CH2CH2CH2).	   13C	  
NMR	  (125	  MHz,	  CDCl3)	  δ	  70.0	  (CHOH),	  66.4	  (CH2OH),	  42.4	  (CHCH2OH),	  33.0,	  24.9,	  23.4,	  20.4.	  	  	  
Experiment	  for	  the	  atribution	  of	  the	  relative	  stereochemistry	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Chapter	  6.	  Stereoselective	  SN1	  type	  reaction	  using	  chiral	  phosphoric	  acid	  as	  catalyst.	  	  
I. Introduction	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Figure	  1.	  Brønsted	  acids	  catalysts	  	  In	   this	  chapter	   the	  discussion	   is	   focused	   in	   the	  chiral	  Phosphoric	  acids	  and	  Super	  acids,	  which	  have	  recently	  emerged	  as	  a	  new	  class	  of	  organocatalysts2	  for	  enantioselective	  C-­‐C	  bond	  forming	  reactions.	  	  	  2.Stronger	  Brønsted	  acids	  such	  as	  chiral	  Phosphoric	  acids	  or	  BINOL	  derivatives.	  	  The	  introduction	  of	  chiral	  Brønsted	  acid	  was	  presented	  by	  Yamamoto	  and	  Ishihara8	   that	  proposed	   the	  concept	  of	  combining	  Lewis	  acid	  with	  chiral	  phenol	  increasing	  the	  H	  acidity	  from	  the	  catalyst.	  From	  this	  seminal	  work	  several	   groups	   developed	   new	   BINOL	   catalyst,	   and	   new	   reactions	   were	  performed	  using	  these	  new	  chiral	  Brønsted	  acids	  combining	  chiral	  BINOL	  catalyst	   and	   Lewis	   acids.	   Other	   generation	   of	   Brønsted	   acids	  were	   then	  introduced	   by	   using	   the	   same	   framework.	   These	   Brønsted	   acids	   are	   the	   chiral	   phosphoric	   acids	  derived	   from	   (R)-­‐BINOL.	  The	  pioneers	   in	   the	  use	  of	   this	  novel	   catalysts	   in	  organocatalysis	  were	   the	  Akiyama9	  and	  Terada	  groups10	  that	  independently	  reported	  reactions	  promoted	  by	  chiral	  phosphoric	  acids.	   They	   reported	   the	   first	   Mannich	   reaction	   using	   chiral	   phosphoric	   acids.	   Studies	   about	   the	  reaction	  mechanism	  have	  been	  carried	  out	  and	  have	  determined	  that	  chiral	  phosphoric	  acid	  acts	  as	  a	  bifunctional	  catalyst.	  The	  phosphoric	  acid	  has	  in	  fact	  a	  Brønsted	  acid	  site	  and	  Lewis-­‐	  basic	  site	  that	  are	  both	  acting	  in	  promoting	  the	  reactions.	  Moreover	  many	  of	  the	  described	  phosphoric	  acids	  are	  bearing	  3,3-­‐substituents	  on	  the	  BINOL	  framework.	  These	  substituents,	  sometimes	  very	  bulky	  are	  playing	  also	  an	  important	  role	  in	  the	  enantiodeterming	  step.11	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up to d.r 95:5














































up to 88% yield 
up to 96:4 % e.r 	  
Scheme	  2.	  Brønsted	  acid	  catalyzed	  enantioselective	  1,4-­‐addition	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  The	  product	   shows	  a	   remarkable	  exhibits	  atropisomerism	  determined	  by	   the	   rotation	  barrier	  about	  the	  bonds	  to	  the	  quaternary	  carbon	  bond.27	  By	  optimizing	  the	  reaction	  with	  different	  bistriflammides	  and	   by	   varying	   the	   temperature,	   solvent,	   catalyst	   loading,	   and	   concentration,	   the	   bis	   indole	   was	  obtained	   with	   a	   remarkable	   72%	   ee.	   In	   the	   supposed	   mechanism,	   a	   stabilized	   vinylic	   carbenium	  indolyl	   intermediate	   is	  supposed,	   that	  undergoes	  a	  SN1	  reaction	  by	   formation	  of	  a	  diastereoisomeric	  ion	  pair.	  	  The	   discrimination	   of	   the	   face	   of	   the	   chiral	   carbenium	   ion	   is	   determined	   by	   the	   hindrance	   of	   the	  flanking	  group.	  In	  the	  case	  of	  the	   	  chiral	  Brønsted	  acids,	  the	  chiral	  counter	  ion	  formed	  after	  effective	  protonation	  or	  partially	  donation	  of	  the	  proton,	  is	  surrounding	  the	  cationic	  intermediate	  created.	  One	  face	  of	  the	  intermediate	  is	  effectively	  covered	  by	  the	  chiral	  counter	  ion	  and	  the	  nucleophiles	  is	  reacting	  with	  the	  less	  covered	  face.	  	  	  My	  last	  4	  months	  my	  research	  field	  has	  developed	  in	  the	  group	  of	  Dr.	  Magnus	  Rueping,	   the	  research	  was	  focused	  on	  selective	  SN1	  type	  reaction	  that	  can	  be	  developed	  by	  using	  phosphoric	  acids.	  	  We	   supposed	   that	   the	   combination	   of	   chiral	   Brønsted	   acids	   with	  coumarine	   derivatives	  was	   able	   to	   form	   stabilized	   carbocations	   from	  the	   starting	   alcohols	   that	   can	   react	   with	   different	   nucleophiles.	   The	  idea	   that	   we	   tried	   to	   follow	   was	   to	   generate	   ionic	   intermediated	  formed	  by	  	  the	   reaction	   of	   the	   electrophile	  1	   and	   the	  phosphoric	   acid	   catalyst,	   able	   to	   control	   the	   attack	   of	   the	  nucleophile	  with	  high	  stereoselectivity.	  	  2-­‐H-­‐chromen-­‐ol-­‐derivative	   from	   coumarine	   was	   used	   as	   a	   model	   substrate	   for	   this	   reaction.	   The	  synthesis	  1	  was	  a	  simple	  reduction	  of	  the	  carbonyl	  group	  with	  DIBAL	  in	  DCM	  at	  -­‐78°C.	  Coumarine	  is	  easy	   to	   use,	   cheap,	   and	   innocuous	   benzopyran	   that	   constitute	   the	   core	   skeleton	   of	   flavonoids	  compounds.	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5 (2eq) 	  	  The	   use	   of	   aldehydes	   or	   ketones	   as	   nucleophiles	   gave	   the	   desired	   product	   but	   not	   presence	   of	  stereocontrol	  in	  the	  reaction.	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III.	  Conclusion	  The	   limitation	   in	   this	   alkylation	   reaction	   has	   been	   the	   compatibility	   between	   nucleophile	   and	  electrophile.	   The	   formation	   of	   the	   carbocation	   in	   the	   reaction	   gave	   other	   by-­‐product,	  moreover	   the	  desired	  product	  was	  performing	  with	  poor	  stereocontrol	  into	  the	  reaction.	  When	  we	  have	  performed	  the	  reaction	  with	  different	  nucleophiles	  such	  as	  enamine,	  ketone	  or	  aldehydes	  that	  can	  be	  able	  to	  be	  activated	   by	   H-­‐bond	   the	   reactivity	   between	   the	   substrate	   was	   quite	   limited	   with	   poor	   yields	   and	  enantioselectivity.	  In	  the	  future	  could	  be	  considerate	  new	  approach	  for	  this	  alkylation	  reaction	  using	  other	  electrophiles	  as	  a	  potential	  carbocations.	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